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ABSTRACT 
 
Bruce E. Mock. FUNCTIONAL AGING OF THE INNER EAR SENSORY SYSTEMS 
IN MOUSE MODELS OF AGE-RELATED HEARING LOSS (under the direction of 
Sherri M. Jones, Ph.D.) Department of Communication Sciences and Disorders; 
September 2008. 
 
 Age related structural and functional change in the cochlea have been well 
described and predisposing factors including genetic background, gender, and 
environmental factors have been identified. To date, nine genetic loci contributing to 
age related hearing loss (ARHL) have been identified and auditory function has been 
described in mouse strains carrying these mutations. The effect of these ARHL 
mutations on the other inner ear modality (vestibular) is poorly understood. The 
objective of the current study was to characterize and compare age related change in 
auditory and vestibular function (more specifically macular function) in three strains 
carrying ARHL mutations (C57BL/6J, CE/J, and NOD NON-H2nb1/LtJ) and one control 
strain with no known mutations (CBA/CaJ). Auditory brainstem response (ABR) and 
distortion product otoacoustic emissions (DPOAE) were used to assess cochlear 
function and vestibular evoked potential (VsEP) was used to assess macular function. 
The macular organs from young, mid-life, and old animals were harvested, prepared, 
and imaged using scanning electron microscopy (SEM) and a qualitative comparison of 
the number and distribution of macular otoconia was made.  
ABR and VsEP thresholds, peak latencies, and peak to peak amplitudes were 
quantified. Linear regression, student’s T-test, and ANOVA were used to describe and 
compare auditory and macular function between genders, within strain, and between 
strains. DPOAE amplitude was plotted as a function of geometric mean frequency for 
11 age groups. No statistical analysis was performed on DPOAE data. 
No significant gender difference was found for auditory or vestibular function in 
any strain so genders were pooled for further analysis. The intra-strain comparison of 
auditory and macular sensitivity reveals a significantly different rate of change in the 
two modalities in all three strains (p<0.0001). Inter-strain comparison of change in 
macular sensitivity shows that the CBA/CaJ and CE/J strains lose sensitivity at a 
significantly faster rate than the C57 strain. A comparison of SEM images from young 
and old mice revealed no apparent qualitative difference in macular otoconia that would 
explain the observed declines in macular sensitivity.  
 These results suggest 1) there are age related declines in auditory and macular 
sensitivity and aging alone affects the two inner ear sensory systems at a similar rate; 2) 
that a genetic disposition for age related functional decline in one inner ear modality 
does not obligate or predict age related decline in the other inner ear modality. Genetic 
background is an important factor in age related hearing loss and vestibular dysfunction 
and will likely play an increasingly important role in diagnosis and treatment of these 
disorders. 
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CHAPTER I: REVIEW OF THE LITERATURE  
 
Introduction 
The mammalian inner ear contains the peripheral organs for two sensory systems: 
the auditory system and the vestibular system. The organ of Corti in the cochlea 
transduces sound into neural impulses and the maculae of the vestibule and the cristae of 
the semicircular canals transduce linear and angular motion of the head, respectively. 
Deficits in these sensory systems or their neural connections can lead to hearing 
impairment and/or balance disorders. Age related hearing loss (ARHL), also known as 
presbycusis, is the most common type of hearing impairment in humans affecting 50% of 
the population by age 80 (Gorlin, Toriello, & Cohen, 1995; Morton, 1991). Factors such 
as disease, ototoxic drugs, genetic background, noise exposure, and even gender may 
influence ARHL. ARHL is a progressive disorder, so as the average age of the population 
increases the prevalence of ARHL also increases. Due to changing demographics in the 
U.S., it is estimated that by 2050, 20.7% of the population will be 75 or older 
(http://www.census.gov). ARHL is one of the most common chronic health problems in 
the elderly and is considered a major public health issue due to its adverse effects on 
quality of life and the economic costs that result from this communication disorder. A 
1999 study by the National Council on Aging 
(http://www.ncoa.org/attachments/UntreatedHearingLossReport.pdf ) reported that those 
with untreated hearing loss were more likely to report depression, anxiety, and paranoia 
and were less likely to participate in organized social activities. Decreases in auditory 
sensitivity with aging have been widely investigated and explained by structural and 
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physiological changes in the outer, middle, inner ear and central pathways (e.g. 
Schuknecht, et al., 1974; Wiley, Cruickshanks, Nondahl, & Tweed, 1999; Ingham, 
Thornton, & Withington, 1998). While many studies have examined the prevalence (50% 
of the population by age 80 (Gorlin, et al., 1995)) and impact of presbycusis on society 
(e.g., decreased potential earnings, increased social isolation, cost of treatment) (Mulrow, 
Aguilar, & Endicott, 1990; Lutman, 1990; Hinchcliffe, 1990; Stach, Spretnjak, & Jerger, 
1990; Gates & Cooper, 1991, Mohr, et al., 2000, Strawbridge, et al., 2000) relatively little 
has been done to investigate the effects of vestibular dysfunction on society or public 
health. Studies by the National Institute on Deafness and other Communication Disorders 
estimated that 3.4% of the U.S. adult population (6.2 million people) suffers from chronic 
dizziness and/or imbalance (Hoffman & Sklare, 2003). It is estimated that as many as 7 
million people per year seek care for disequilibrium and/or vertigo and that 30% of the 
population experiences episodes of dizziness before age 65 (Roydhouse, 1974). The 
increased probability of falls and injury in the elderly has become accepted as a fact of 
life. In 1992, the 75 and older age group, while comprising only 5.2% of the population 
accounted for 58.8 % of deaths due to falling (National Safety Council, 1992).  
A Short Primer on Cochlear Anatomy & Physiology 
 There are several sources that describe general cochlear function (see Jahn & 
Santos-Sacchi, 2001). The cochlea is the sensory organ for audition and the organ of 
Corti within the cochlea houses the sensory cells for hearing. The cochlea is a spiral 
shaped organ, divided into three partitions: the scala vestibuli, the scala media, and the 
scala tympani, with an average of two and three quarter turns around a finely perforated 
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portion of the temporal bone. A bony ridge, the spiral lamina, extends out from the 
central portion of the cochlea and provides structural support for the organ of Corti. 
Within the spiral lamina a tube shaped cavity, known as the modiolus, houses the cell 
bodies of the axons of the auditory nerve.  This collection of neural cell bodies forms a 
helical shape that parallels the scala of the cochlea and is known as the spiral ganglion 
(SG). The scala media is separated from the scala vestibuli and the scala tympani by 
Reisner’s membrane and the basilar membrane, respectively. The scala tympani and scala 
vestibuli are filled with a fluid called perilymph and the scala media is filled with a fluid 
called endolymph. The endolymph of the scala media has a resting potential of about +80 
mV, known as the endolymphatic potential (EP). This positive charge is a result of 
potassium ions (K+) being pumped into the endolymph by the stria vascularis (Pickles, 
1988), a structure located on the lateral wall of the cochlear duct. The positive charge of 
the endolymph, in conjunction with the negative intracellular potential of the hair cells 
(approximately -70mV), results in a large electrical gradient, which contributes to 
sensory transduction by the inner hair cells. Pathologies of the stria vascularis, often in 
the form of reduced blood supply and atrophy have been shown to play a role in ARHL 
in humans and animals (Gratton, Schmiedt, & Schulte, 1996; Gratton & Schulte, 1995: 
Wu & Marcus, 2003).  
 Sound energy in the medium of air is transferred into mechanical energy by the 
tympanic membrane and bones (ossicles) of the middle ear. This mechanical energy is 
introduced to the cochlea when the stapes, the most medial of the ossicles, moves in and 
out of the oval window of the cochlea and creates a pressure wave in the fluids of the 
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cochlea and a traveling wave along the basilar membrane. The traveling wave progresses 
from the basal region of the cochlea towards the apical region of the cochlea.  
There are two types of hair cells present in the organ of Corti, inner hair cells 
(IHC) and outer hair cells (OHC). The inner hair cells are supported by the border cells of 
the inner sulcus and the outer hair cells are supported by Deiter’s cells. The pillar cells 
provide support for the IHC and OHC on their medial aspect. The upper portions of the 
hair cells are embedded in a cellular matrix known as the reticular lamina, through which 
stereocilia project into the endolymph. OHC stereocilia are embedded in the tectorial 
membrane while those of the IHC approach the tectorial membrane but are not believed 
to have mechanical attachment like the OHCs. There is one row of IHC, stretching from 
cochlear base to apex, numbering approximately 3500. Innervation to the IHC consists of 
primarily type I afferent fibers, which are large, myelinated fibers and each hair cell 
receives many of these fibers. This “many to one” connection is known as convergence. 
The IHCs are stimulated when their stereocilia are moved or sheared by the traveling 
wave. The IHCs convert the mechanical energy of the traveling wave into an 
electrochemical impulse that is transmitted as an action potential by the eighth cranial 
nerve to the brainstem and ultimately to the cortex where perception occurs. The organ of 
Corti also contains an average of 12000 OHCs, each cell topped by approximately 150 
stereocilia aligned in a “v” or “w” shaped pattern. There are three rows of outer hair cells, 
broadening to four in the apical region. Innervation of the OHCs is comprised of SG that 
contain primarily efferent fibers and each OHC shares innervation with many other 
OHCs. This “one to many” type of innervation is known as divergence. The efferent 
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fibers have been shown to play a role in inhibiting or modulating afferent output (Bonfils, 
Remond, & Pujol, 1986). The outer hair cells and their stereocilia have been shown to 
contain motor proteins (prestin in particular) that produce muscle like contractions. 
Significant evidence exists to suggest that the OHC are motile, changing in length and 
stiffness with stimulation (Zheng, Madison, Oliver, Fakler, & Dallos, 2002; Zenner, 
1986; Santos-Sacchi & Dilger, 1988). This motility influences the mechanical coupling 
of the basilar and tectorial membranes and the manner in which inner hair cells shearing 
occurs. The complex interaction among the OHC, IHC, basilar membrane and tectorial 
membrane is known as cochlear micromechanics. It is believed that the motility of the 
OHC serves as an amplifier for basilar membrane motion and fine tunes the traveling 
wave passing through the cochlear partition. This “cochlear amplifier” is a primary 
contributor to the exceptional frequency resolution and sensitivity of the “normal” 
cochlea (Ryan, Dallos, & McGee, 1979).  
 The cochlea, the auditory nerve, brainstem relays, and cortex are tonotopically 
organized, meaning that each frequency corresponds to a specific anatomical location. In 
the cochlea, basal regions are most sensitive to high frequencies with a progression to 
low frequencies in the apical regions. The cochlea is innervated by cranial nerve VIII, the 
vestibulocochlear nerve, which also innervates the vestibular organs.   
A Short Primer on Vestibular Anatomy & Physiology 
 The vestibular labyrinth of the inner ear is comprised of a membranous labyrinth 
enclosed within the osseous labyrinth. The membranous labyrinth is filled with 
endolymph and the space between the membranous and osseous labyrinth is filled with 
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perilymph. Within the vestibular labyrinth there are five sensory organs: the macular 
organs (utricle and saccule) and three semicircular canals (SCC) (posterior, superior, and 
horizontal). These five vestibular end organs are responsible for the detection and sensory 
transduction of gravitational forces, linear, and angular accelerations.  
 The utricle and saccule are elliptical sacs located in the posterior portion of the 
vestibule and contain the sensory neuroepithelium for the transduction of gravitational 
forces and linear accelerations. The macular organs contain hair cells (types I and II) and 
their stereociliary bundles are embedded in a gelatinous layer (statoconial membrane) 
containing calcium carbonate crystals (otoconia). The otoconia impart density to the 
statoconial membrane that is greater than that of the endolymph. As a result of the high 
density of the otoconia, the gelatinous layer moves in response to gravity or linear 
acceleration. When the head is tilted or linear accelerations act on the head, the weight of 
the gelatinous membrane results in movement of the gelatinous layer relative to the 
sensory epithelium. In linear accelerations, the gelatinous layer lags behind head 
movement due to inertia. This movement causes a shearing motion of the stereociliary 
bundles and generates an excitatory (depolarizing) or inhibitory (hyperpolarizing) 
response in the hair cells depending on the direction of shearing. Vestibular stereociliary 
bundles are comprised of one kinocilium and multiple stereocilia, all of which protrude 
from the apical surface of the hair cell. Shearing motion of the stereociliary bundle 
toward the kinocilium results in a depolarization of the hair cells and creation of an 
excitatory action potential in afferent neurons. Movement of the stereociliary bundle 
away from the kinocilium results in hyperpolarization of hair cells and inhibits firing of 
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their corresponding neurons. The saccule is oriented in a predominantly vertical position, 
while the sensory area of the utricle is predominately horizontal in orientation. The 
sensory areas of the utricle and saccule both contain a distinctive curved central zone 
known as the striola. The stereociliary bundles on the two sides of the striola are oriented 
so that their kinocilia point in opposite directions. The result of this complex spatial 
orientation is that displacement of the gelatinous membrane in one direction results in 
excitation in one portion of the hair cells and inhibitory response in another portion. 
Furthermore, due to the curvature of the striola, hair cells are oriented at different angles 
making the end organ sensitive to and capable of encoding movement in a variety of 
directions. When the head is in the upright, neutral position, utricular and saccular hair 
cells are most sensitive to movement in the horizontal and vertical planes, respectively.  
 The three SCC, posterior, anterior, and horizontal, are membranous ducts housed 
within the enclosed channels of the osseous labyrinth. When the head is in a neutral 
upright position, the anterior and posterior canals are oriented vertically at approximately 
45º angles to each other and the horizontal canal is oriented horizontally at approximately 
30º above the horizontal plane. Contained within the ampulla of each semicircular canal 
is a neuroepithilial area known as the crista ampullaris which contains hair cells with 
stereocilia/kinocilia that are sensitive to angular accelerations of the head. The crista 
ampullaris is coupled to a gelatinous membrane, known as the cupula, which projects into 
the endolymph and spans the ampulla. The cupula is deflected by movement of the 
endolymph within the canal in response to angular movements of the head. The 
stereociliary bundles within each crista are oriented such that the kinocilia face the same 
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direction. In the anterior and posterior canals, kinocilia are oriented toward the canal side 
of the ampulla. This is in contrast to the horizontal canal in which the kinocilia are 
oriented toward the utricle. In the anterior and posterior canals, movement of endolymph 
away from the utricle results in depolarization of the hair cells and increases neural firing 
while movement towards the utricle results in hyperpolarization and decreased neural 
firing. In the horizontal canal, movement of endolymph towards the utricle results in 
depolarization and increased neural firing while movement away from the utricle results 
in hyperpolarization and decreased neural firing. The multi-plane orientation of the SCC 
is the basis for the directional sensitivity of the SCC system. 
 In summary, the peripheral vestibular organs consist of two macular organs 
(utricle and saccule) and three semicircular canal organs (posterior, anterior, and 
horizontal). The macular organs are responsible for sensory transduction of gravitational 
forces and linear acceleration. The SCC are responsible for sensory transduction of 
angular acceleration. The five organs contain type I and II hair cells and their 
corresponding stereocilia and kinocilia, which are stimulated by the mechanical 
movement of overlying membranes (the cupula of the SCC and statoconial membrane of 
the macula) in response to head movement. 
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Background 
Auditory Structural Change with Aging  
 Structural changes in the aging auditory system have been studied in depth and 
changes have been identified in all parts of the auditory system from the outer ear to the 
cortex. In the outer and middle ear, alterations include: decreased elasticity and 
increased pinna size, changes in ear canal epithelium resulting in flaccidity of canal 
walls, excess cerumen accumulation (Ballachanda, 1995), thickening of the tympanic 
membrane (Etholm & Belal, 1974) and arthritic alterations in the ossicular chain 
(Rosenwasser, 1964). Small age related changes in middle ear tympanic membrane 
velocity are reported in mice (Rosowski, Brinsko, Tempel, and Kujawa, 2003). 
  In the inner ear, the cochlea is most susceptible to age related structural change. 
Studies examining the pathology of age related changes in the cochlea have utilized 
human as well as animal models of presbycusis. Cochlear pathologies associated with 
ARHL include: reduction in the number and integrity of sensory cells (IHC & OHC) 
(Willott, Parham, & Hunter, 1991; Willott, Chisholm, & Lister, 2001; Mizuta, Nozawa, 
Morita, & Hoshino, 1993; Spongr, Flood, Frisina, & Salvi, 1997; Francis, Ryugo, 
Golelikow, Prosen, & May, 2003; Li & Hulcrantz, 1994; Felder & Schrott-Fischer, 
1995), damaged OHC stereocilia (Li & Hulcrantz, 1994), reduction in the number and 
integrity of neurons innervating the organ of Corti (Felder & Schrott-Fischer, 1995; 
Ohlemiller & Gagnon, 2004;Willott & Erway, 1998; Felix, 2002; Otte, Schunknecht, & 
Kerr, 1978;  Johnsson & Hawkins, 1972), ruptures of the reticular lamina (Li & 
Hulcrantz, 1994), development of giant IHC cilia (Li & Hulcrantz, 1994, Johnsson, 
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Felix, Gleeson, & Pollak, 1990), elevation of the head of pillar cells (Li & Hulcrantz, 
1994), accumulation of lipofuscin in the OHC (Schuknecht & Gacek, 1993; Li & 
Hulcrantz, 1994; Ishii, 1977), collapse of the organ of Corti and replacement by a single 
epithelial layer (Bartolomé, del López, Carricondo, Poch-Broto, & Gil-Loyzaga, 2002; 
Li & Hulcrantz, 1994; Schuknecht & Gacek, 1993), changes in vascular supply (Gratton 
& Schulte, 1995;  Brown, Miller, & Nuttall, 1995; Nakashima, Miller, & Nuttall, 1995) 
reduced efficiency of metabolic processes (Saitoh et al., 1995; Spicer & Schulte, 2005; 
Brown et al., 1995; Hequembourg & Liberman, 2001), and increased thickness of the 
basilar membrane (Nadol, 1979; Hequembourg & Liberman, 2001). Typically, the most 
basal and apical regions of the cochlea are affected first with pathology progressing to 
include more central portions of the cochlea.  
 Schuknecht and Gacek (1993) classified age-related pathologic changes in the 
cochlea into four forms of presbycusis: 1) sensory - involving the loss of IHC and OHC 
in the organ of Corti, sterociliary bundles, and their supporting structures; 2) neural - 
involving the neural fibers innervating the cochlea (focus has primarily been on afferent 
innervation); 3) vascular or metabolic - involving blood supply to the cochlea and 
maintenance of endolymphatic homeostasis and cochlear potentials; and 4) structural or 
mechanical - involving the spiral ligament and structural integrity of the organ or Corti.  
Sensory Presbycusis 
Sensory presbycusis is characterized by pathologic changes affecting the hair cells 
in the organ of Corti. Damaged or missing hair cells are a common finding in both animal 
models of presbycusis and in human temporal bone studies. Morphological studies of 
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human temporal bones from subjects diagnosed with presbycusis have reported reduced 
hair cell counts that vary by location in the cochlea. OHCs are reduced in number more 
than IHCs and the basal and apical regions show a greater loss of both types of hair cells 
compared to more central regions (Wright, Davis, Bredberg, Ulehlova, & Spencer, 1987). 
Felder and Schrott-Fischer (1995) reported an approximately 80% reduction of OHC in 
the apical portions of the cochlea when compared to normal hearing middle-aged 
persons, and very little change in the number of IHCs. Wright et al., (1987) reported 
similar findings of exacerbated loss of OHCs in apical and basal regions but also found 
deceases in IHC densities. The reduction in IHCs was less than that of the OHC and was 
accentuated in the basal regions of the cochlea. Animal studies investigating age related 
changes in cochlear hair cells have varied in their findings depending on the species and 
genetic strain examined.  
The inner ear anatomy of the C57BL/6 strain has been studied extensively 
because it is a widely accepted model for precocious presbycusis. This mouse strain 
develops a progressive, sensorineural hearing loss reaching profound levels with onset 
occurring in the high frequencies as early as three  to six months of age (Henry & 
McGinn, 1991, Henry, 2004). Quantitative measures of hair cell loss in this strain have 
described the time course and extent of hair cell loss over the entire lifespan. Spongr et al. 
(1997) examined temporal bones from mice ranging from 1 to 26 months of age. At one 
month of age only a few OHCs were missing at the extreme basal and apical regions. By 
three months of age there was an 88% loss of OHCs and 55% loss of IHCs at the base of 
the cochlea.  Measures at eight months of age revealed a loss of 100% of OHCs in basal 
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regions and 87% loss of IHCs in basal regions. The loss of sensory hair cells in the 
cochlea is a primary morphological change that contributes to ARHL. 
Neural Presbycusis 
  Neural presbycusis has typically been investigated by measuring the density of 
SG that innervate the cochlea. Numerous studies have shown that a loss of SG is one of 
the defining characteristics of presbycusis (Schuknecht et al., 1974; Johnsson & Hawkins, 
1972; Willott, et al., 2001; Willott, et al., 1991). The loss of SG has been shown to vary 
as a function of location within the cochlea. Post mortem microscopic study of humans 
diagnosed with presbycusis reveals a pattern of progressive neural degeneration. Otte et 
al. (1978) counted neurons in 100 subjects spanning nine decades of life and reported a 
range from 37,000 neurons at the end of the first decade of life to 18,000 neurons in the 
ninth decade. This amounts to an average loss of around 2,100 neurons per decade. The 
literature suggests that the loss of nerve fibers occurs throughout the cochlea and that 
reduction in neurons is typically more severe in the basal regions compared to the rest of 
the cochlea (Johnsson et al., 1990). Ohlemiller and Gagnon (2004) reported a strong 
correlation between abnormalities in pillar cells and Reissner’s membrane and neuronal 
loss in four strains of mice. This finding indicates that neural presbycusis may be 
proceeded by or concomitant with changes in non-sensory structures. In addition, 
Ohlemiller and Gagnon (2004) described an apical to basal progression for pathology of 
non-sensory structures which is in contrast to most reports of age related cochlear change 
(i.e. basal to apical progression). Spongr et al. (1997) for example, describes a 
pronounced base to apex gradient of SG in the C57BL/6J strain of mice, which 
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progresses to a severe loss by 30 months of age. Felix et al. (1990) performed 
quantitative analysis of primary afferents at three locations in the inner ear: the osseous 
spiral lamina, the modiolus, and the internal auditory canal. In young individuals they 
found that the primary afferents are almost identical at the three sites yet in normal 
hearing individuals over 60 years of age they found that the loss of peripheral nerve 
processes in the spiral lamina was consistently more severe than the loss in more central 
locations (i.e. internal acoustic meatus). This suggests that dendrites of primary afferents 
degenerate at a faster rate than axons projecting to the brainstem.  
Metabolic Presbycusis 
Reduced blood supply to the cochlea, and more specifically to the stria vascularis, 
is widely reported in histological studies of age related cochlear change (Gratton et al., 
1996; Schmiedt, 1996; Wu & Marcus, 2003; Gratton & Schulte, 1995; Saitoh et al., 
1995). The stria vascularis, with it’s dense layer of blood vessels and specialized cells, 
provides metabolic energy to the cochlea and is the primary source of potassium 
recycling required to maintain the endolymphatic potential (Bosher & Warren, 1971). 
Historically the spiral ligament was thought to simply provide mechanical support for the 
organ of Corti as a suspension point for the basilar membrane on the lateral wall of the 
cochlea. Spicer and Schulte (1991), in a detailed study of spiral ligament 
cytoarchitecture, classified four types of fibrocytes (types I - IV) and characterized the 
ion transport properties of these structures. This work uncovered a network of cell 
membrane transporters and gap junctions among cell groups within the spiral ligament 
and surrounding structures, principally the stria vascularis. This suggests that the spiral 
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ligament likely plays an important role in potassium recycling between the organ of Corti 
and stria vascularis (Spicer & Schulte, 1996). Studies of the EP and the cochlear 
structures responsible for the ion pumping necessary to maintain the EP (Gratton & 
Schulte, 1995; Gratton, et al., 1996; Gratton & Schulte, 2003; Hequembourg & 
Liberman, 2001; Lang, Schulte, & Schmiedt, 2003; Ohlemiller, Lett & Gagnon, 2006) 
have identified degenerative changes in the stria vascularis and spiral ligament. 
Hequembourg and Liberman (2001) found “significant and widespread degeneration in 
the spiral ligament in the aging C57BL/6 mouse” and proposed that a widespread 
degeneration of fibrocytes of the spiral ligament precedes the loss of hair cells and 
afferent neurons. Pauler, Schuknecht, and White (1988) using human subjects, compared 
histology of the stria vascularis with behavioral pure-tone thresholds and showed a direct 
correlation between cell losses of the stria vascularis and hearing loss. Gratton and 
Schulte (1995) examined age-related changes in the stria vascularis and its 
microvasculature and found a progressive degeneration of capillaries, beginning at the 
extreme base and apex of the cochlea and progressing towards middle regions with age. 
Kusunoki et al., (2004) examined human temporal bones ranging from 1 day of age to 86 
years of age and found a significant loss of stria vascularis area in the basal turns of the 
cochlea in the elderly group versus infants. Wright and Schuknecht (1972) studied 
temporal bones of human ears with known high frequency hearing loss and found severe 
spiral ligament atrophy, manifested as a patchy loss of fibrocytes. Interestingly, they also 
found patchy loss of spiral ligament fibrocytes in ears with no reported hearing loss.  
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There is abundant evidence that age-related degenerative changes occur in the 
stria vascularis and spiral ligament; however the results concerning the EP itself 
(measured in situ in animal models) are mixed. The EP is inherently difficult to measure 
and varies by measurement site, species, and genetic strain and their findings concerning 
the EP itself vary depending on the animal model and genetic strain utilized. Gerbils and 
BALB/cJ mice show a reduced EP as a function of age (Gratton et al., 1996) while the 
C57 and CBA/CaJ mouse strains do not (Lang, et al., 2002; Ohlemiller, et al., 2006; Wu 
& Marcus, 2003).   
In summary, there is strong evidence from animal models and humans temporal 
bone studies that degeneration of the stria vascularis and spiral lamina occur as a result of 
aging. These structural changes would suggest decreased potassium recycling and a 
reduction in the EP leading to ARHL. In vivo, measurement of the EP is currently only 
possible in animal models. These studies show mixed age-related change in the EP results 
(see below). The role of stria vascularis/spiral ligament degeneration and reductions in 
the EP in ARHL have not been definitively determined. 
Mechanical Presbycusis 
Schuknecht and others (Covell & Rogers, 1957; Nomura, 1970; Nadol, 1979) 
have suggested that stiffening of the basilar membrane and resulting change in the 
resonant characteristics of the cochlea could explain a fourth type of presbycusis deemed 
mechanical presbycusis.  This hypothesis is based on findings of animal and human 
temporal bone studies that have identified increased basilar membrane thickness with age 
in the basal region of the cochlea. Nadol (1979) examined a limited number of human 
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temporal bones and found a “marked” thickening of the basilar membrane. Ishii, 
Murofushi, and Takeuchi (1994) performed light and electron microscopy of the temporal 
bones of aged rats and reported a reduced number of collagen fibers and a thickening of 
the basilar membrane at the base due to an increase in a homogeneous ground substance. 
Bhatt, Liberman, and Nadol (2001) quantified age related changes in the basilar 
membrane and correlated the finding with audiometric patterns. They measured basilar 
membrane thickness in four regions of the cochlea in normal subjects and those with 
hearing loss. While finding age related thickening of the basilar membrane in both 
groups, they found no significant increase in basilar membrane thickness between 
controls and those with hearing loss. They concluded that while basilar membrane 
thickening could conceivably contribute to ARHL, the most affected areas of the cochlea 
correspond to frequencies higher than those typically tested audiometrically (i.e. >8000 
Hz). The existing evidence suggests that there are pathologic changes in the basilar 
membrane but the role such changes play in ARHL remains speculative. 
Auditory Functional Change with Aging 
Age-related functional changes in the auditory system are influenced by 
individual differences in terms of noise exposure, exposure to ototoxins, ear disease 
(e.g., see review by Gratton & Vazquez, 2003), the central auditory system (Willott, et 
al., 2001), lifestyle (diet, exercise, etc.) (Willott et al., 2001) and genetic make up 
(Johnson, Erway, Cook, Willott, & Zheng, 1997; Li, 1992; Fransen, Lemkens, Laer, & 
Van Camp, 2003). These are potential confounding variables to studies which attempt 
to investigate the effect of age on auditory structures and function. These factors, along 
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with the inherent genetic variability of humans, make the genetic study of age-related 
hearing loss in humans especially problematic. These factors are difficult to control for 
in aging studies in humans, so while there is a wealth of research describing ARHL in 
humans, it is difficult to separate hearing loss due to age alone and hearing loss due to 
environmental, genetic, or environmental and genetic interactions. It is for this reason, 
that much of the literature is focused on describing functional changes measured 
behaviorally and using physiological measures in animal models of ARHL. The review 
that follows will discuss behavioral measurement of hearing sensitivity, physiological 
tests that indicate cochlear function, and reports in the literature of age related change in 
these measures in humans and animal models.  
Longitudinal studies in humans, using pure tone audiometry (the gold standard 
measurement of auditory sensitivity) to characterize ARHL, report a progressive decline 
in auditory sensitivity beginning as early as age 30. The loss of auditory sensitivity 
typically begins in the high frequencies and progresses to lower frequencies with age 
(Pearson et al., 1995). Behavioral measures indicate that the rate of decline in hearing 
sensitivity is age and frequency dependent with rates of 3 dB per decade reported for 
those under 55 years of age and 9 dB per decade reported for those over 55 years of age 
(Davis, Ostri, & Parving, 1991). Objective measures of peripheral auditory status; ABR, 
DPOAE, and electrocochleography (ECochG), indicate that the primary site of lesion 
for presbycusis is the cochlea. 
  
 18
Auditory Brainstem Response (ABR) 
ABR is an electrophysiological measure which can be measured in humans as 
well as animals, and provides an objective indication of auditory peripheral sensitivity, 
allows differentiation between cochlear and retro-cochlear pathology, and assesses the 
neurological integrity of the auditory pathway in the brainstem. The ABR response is 
evoked with the presentation of transient stimuli such as tone bursts/pips or clicks, and is 
measured at some distance from the neural generators with electrodes placed on the scalp 
(known as a far field response). Filtering, amplification, and signal averaging techniques 
are used to resolve the response from internal and external sources of electrical noise. 
The normal human response consists of a waveform with five to seven peaks occurring 
around 1 to 7 milliseconds (ms) following stimulus presentation. Mouse ABR waveforms 
generally show 4 to 6 peaks (see Figure 1). 
The ABR represents the depolarization of cochlear hair cells, synchronous firing 
of neurons in the auditory portion of cranial nerve VIII and auditory relays of the 
brainstem. In the elderly, prolonged absolute peak latencies and reduced response 
amplitude are reported when compared to young normal subjects (Rosenhall, Bjorkman, 
Pederson, & Kall, 1985; Boettcher, 2002). The effect of aging on ABR interpeak 
latencies is disputed in the literature. Numerous studies indicate that inter-peak latencies 
are unaffected by age (Beagley & Sheldrake, 1978; Harkins, 1981; Costa, Benna, Bianco, 
Ferrero, & Bergamasco, 1990). While others suggest that aging results in increased 
interpeak latencies (Oku & Hasegawa, 1997; Rosenhall et al., 1985). Studies 
investigating the effect of age on ABR amplitudes are in agreement that ABR amplitudes  
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Figure 1.  Representative ABR waveforms for one mouse.  Stimuli used to obtain these 
waveforms were 16 kHz tone bursts presented in decreasing stimulus intensity (12 dB 
steps).  P1, P2, P3, N1, N2, and N3 peaks are labeled. Threshold for this intensity series 
was designated as 45.3 dB pe SPL. 
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decrease with age, even in individuals who show no loss of sensitivity on behavioral 
measures or when loss of auditory sensitivity is accounted for (Sand, 1991; Psatta & 
Matei, 1988; Oku & Hasegewa, 1997; Jerger & Hall, 1980; Boettcher, Mills, Norton, & 
Schmiedt, 1993; Beagley & Sheldrake, 1978; Harkins, 1981; Costa et al., 1990). Wave I 
amplitude is typically affected more by aging than wave V amplitude (Costa et al., 1990; 
Psatta & Matei, 1988; Sand, 1990). Boettcher et al. (1993) reported that as ABR 
thresholds increased in gerbils, ABR peak to peak amplitudes decrease. In summary, 
ABR amplitudes are reduced with decreases in auditory sensitivity but have also been 
shown to decrease independently of age related changes in auditory sensitivity. 
The latency of an auditory evoked potential is defined as the amount of time that 
passes from the onset of the stimulus to occurrence of each response peak. The latency of 
auditory evoked potentials is influenced by characteristics of the stimulus, the integrity of 
the cochlea, cranial nerve VIII, and auditory brainstem structures. The ABR response 
consists of 5 to 7 peaks with each peak corresponding to an anatomic location where the 
response is generated. More medial or rostral generators produce longer latency 
responses. The ABR response originates in the primary afferents of the cochlea, 
progresses to cranial nerve VIII, travels through the auditory relays of the brainstem and 
ultimately to the auditory cortex. The generation of ABR peaks, especially in more 
central structures, likely arises from multiple sites. Peak 1 is generated by the peripheral 
portion of cranial nerve VIII (Wada & Starr, 1983; Anchor & Starr, 1980; Hashimoto, 
Ishiyama, Yoshimoto, & Nemoto, 1981). Peak 2 is likely generated in the central or 
intercranial portion of cranial nerve VIII (Hashimoto, et al., 1981; Pratt et al., 1992; 
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Moller & Jannetta, 1982). Peak 3 is believed to originate in the cochlear nucleus (Moller 
& Jannetta, 1982). The generator for peak 4 is believed to be the superior olivary 
complex (SOC) (Moller & Jannetta, 1982; Moller, Jho, Yokoto & Janetta, 1994). Peak 5 
is likely generated in neural tracts of the SOC and lateral lemniscus (Hashimoto et al., 
1981; Moller & Janetta, 1982).  
Interpeak latencies are a measure of neural conduction time. The latency of ABR 
peaks are influenced by the rate of onset and spectral characteristics of the stimulus. The 
ABR response is primarily an onset response (Suzuki & Horiuchi, 1981). The basilar 
membrane is tonotopically organized with basal portions most sensitive to high 
frequencies and a progression to apical portions which are most sensitive to low 
frequencies. As a result of the tonotopic organization of the cochlea, the latency for high 
frequency stimuli is shorter than that for low frequency stimuli. Latency of ABR peaks is 
influenced not only by the point of maximal displacement on the basilar membrane but 
also by the EP and synchrony of firing of the population of neurons that innervate the 
area being stimulated.  
A threshold is defined as the point that must be exceeded to begin producing a 
given effect or result or to elicit a response. Threshold is by definition a measure of 
sensitivity. Age-related hearing loss is characterized by a loss of sensitivity beginning 
with the high frequencies and progressing with age to affect lower frequencies. This loss 
of sensitivity is reflected in ABR measures by increased thresholds beginning in the high 
frequencies progressing to lower frequencies with increased age. In humans, ABR peak 5 
is the most robust and is typically the last detectable peak as intensity goes to sub-
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threshold levels (Worthington & Peters, 1980). In this author’s experience, mouse peaks 
P1 and P2 are typically the most robust and are the last detectable peaks before sub-
threshold levels are reached.  
Otoacoustic Emissions (OAE) 
Kemp (1978) was the first to describe acoustic events measured in the external 
auditory meatus (EAM) which occur spontaneously and in response to acoustic stimuli 
presented to the EAM. These evoked acoustic responses have become known as 
otoacoustic emissions (OAE) and are a valuable clinic tool for assessment of cochlear 
function and more specifically outer hair cell (OHC) function. Animal models were a 
valuable tool in investigating the source of OAEs and provided strong evidence that 
OAEs are critically dependent on OHC function (Whitehead, Lonsbury-Martin, & 
Martin, 1992, Horner, Lenoir, & Bock, 1985; Schrott, Puel, Rebillard, 1991).  
OAEs can be divided into two broad categories: spontaneous and evoked. 
Spontaneous emissions are measured in the EAM in the absence of an evoking stimulus. 
Spontaneous emissions are measurable in normal ears and pathological ears, although to 
a lesser degree, making them of little use clinically.  
Evoked emissions are measured using acoustic stimuli and the two most 
commonly used OAEs in clinical settings are transient (TEOAE) and distortion product 
evoked emissions (DPOAE). DPOAEs occur following the introduction of two distinct 
acoustic signals (primary frequencies known as f1 and f2). The non-linear properties of 
the cochlear amplifier (OHC) result in a third distinct acoustic signal measurable in the 
EAM. DPOAEs occur at many frequencies but research has shown that the most robust 
  
 23
DPOAE response in humans occurs at the cubic difference tone (2f1-f2) when the ratio of 
the frequencies of the primaries is 1.2 (f2/f1 = 1.2). Due to the robustness of the 2f1-f2 
emission, it is the most commonly utilized response both clinically and in research.  
The amplitude of the DPOAE response is dependent on stimulus parameters such 
as frequency spacing and amplitude as well as properties of and the status of the EAM, 
the tympanic membrane, the middle ear ossicles, and cochlear function, as well as the 
level of the primaries. DPOAE response amplitude (in dB SPL) is generally plotted as a 
function of geometric mean frequency and is plotted along with the noise floor. The noise 
floor is generally measured by averaging sound pressure levels in two to three noise bins 
on either side of the 2f1-f2 frequency. If the sound pressure measured at 2f1-f2 is more 
intense (by some predetermined criteria usually 3 to 6 dB SPL) than the average sound 
pressure level in the surrounding bins, then that is considered a DPOAE response. The 
resulting plot of DPOAE amplitude and noise floor is known as a DP Gram (see Figure 
2). Kemp (1986) reported the presence of the evoked acoustic response in all normal ears 
tested and the absence of the response in ears with cochlear deafness. OAEs are typically 
present in ears with normal pure tone sensitivity and mild hearing loss and generally 
absent in ears with peripheral hearing loss greater than 50 dB HL (Gorga et al., 1997). 
Aging studies utilizing distortion product otoacoustic emissions (DPOAE) have shown 
significant interaction between age, frequency, and threshold. As age and frequency 
increase, DPOAE amplitude decreases (Dorn et al., 1998). However, when hearing loss is 
controlled for, there is no direct effect of age on DPOAE amplitude (Dorn et al., 1998;  
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Figure 2.  DPOAEs for one mouse.  The left panel depicts the Fast Fourier Transform 
(FFT) for one frequency pair (f1 and f2 primaries) and the 2f1-f2 response.  The DPOAE 
at 2f1-f2 is clearly visible.  The right panel shows the DP Gram (DPOAE amplitude as a 
function of geometric mean frequency) for this same mouse.  The solid line represents the 
noise floor amplitude (i.e., amplitude of frequency bins surrounding the 2f1-f2 frequency 
bin) and points represent DPOAE amplitude as a function of geometric mean frequency.
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Strouse, Ochs, & Hall, 1996; Oeken, Lenk, & Bootz, 2000). Jimenez et al. (1999) 
measured DPOAEs in the CBA/CaJ, a strain with no known genetic mutations, to the age 
of 15 months in order to assess the effect of age alone on DPOAE threshold and 
amplitude. They reported robust and unchanged DPOAEs for all test frequencies through 
the oldest ages. Parham, Sun, & Kim (1999) measured DPOAEs to 25 months of age in 
the CBA/JNia strain, a related strain with no known genetic mutation. They found small,  
frequency dependent, age related changes in DPOAE amplitude and threshold levels at 
the advanced age of 17 months, and moderate changes at the very advanced age of 25  
months. These results are in agreement with ABR findings (a slow progressive loss of 
auditory sensitivity beginning at advanced age) for this strain and confirm cochlear 
pathology as the origin of hearing loss. 
DPOAE measures in the C57BL/6J mouse strain (a strain widely accepted as a 
precocious model for presbycusis) have revealed age and frequency dependent changes in 
DPOAE threshold and amplitude (Jimenez et al., 1999; Martin et al., 2007; Parham, 
1997). Parham (1997) reported increased DPOAE threshold levels and reduced response 
amplitudes, effecting higher frequencies first and progressing to include lower 
frequencies, with changes beginning between 2 and 8 months of age. Jimenez, Stagner, & 
Martin (1999) tested the C57 strain up to 15 months of age, at monthly intervals, and 
showed similar results; DPOAE amplitude decreased and threshold increased in an age 
and frequency dependent manner. Jiminez et al. (1999) tested at monthly intervals which 
allowed a more detailed assessment of the onset of cochlear functional change. Their 
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results show age related reduction in DPOAE amplitudes after 2 months of age, 
beginning in the high frequencies and progressing with age to affect all frequencies.  
DPOAE provide an objective measure of OHC function and provide important 
information concerning the site of lesion for age related pathology. In summary, the 
literature on mouse models of ARHL supports the idea that age related changes in 
DPOAE threshold and amplitude are strain and frequency specific and that OHC 
pathology is one component of ARHL. 
Gender Differences in Age Related Hearing Loss 
Gender differences in auditory function, including ARHL, are reported in animal 
models as well as humans and include reports that young women generally have better 
hearing than young men (Corso, 1963; Rosen, Plester, & El-Mofty, 1964; Northern, 
Downs, Rudmose, Glorig, & Fletcher, 1972; Surjan, 1973), ARHL progresses faster in 
men than women (Corso, 1963; Pederson, Rosenhall, & Moller, 1989; Wallhagen, 
Strawbridge, Cohen, & Kaplan, 1997; McFadden & Pasanen, 1998) and that female mice 
lose hearing earlier than males in mouse models of early onset ARHL (C57 strain) 
(Henry, 2004). 
 Some researchers have hypothesized that the female hormone estrogen may 
inhibit ARHL. Kilicdag et al. (2004) measured auditory sensitivity in postmenopausal 
women using estrogen therapy, hormone replacement therapy (a mixture of estrogen and 
progesterone), and a control group receiving no therapy. Their results show that the 
estrogen therapy group had better hearing at all frequencies than the hormone 
replacement group and the control group and concluded that estrogen therapy may slow 
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the rate of ARHL. Guimaraes et al., (2006) conducted a similar study that compared pure 
tone sensitivity, DPOAE, TEOAE, and hearing in noise in post menopausal women 
treated with estrogen and progestin, estrogen alone, and a third non-hormone replacement 
therapy control group. Their results show poorer auditory function for all measures in the 
group treated with estrogen and progestin. These results suggest that progestin may 
negate any protective effect that estrogen may have on ARHL. A study by Stenberg, 
Wang, Sahlin, & Hulcrantz (1999) revealed widespread immunostaining of the estrogen 
receptors ERα and ERβ in cochlear structures in CBA mice. Estrogen is known to have 
widespread effects on physiology and this finding suggests that it may have a direct 
influence on cochlear structures. A study by Hulcrantz, Stenberg, Fransson, & Canlon 
(2000) using a mutant mouse, X,O “Turner mouse” which produces no estrogen, further 
supports the idea of estrogen influence on cochlear structure and function. They found a 
loss of OHC, primary afferent pathology, increased ABR thresholds, and decreased 
DPOAE amplitudes relative to controls. The idea that estrogen may provide a protective 
effect for cochlear structures is further bolstered by the results of Guimaraes et al. (2004). 
Using both ABR and DPOAE, they found differences in auditory sensory function pre 
and post menopause in female CBA mice. Females had lower ABR thresholds and larger 
amplitude DPOAEs than males at middle and old ages but much of this advantage was 
lost following menopause. The role of female hormones on inner ear structure and 
function is poorly understood but there is growing evidence suggesting that female 
hormones may have a protective effect against ARHL.  
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 In summary, gender differences in auditory sensitivity are apparent throughout the 
lifespan. Gender differences in ARHL are reported in humans and animal models and 
research suggests that the female hormone estrogen may inhibit ARHL. More work is 
needed to understand the complex role of hormones in relation to ARHL. 
Genetics and Age Related Hearing Loss (ARHL) 
The association between inheritance and hearing loss has a long history but 
investigations of the epidemiology of hearing loss did not begin until the 19th century 
(Nance & Pandya, 2002). Hearing loss is one of the most common genetic disorders 
found in humans (Keats & Berlin, 2002) and genetic studies have identified a large and 
ever growing number of genes that contribute to both syndromic and non-syndromic 
hearing loss. These studies have revealed the heterogeneous nature of hearing loss and 
there is an increasing body of evidence concerning the additive and interactive effects of 
multiple genes upon auditory structures and function. The study of the genetic basis for 
hearing loss is potentially confounded by environmental causes (exposure to ototoxins, 
noise, and viral infection) and is difficult to study in humans due to heterogeneity of 
human genetics. Mice have been an invaluable tool in the attempt to control for 
environmental factors and genetic heterogeneity. Mice can be kept in a controlled 
environment, reproduce rapidly and in large numbers, and can be selectively bred which 
allows for the reduction of genetic heterogeneity.  
Genetic studies of ARHL have illustrated the complex nature of ARHL 
inheritance. Throughout this discussion, ARHL will be used to signify the behavioral or 
physiological findings of a loss of auditory sensitivity (phenotype) and Ahl will be used 
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to designate genes or loci related to ARHL (genotype). To date seven mutations that 
contribute to ARHL have been identified. Johnson, Erway, Cook, Willott, & Zheng 
(1997) were the first to identify a specific gene (Ahl) that results in ARHL in mice. Ahl 
is a recessive, point mutation on the Cadherin 23 gene (Cdh23) located on Chromosome 
10 in the C57BL/6J strain. The Ahl mutation is a single substitution at nucleotide 753 
(A/G) on the Cdh23 gene. This mutation occurs in approximately 80% of inbred strains 
with hearing loss (Drayton & Noben-Trauth, 2006) and is referred to as Cdh23753A 
(Noben-Trauth, Zheng, & Johnson, 2003). Cdh23 is a gene that encodes cadherin, a 
protein necessary for inner ear development and maintenance of sensory cell structures 
such as stereociliary tip links (Siemens et al., 2004; Sollner et al., 2004) and transient 
lateral links between stereocilia (Michel et al., 2005; Lagziel et al., 2005). Mutations in 
Cdh23 are associated with syndromic (Usher syndrome type 1D) and non-syndromic 
hearing loss (DFNB12) and have been shown to result in deafness and vestibular 
disorders in humans and mice (Bolz et al., 2001, Jones et al., 2004, 2005). Cochlear and 
vestibular cytoarchitectural abnormalities in strains that carry the Ahl mutation include: 
loss of IHC and OHC, loss of SG, degeneration of fibrocytes in the spiral ligament, 
disorganized stereociliary bundles, misplaced kinocilia, and disruption of stereociliary 
tip links (Di Palma, et al., 2001; Alagramam et al., 2001; Holme & Steel, 2002; 
Raphael, Kobayashi, & Dootz, 2001; Shiga et al., 2005).  
Johnson and Zheng mapped a second mutation, called Ahl2, to chromosome 5 
using backcross and linkage analysis in the NOD/LtJ strain. Johnson and Zheng 
concluded that the contribution of Ahl2 to hearing loss is dependent on a predisposing Ahl 
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genotype and that the interaction between Ahl and Ahl2 results in an earlier onset hearing 
loss than for Ahl alone. More studies are needed concerning Ahl2 but the existing 
research suggests that Ahl2 interacts with Ahl and accelerates the onset of hearing loss 
(Johnson & Zheng, 2002).  
 A third ARHL locus has been identified and designated Ahl3. Nemoto et al. 
(2004) identified and mapped Ahl3 to chromosome 17. They showed that when the Ahl3 
gene is present along with Ahl, there is a protective effect and that hearing sensitivity is 
preserved until late in life. In contrast to Ahl and Ahl2, it appears that Ahl3 does not result 
in age-related hearing loss but functions to inhibit age-related hearing loss.  
Zheng, Ding, Yu, Salvi, & Johnson, (2007) identified and mapped a fourth ARHL 
locus, designated Ahl4, on Chromosome 10 of the A/J inbred mouse strain. The A/J strain 
harbors the Cdh23ahl (Ahl) mutation that is present in numerous strains and results in 
ARHL. The onset of hearing loss in the A/J strain is much earlier than other strains that 
carry Ahl alone. A/J mice show reduced cochlear sensitivity at very young ages 
(following weaning) and by 3 months of age have severe hearing loss at all frequencies. 
While information for ages as young as immediately following weaning is not available 
for the NOD NON strain, which carries Ahl and Ahl2, this strain also shows a severe to 
profound hearing loss by 3 months age. Zheng et al.’s genetic analysis of a backcross 
strain provides a compelling argument that Ahl4 contributes to the accelerated onset of 
hearing loss in the A/J strain. Scanning electron microscopy images of macular otoconia 
in the A/J strain taken in our laboratory show abnormal otoconia and poor macular 
sensitivity by mid-age in this strain (Jones et al., 2006). 
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Dreyton and Noben-Trauth (2006) investigated the genetic basis of hearing loss in 
the non-inbred strain Black Swiss and identified two loci (Ahl5 and Ahl6) that contribute 
to hearing loss in this strain. Ahl5 and Ahl6 were localized to chromosome 10 and 18, 
respectively. Black Swiss mice demonstrate an early onset hearing loss which begins in 
the high frequencies and eventually reaches profound levels at all frequencies. 
The most recent ARHL locus to be identified is Ahl8 (Ahl7 is reserved) in the 
DBA/2J strain (Johnson, Zheng, & Noben-Trauth, 2006). The specifics of Ahl8 have not 
been published beyond the fact that it results in accelerated hearing loss and is located on 
the distal portion of Chromosome 11. 
In summary, there are seven known loci related to ARHL and one gene has been 
identified. These seven loci have different auditory phenotypes. The Ahl mutation, in the 
absence of other ARHL mutations, results in an early to mid-life onset, progressive 
hearing loss that begins in the high frequencies. The Ahl2 and Ahl4 mutations accelerate 
ARHL when present in conjunction with Ahl. The Ahl3 mutation inhibits ARHL when 
present along with Ahl. Ahl5 and Ahl6 have been identified in non-inbred strains and 
result in early onset hearing loss. The Ahl8 locus is present on Chromosome 11 and 
accelerates ARHL in the DBA/2J strain. 
Vestibular Structural Change with Aging  
 Morphological changes in the vestibular epithelium due to aging have been 
investigated in humans and in several animal species. These studies have identified 
structural changes in the sensory epithelium of the macular organs and the semi-circular 
canal (SCC) organs but findings are mixed depending on the species utilized. Rauch, 
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Velazquez-Villaseñor, Dimitri, & Merchant (2001) performed a study on a large sample 
(n = 67) of human temporal bones using interference contrast microscopy in order to 
establish normative data for type I and II hair cells as a function of age. The results 
showed a continuous decrease in both cell types from birth to 100 years of age. Type I 
hair cell densities for the crista decreased at a faster rate than type I hair cells densities of 
the macular organs. Type II hair cells counts decreased at a similar rate for the five 
sensory organs. The findings of Gopen, Lopez, Ishiyama, Baloh, & Ishiyama (2003), 
using an unbiased stereology technique to count type I and II hair cells of the utricle, 
conflict with the results of Rauch et al, (2001). Gopen et al. found no age effect on total 
hair cell counts in the utricle but the authors conceded that a broader age range than that 
used (42-96 years) may be needed to establish an age effect. Shiga et al. (2005) 
performed hair cell counts on the horizontal SCC in C57BL/6J mice (ages 3 to 60 weeks) 
and found that hair cell densities decreased by an average of 30% in the oldest animals. 
Similar studies of hair cell counts have been performed in gerbils, rats, and mice and 
findings differ based on the species and genetic strain used. Kevetter, Zimmerman, & 
Leonard (2005) found no age effect on hair cell counts in the crista ampullaris of 
Mongolian gerbils. Nakayama, Helfert, Konrad, & Caspary (1994) performed an 
ultrastructural study of the vestibular epithelium of Fischer 44 rats and found a significant 
loss of hair cells, as well as a reduction in the number and integrity of stereocilia and 
kinocilia in the crista ampullaris. Interestingly, these age-related pathological changes 
were not seen in the macular organs. Park, Hubel, and Woods (1987) measured hair cell 
densities of vestibular epithelia in C57BL/6NNia mice. They reported age related hair 
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cell pathology and decreased hair cell counts in the five vestibular organs. In addition to 
reduced hair cell counts, other age related pathological changes in vestibular epithelia are 
reported in the literature. These changes include cytoplasmic protrusions/ herniations 
(Gleeson, Felix, & Johnsson, 1990; Bloom & Hultcrantz, 1994), disarranged and fused 
stereocilia (Rosenhall & Ruben, 1975: Bloom & Hultcrantz, 1994), the presence of giant 
cilia (Nakayama et al., 1994; Rosenhall & Ruben, 1975; Bloom & Hultcrantz, 1994), the 
accumulation of lipofuscin (a melanin like substance which is a by product of metabolic 
processes and considered a wear-and-tear pigment) in sensory and supporting cells 
(Rosenhall & Ruben, 1975; Anniko, 1983; Park et al., 1987; Gleeson et al., 1990), 
membrane bound inclusions of sensory cells (Park et al., 1987; Gleeson et al., 1990; 
Anniko, 1983), neural degeneration (Gleeson et al., 1990, Rauch et al., 2001), reduced 
blood flow to the utricle (Lyon & Davis, 2001), reduced number of globular substances 
(which are secreted precursors to mature otoconia) (Suzuki, Ikeda, & Takasaka et al., 
1997), age related degeneration of otoconia (Campos, Canizares, Sanchez-Quevedo, & 
Romero, 1990), and increased fragility and disintegration of the cuticular plate (Anniko, 
1983; Bloom & Hultcrantz, 1994). Reports of widespread structural changes in vestibular 
organs support the notion that vestibular function should decline as a result of age. 
Vestibular Functional Changes with Aging  
Balance is a complex process that involves input from and integration of multiple 
sensory and motor systems. Sensory input is necessary for monitoring of body position in 
relation to gravity and surroundings. The visual, somatosensory, and vestibular systems 
provide this sensory input. Vestibular end organs make an important contribution to 
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balance and their structural degeneration and reduced function due to aging is likely an 
important factor in the increased incidence of falls in the elderly. Compensation by the 
central nervous system and other sensory systems may conceal peripheral vestibular 
dysfunction leading to many undiagnosed cases of vestibular disorders.  
Studies that have utilized functional measures to assess vestibular aging have 
typically relied on the vestibuloocular reflex (VOR), optokinetic response (OKN), 
vestibular evoked myogenic potentials (VEMP), otolith-ocular responses and tests of 
posture to make inferences about vestibular function. These measures can all be classified 
as indirect measures of vestibular function because they rely on sensory input (postural 
measures rely on input from three separate sensory systems), integration of output to the 
central nervous system, and motor output.  As a result, they do not readily allow for the 
separation of central and peripheral influences on the motor output and the status of 
vestibular end organs must be inferred from the observed motor response. In studies of 
the VOR and OKN in the elderly, Paige (1992,1994) and Baloh, Jacobson, & Socotch 
(1993) reported decreases in VOR gain (a ratio of eye velocity to head velocity), 
increased  VOR phase lead, decreased ability to suppress the VOR with vision, and lower 
OKN slow-phase velocity saturation. Studies of the effect of age on VEMP describe age 
related decreases in amplitude (Basta, Todt, & Ernst, 2007; Brantberg, Granath, & Schart, 
2007; Su, Huang, Young, & Cheng, 2004, Ochi & Ohashi, 2003), increased threshold 
(Ochi & Ohashi, 2003), and increased latency (Brantberg et al., 2007; Su et al., 2004). 
Furman and Redfern (2001) demonstrated age effects on two otolith related measures.  
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1) The otolith-ocular response, assessed with off vertical axis rotation (OVAR), 
demonstrated increased modulation and reduced bias with age, suggesting increased 
fluctuations in slow component eye velocity produced by OVAR. 2) The SCC-otolith 
interaction measure demonstrated that elderly subjects showed reduced ability to shorten 
VOR time constants with post rotary head tilt. Furman and Redfern (2001) suggested that 
these two findings are similar to those seen in subjects with vestibulo-cerebellum 
dysfunction who also display reduced central inhibition on these measures. They argue 
that the age related changes observed were due to degeneration of central structures 
responsible for processing of gravity receptor information rather than degeneration of 
peripheral vestibular function. Tests of postural control, utilizing computerized dynamic 
posturography (CDP), have demonstrated postural instability in the elderly as a result of 
increased muscle response latency (Goebel, 2001; Baloh, Spain, Socotch, Jacobson, & 
Bell, 1995; Borah, et al., 2007). Decreases in postural control may be due to deterioration 
of peripheral or central mechanisms.  
In summary, the measures historically used to assess peripheral vestibular 
function (VOR, OKN, VEMP, otolith-ocular reflex, CDP) reflect sensory input, 
integration in the central nervous system and motor output to the eyes and postural 
muscles. As a result, these measures are indirect measures of inner ear vestibular function 
and functional changes due to peripheral or central mechanisms may not be readily 
distinguishable. It is well known that visual acuity, somatosensory, and central nervous 
system regions degenerate with increasing age. Baloh et al. (1993) and Paige (1992) have 
suggested that age-related degeneration of oculomotor and vestibuloocular central 
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nervous system pathways are responsible for the age related declines reported for indirect 
vestibular measures.  
 Research by Shiga et al., (2005) highlights the fact that central mechanisms may 
compensate for peripheral deficits. They found an age dependent progressive decrease in 
the number of sensory cells of the lateral semicircular canal in C57 mice yet no 
functional decline was seen in VOR gain. The decrease in the number of peripheral 
sensory cells without concomitant reduction in VOR gain strongly suggests central 
compensation for degeneration of peripheral structures. While there are no direct 
measures available to assess human inner ear vestibular function, non-invasive direct 
measures of macular organ function are possible in animal models. 
 Short latency vestibular evoked potentials (VsEP) are compound action potentials 
generated by the vestibular nerve and vestibular brainstem relays (Nazareth & Jones, 
1998; Jones & Jones, 1999) in response to linear or angular acceleration. The VsEP in 
response to linear acceleration consists of a series of positive and negative peaks 
occurring within 10 ms of stimulus onset. Far field VsEPs are recorded at the scalp and 
have been shown to be critically dependent on the utricle and saccule (Jones & Pederson, 
1989; Jones, Erway, Bergstrom, Schimenti, & Jones, 1999). The VsEP response is 
resistant to intense acoustic masking and extirpation of the cochlea but is abolished 
following bilateral labyrinth-thectomy, toxic insult to the macular sensory cells, and 
pharmacological blockage of labyrinth. Peaks PI and NI are generated by the peripheral 
portion of the vestibular branch of cranial nerve eight and later peaks correspond to more 
medial generation sites in the vestibular brainstem relays and cerebellum (Nazareth & 
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Jones, 1998; Jones & Jones, 1999). VsEP intensity functions are characterized by 
increasing amplitudes and decreasing latency as stimulus intensity increases. The 
dynamic range for VsEP in mice is relatively limited (generally less than 40 dB re: 1 
g/ms) when compared to auditory dynamic range (generally in excess of 70 dB pe SPL).  
VsEP measures provide an objective direct measure of gravity receptor sensitivity, the 
number and synchrony of firing of vestibular primary afferents, and the relative amount 
of time required for: 1) sensory transduction of linear accelerations 2) transmission across 
the first synapse, 3) neural conduction time through the vestibular nerve and brainstem 
relays. VsEP measures of peripheral vestibular function in animal models suggest 
decreased sensitivity of the gravity receptor organs and potential changes in neural timing 
and conduction velocity of primary afferents with age (Jones et al., 2006). 
 A Comparison of Auditory and Vestibular Aging in Humans and Animal Models  
  There are many advantages to the use of mouse models. The biology of the 
mouse is the most studied of any mammal commonly used in auditory research (Henry &  
McGinn, 1992). Mice are relatively inexpensive to acquire and maintain. Use of animal 
models permits greater control of environmental and genetic factors that are not easily 
controlled in humans. The mouse has a long history as a model for human hearing and 
balance disorders (e.g. Yerkes, 1907; Lord & Gates, 1929; Lyon, 1953; Steel, 1995; Petit, 
Levilliers, & Hardelin, 2001; Ahituv & Avraham, 2002) and the genetics for many strains 
are well characterized. Standardization makes the same strain available to many 
researchers. The use of mice for auditory research has lead to numerous mouse models of 
syndromic and nonsyndromic hearing loss in humans and facilitated the study of genetic 
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and environmental causes of hearing loss, including ARHL. Changes in auditory and 
vestibular function can be measured over the whole lifespan due to the relatively short 
life of the mouse species (2 to 3 years). Tissue samples are immediately available to 
investigate the anatomical basis for functional change. Mice were chosen specifically for 
the proposed research because 1) they are mammals; 2) they have vestibular organs 
similar to humans; 3) they are the species specifically identified by the National Institute 
of Health for characterizing nervous system function; 4) data concerning morphology of 
the vestibular system in several genetic mutants are available; 5) several mouse strains 
have been identified as the genetic models for humans diseases and disorders, including 
inner ear disorders; 6) genetic studies can be conducted readily with mice; 7) genome 
data are readily available for the mouse; 8) only living organisms have vestibular 
systems.  At the present time, there is insufficient knowledge about normal and abnormal 
vestibular ontogeny to create inanimate models. 
 The peripheral auditory system of man and mammalian animal models (guinea 
pig, rat, cat, monkey, and mice) although similar, are not identical. Small anatomical 
differences exist. These difference may include but are not limited to: the length and 
width of the basilar membrane, the number of IHC and OHC, the length of stereocilia of 
both types of hair cells, the innervation pattern and number of afferent and efferent nerve 
terminals to each hair cell type, the degree of branching of efferent fibers and number of 
synapses per afferent nerve terminal, the presence or absence of pre-synaptic bodies, the 
number of spiral ganglion cells and cochlear nerve fibers, the percentage of myelinated 
SG and variability in the presence of synapses on SG (Felix, 2002; Nadol, 1988).  The 
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dynamic range for frequency selectivity of mice is larger than that measured in man (5 to 
80 kHz and 20 Hz to 20 kHz for mice and man respectively). However, the anatomy and 
physiology of the inner ear of mice and other mammalian models are representative of 
the form and function of the human inner ear. The advantages offered by the use of 
murine models mouse model far outweighed the disadvantages of anatomical and 
function differences. We chose to study vestibular function in murine models of ARHL 
based on these advantages. 
How might aging of auditory and vestibular function compare?  We are aware of 
only two studies that compared age related functional change in the two sensory systems 
simultaneously.  Enrietto, Jacobson, and Baloh (1999) measured hearing and VOR in a 
longitudinal study of human subjects.  They showed that hearing declined about 1 dB per 
year, VOR gain decreased an average of 0.05 per year (for high velocity stimuli), and 
phase lead (for high velocity stimuli) increased an average of 2.3 deg/sec per year over 
the five-year study.  They concluded that the age-related changes in hearing were not 
correlated with the age-related changes in the VOR and suggest that the vestibular and 
auditory systems in humans may not age at the same rate. However, the researchers 
acknowledged that the differences in auditory and vestibular functional aging might have 
been due to both peripheral and central mechanisms, not the periphery alone. Shiga et al. 
(2005) examined age related changes in auditory and vestibular morphology and function 
in C57BL/6J mice using VOR gain as a measure of vestibular function and ABR as a 
measure of cochlear function. Histology was performed to examine the anatomical 
correlates of cochlear and vestibular function. Histology showed sensory degeneration of 
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the cochlea with a corresponding decrease in auditory sensitivity. A decrease in lateral 
semicircular canal hair cell density, beginning between 12 and 24 weeks of age was 
reported. At 24 weeks of age, hair cells counts were reduced by 80%, compared to those 
measured at 3 weeks, but no corresponding decrease in VOR gain was observed.  Based 
on these findings, the investigators suggested that the mechanisms for vestibular 
functional changes differ from those for the cochlea.  However, they acknowledged the 
use of an indirect measure of vestibular function and the possibility that central plasticity 
may have compensated for the observed peripheral deficit.  
The direct measurement of vestibular function is currently limited to VsEP in 
animals (Figure 3). Research using direct measures of inner ear sensory function: 
otoacoustic emissions (OAE), auditory brainstem response (ABR), and vestibular evoked 
potentials (VsEP) in mice has shown differences in auditory and vestibular function 
between various mutant strains, suggesting an important genetic influence on functional  
aging (Jimenez et al., 1999; Johnson et al., 2000; Jones et al., 2006). Jones et al. (2006) 
measured auditory and vestibular function in inbred mouse strains and the results showed 
some interesting trends.  Some strains (e.g., BUB/BnJ, NOD/LtJ, A/J) showed severe 
hearing loss and severe vestibular impairment at the ages tested.  Other strains (e.g., 
DBA/2J, A/WySnJ, NOD.NONH2kb, A/HeJ) had severe vestibular impairment with 
relatively little change in hearing at the ages tested. Three strains (MRL/MpJ, Ce/J, 
SJL/J) had significant vestibular loss with no concomitant hearing loss (at least to 32  
kHz).  These results demonstrate that genetic background plays a role in age-related 
changes in the two sensory systems and that functional change in one sensory system  
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Figure 3.  Linear VsEPs are shown for five different mice as a function of age.  
Responses are resolved first at ages 8 to 10 days after birth.  PI, PII, NI, and NII peaks 
are labeled. Amplitudes increase and latencies become shorter during maturation.  Age 
related change in waveform morphology are apparent at advanced age (>2 years).
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does not obligate change in the other. Inferences concerning age related functional 
change in these strains are limited by the small numbers of animals used (4 or less) and 
the fact that measurements of auditory and vestibular function were not made in the same 
animal.  
 In summary, much is known about structural and functional change in the 
auditory system with aging but little is known about age-related changes in the vestibular 
system. Furthermore, even less is known about the relationship between aging of the two 
modalities. 
A Short Statement about the Nature of the Problem 
What little is known about age-related changes in the peripheral vestibular system 
is based primarily on structural changes and indirect measures of vestibular function. The 
effects of age, gender, and genetic background as related to vestibular functional aging 
are not known. Genetic background is known to predispose one to disease or disorder, 
including ARHL (Johnson et al., 1997). Comparison of auditory and vestibular functional 
changes due to aging, using indirect measures, has suggested that functional changes in 
the two sensory systems may occur independently. In reality, we are poorly informed 
about functional aging of the vestibular periphery.  
Research Questions 
1) Are there changes in macular function due to age alone? 
If so, is the time course the same as for auditory change? 
2) Are there qualitative changes in macular otoconia that may explain functional 
change? 
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3)  Do Ahl strains show age related changes in macular function? 
If so, are there qualitative changes in macular otoconia that may explain 
functional change? 
4) If change is found in macular function in Ahl strains, how do these changes 
compare to those seen in auditory function? 
5) Are age related changes in vestibular and auditory function different between 
males and females? 
The proposed research tested the following hypotheses: 
1) Functional changes in the macular organs, due to age alone, are concurrent 
with age related functional changes in the cochlea. 
2) Mouse strains, which harbor Ahl genetic mutations, will show age related 
change in macular function concurrent with ARHL. 
3) Change in macular and cochlear function, due to age alone, is the same for 
males and females. 
How were these hypotheses tested?  
We used VsEP measures to assess macular function and ABR and DPOAE 
measures to assess auditory function. Scanning electron microscopy (SEM) was used to 
assess macular otoconia. Auditory and vestibular function were tested in CBA/CaJ (age 
alone model) and C57BL/6J, CE/J, and NOD.NON-H2nb1/LtJ (three Ahl strains) mice 
from 1.1 to 23.8 months of age. Temporal bones were dissected at the end of the 
functional experiments, fixed and processed for SEM imaging. SEM images were taken 
for representative samples of the macular organs from the young, middle aged and old 
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animals from each strain. This was done in an attempt to characterize any age related 
changes in the number and/or distribution of macular otoconia. ABR and VsEP response 
thresholds, latencies, and amplitudes were quantified and plotted as a function of age. 
ABR and VsEP thresholds were normalized in order to compare function between 
modalities. Linear regression was performed on raw ABR and VsEP thresholds, 
normalized ABR and VsEP thresholds, and on the difference between male and female 
thresholds for the two measures. Student’ T-tests were performed on the slope and 
intercept of the linear regression line in order to compare auditory and macular sensitivity 
and age related change in sensitivity within and between strains and genders. DPOAE 
amplitude was plotted as a function of age and geometric mean frequency. 
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CHAPTER II: METHODS 
Overview of the Experiment 
  The present research tested the following hypotheses: 1) functional changes in 
the macular organs, due to age alone, are concurrent with age related functional changes 
in the cochlea 2) mouse strains, which harbor Ahl genetic mutations, will show age 
related change in macular function concurrent with ARHL 3) change in macular and 
cochlear function, due to age alone, is the same for males and females. 
 We used VsEP measures to assess macular function. VsEPs are critically 
dependent on utricular and saccular function and provide an indication of the sensitivity 
of macular end organs, as well as the timing and synchrony of firing of vestibular 
afferents. ABR and DPOAE measures were used to assess auditory function.  ABR 
provides an objective measure of auditory sensitivity and the timing and synchrony of 
firing of auditory afferents. DPOAEs provided an additional measure of cochlear function 
(more specifically OHC function). The three measures were taken in a single session 
from the same mouse. Following functional measures, temporal bones were harvested 
and the macular organs were prepared for imaging with scanning electron microscopy. 
ABR and VsEP thresholds were normalized in order to make comparisons 
between modalities and descriptive statistics were generated. Normalized ABR and VsEP 
threshold slopes and intercepts were compared using linear regression and student’s T-
test. Comparisons were limited to ABR 8 kHz due to the fact that Ahl mice exhibit 
hearing loss in the mid and high frequencies from a very early age resulting in a high 
number of “no response” for mid and high frequency stimuli. Peak latencies (i.e., P1, P2, 
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and P3) and peak to peak amplitudes (P1-N1, P2-N2, P3-N3), were quantified for 
responses at the maximum stimulus intensity and were plotted as function of age. 
DPOAE amplitude and noise floor were plotted for each strain as a function of age and 
2f1-f2 geometric mean frequency. Extensive statistical analysis was not performed on 
DPOAE data as the main purpose of DPOAE measures in the current study was to 
confirm the cochlea as the site of lesion.  
In summary, the CBA/CaJ strain (no known ear related genetic mutation) served 
as the model for age alone and the C57, CE/J, and NOD NON strains served as ARHL 
models. Auditory and vestibular thresholds, latencies, and amplitudes were quantified 
and plotted as a function of age. DPOAE responses were plotted as a function of age and 
geometric mean frequency. Within strain comparisons were made between auditory and 
vestibular function. Between strain comparisons were made for vestibular function. A 
between-strain auditory comparison was not made as each strain carries a unique genetic 
background so any auditory functional differences observed between strains was not 
surprising and in fact were expected (strain differences are well documented in the 
literature). Temporal bones were dissected at the end of the functional experiments, fixed 
and processed for imaging with SEM. A qualitative comparison was made between the 
macular organs and otoconia of “young” and “old” mice to determine if age related 
changes in macular otoconia would explain any observed loss of macular sensitivity. 
Animals  
 This study utilized a murine model.  Four inbred mouse strains were used: 
C57BL/6J, CE/J, CBA/CaJ and NOD.NON-H2nb1/LtJ. The C57BL/6J, CE/J, CBA/CaJ, 
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and NOD/NON inbred mouse strains were chosen because some functional information 
(although limited information in many ways) is available for at least one of the sensory 
modalities for each of these strains (see Table 1). The primary focus of this project was to 
characterize age related change in auditory and vestibular function over the majority of 
the lifespan of the selected murine models. For this reason we chose linear regression as 
the statistical tool. Animals were not separated into arbitrary age groups for analysis of 
ABR and VsEP data. DPOAE data was divided into bimonthly age groups for averaging 
and plotting of DP grams. The age groups were divided as follows: <2, 2-3, 4-5, 6-7, 8-9, 
10-11, 12-13, 14-15, 16-17, 18-19, 20-21, 22-23. Approximately 8-10 mice were tested 
for each age group.  ABR, VsEP, and DPOAE were measured once in each animal, after 
which the animal was killed in order to avoid affects of repeated anesthesia and to obtain 
temporal bones at the various ages for SEM. 
 The mouse strains were chosen based on their known genetic background and 
existing data for vestibular and auditory function. The CBA/CaJ strain was chosen 
because it is has no known ear related genetic mutations and is a useful model for 
examining the effect of age alone on inner ear function. The C57BL/6J and the CE/J 
strains were chosen because they are known to carry the Ahl mutation, which is expressed 
in the inner ear with age, and demonstrate ARHL. The NOD.NON-H2nb1/LtJ strain was 
chosen because it is known to carry the Ahl and Ahl2 mutations, both of which affect the 
inner ear with age. Table 2 lists the number of data points for each measure for each 
strain.  
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Table 1. Strains utilized and pre- existing knowledge of auditory and vestibular function 
and genetic mutations. Direct comparisons between auditory and vestibular functional 
aging in these strains are limited to small n and few ages. 
________________________________________________________________________ 
Strain   Vestibular function Auditory function Known mutations 
 
C57BL/6J 
 
 
Normal gravity receptor 
function through 190 days of 
age.  Elevated VsEP 
thresholds at 389 days of age 
(Jones et al., 2006) 
 
 
Age related, progressive 
hearing loss (Henry, 1980).  
Apparent gender differences 
in auditory aging (Henry, 
2002). 
 
Ahl on chromosome 10 
(Johnson et al. 1997; 2000). 
 
CE/J May have significant gravity 
receptor dysfunction by 90 
days old  (Jones et al., 2006) 
Normal hearing at less than 13 
weeks of age (Zheng et al., 
1999; www.jax.org).  
 
Ahl on chromosome 10 
(Johnson et al., 1997; 2000). 
 
CBA/CaJ Normal macular function to 
166 days (Jones et al., 2005). 
Retain normal hearing and 
OAE to advanced age 
(Jimenez et al., 1999; Frisina, 
2001). Potential gender 
differences (Guimaraes et al., 
2004; Henry, 2004) 
 
None known 
NOD.NON-H2nb1/LtJ Potential gravity receptor 
dysfunction by 66 days of age. 
Early onset profound hearing 
loss (Jones et al., 2006). 
Ahl on chromosome 10 
(Johnson et al., 1997; 2000). 
Ahl2 on chromosome 5 
(Johnson & Zheng, 2002) 
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Table 2. Number of data points per measure for each strain. Instances in which the 
measure was performed but no response was present are included (no responses). 
Strain  8 kHz      16 kHz  32 kHz     41.2 kHz            VsEP         DPOAE 
CBA/CaJ 129 130 131 130 118 121 
 
C57BL/6J 147 147 148 145 133 144 
 
CE/J 90 92 92 92 95 96 
 
NOD.NON-
H2nb1/LtJ 
22 22 22 21 19 22 
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 Animal Preparation 
Studies were conducted at East Carolina University.  Use of animals in this work was 
approved by the Institutional Animal Care and Use Committee (AUP #P028) and national 
and international regulations regarding the use of animals were followed. Ambient noise 
levels in the animal housing area were monitored through out the study to assure that 
noise levels were below those which might result in noise induced hearing loss (See 
Appendix M). Sibling breeding pairs were obtained from The Jackson laboratory (Bar 
Harbor, ME). Animals were housed and maintained using standard husbandry until 
appropriate age for testing. During testing mice were anesthetized with ketamine (120 to 
126 mg/kg) and xylazine (10 to 14 mg/kg) injected intraperitoneally. Core body 
temperature was maintained at 37.0 ± 0.2°C using a homeothermic heating blanket and 
rectal thermocouple (FHC Inc., Bowdoin, ME). Mice were excluded from the study if 
they showed abnormal outer or middle ear appearance, as determined by examination 
with an operating microscope under anesthesia. Any signs of ruptured tympanic 
membrane, excessive cerumen, redness or inflamed tympanic membrane lead to 
exclusion. In total, three mice were excluded for a ruptured tympanic membrane. During 
evoked potential testing, subcutaneous needle electrodes were placed just posterior to the 
lambdoidal suture (noninverting), behind the left pinna (inverting) and at the neck 
(ground). A noninvasive head clip was used to secure the head to a mechanical shaker for 
delivery of vestibular stimuli. Auditory stimuli were delivered via plastic tubing secured 
at the entrance of the external acoustic meatus. The three measures (VsEP, ABR, and 
DPOAE) were performed during the same session after which the mice were euthanized. 
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Measurements began with DPOAEs followed by ABR and VsEPs. This order was chosen 
in an attempt to limit exposure to high stimulus levels that could result in a temporary 
threshold shift. Stimulus levels for DPOAE were limited to 60 dB SPL compared to ABR 
maximum stimulus levels which could be as high as 100 dB SPL. The intense forward 
masker that was presented during VsEPs has an average intensity level ranging from 94 
to 100 dB SPL. Test frequencies for ABR and DPOAE were tested in a random order. 
The time required for recording VsEP and DPOAE was consistent from mouse to mouse 
and was typically 30 minutes per measure. The time required to record the ABR 
thresholds varied depending on the sensitivity of the auditory system. When good 
auditory sensitivity was present, more stimulus presentations were required to determine 
threshold and as a result testing required more time. Recording time for the four 
frequencies did not generally exceed 45 minutes in mice with good auditory sensitivity 
and in mice with poor auditory sensitivity testing was as short as 30 minutes. In general, 
the three measures were completed in one mouse in less than two hours. 
Recording Protocol for Evoked Potentials 
 Single channel signal averaging was used to record VsEP and ABR response 
waveforms. Offline analysis was used to determine response thresholds, response peak 
latencies, and peak-to-peak amplitudes. Subcutaneous electrodes were placed as 
described above. The electroencephalographic activity was amplified (200,000X, Grass 
P511), band pass filtered (300 to 3000 Hz, -6 dB points, Grass P511) and digitized (10 µs 
per point for 1024 points, TDT AD1) beginning at stimulus onset (TDT TG6 triggers 
system). 256 samples were averaged to produce the final VsEP or ABR waveform. 
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Stimuli for VsEPs were linear jerk pulses that physically moved the mouse’s head. ABR 
stimuli were short duration tone bursts. Stimuli for VsEP and ABR are described in detail 
below. 
Vestibular Evoked Potential (VsEP) Stimulus 
 A linear jerk pulse generated by Tucker Davis Technologies (TDT, Alachua, FL) 
modules (TG6, DA3-2, PA4) and controlled by custom software (Jones & Jones, 1996) 
was used to elicit VsEPs. The jerk pulse was generated using a linear voltage ramp of 2 
ms duration, routed through a power amplifier (Peavey, Meridian, MS) which drove a 
mechanical shaker (Labworks Inc., Model E2-203, Costa Mesa, CA). The applied voltage 
produced an acceleration ramp, which was measured by an accelerometer (Endevco Inc., 
San Juan Capistrano, CA), 10mV/g where g = 9.81 m/sec2. Output of the accelerometer 
was measured using a custom built electronic differentiator; the output of which was 
monitored with an oscilloscope. The linear jerk pulses were coupled to the head through a 
custom platform mounted atop the shaker. Systematically increasing or decreasing the 
amplitude of the stimulus waveform controlled the intensity of the stimulus. Amplitude 
of the jerk stimuli was recorded as the mean peak jerk level (measured using an 
oscilloscope) and was expressed in dB relative to 1.0 g/ms. Magnitude of the stimulus 
was calibrated to produce an onset jerk magnitude of 1.0 g/ms with an attenuator setting 
of 0 dB. Stimulus amplitude ranged from –18 to +6 dB re: 1.0 g/ms and was adjusted in 3 
dB steps. Maximum stimulus amplitude (+ 6 dB re: 1.0 g/ms) resulted in a jerk amplitude 
of 2 g/ms and platform displacement of approximately 26 µm at peak acceleration. Jerk 
stimuli had two directions of motion: normal and inverted. Mice were placed in a supine 
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position with nose up. The axis of motion for normal polarity began with upward 
movement (naso-occipital +X). Inverted stimulus polarity began with downward 
movement (naso-occipital -X). Responses were collected for both normal and inverted 
polarities with the resulting waveforms averaged online to produce the final waveform 
for analysis. 
Auditory Brainstem Response (ABR) Stimulus 
 Tone burst stimuli were used for ABR testing. Continuous pure tone stimuli were 
generated by a digital signal analyzer (Stanford Research Systems, SR785, Sunnyvale, 
CA) and shaped and controlled using custom software and Tucker Davis Technologies 
(TDT, Alachua, FL) modules (TG6, SW2, PA4). Tone bursts at 8, 16, 32, and 41.2 kHz 
had a 1.0 ms rise-fall times with 1.0 ms plateau (3 ms total duration).  Stimuli were 
presented to the left ear via commercial OAE tips (Etymotic, ER10D-TO5 5mm, Elk 
Grove Village, IL) and PE-25 tubing. Auditory stimuli were presented at a rate of 17 
stimuli/s. Intensity series were collected with a descending series of stimulus intensities 
(6 or 12 dB steps) beginning at +6 dB. The average maximum stimulus levels were 97, 
90, 78, and 92 dB pe SPL for 8, 16, 32, and 41.2 kHz respectively. Stimulus levels were 
decreased until no response was visible and then dropped an additional 6 dB, in order to 
ensure that a sub-threshold level has been reached.  The left ear only was tested.  
Distortion Product Otoacoustic Emission (DPOAE) Stimulus  
 Methods for DPOAE stimuli and recording were similar to Jiminez et al. (1999) 
and Guimareaes et al. (2004).  Stimuli for DPOAEs were generated and shaped using 
custom software and modules from TDT (TG6, PA4, and SW2).  Pure tone frequencies 
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(f1, f2, f2/f1 ratio = 1.25), at equal levels (L1 = L2 = 60 dB SPL), 150 ms duration, were 
generated with independent sources (HP Agilent 33220A signal generators, Santa Clara, 
CA) and routed through separate drivers to mix acoustically in the ear canal. Stimuli were 
calibrated in a 0.35 ml coupler.  Stimulus frequencies for the primaries were such that 
geometric mean (GM = (f1 x f2)0.5) frequencies ranged from 6.0 to 48.5 kHz (at least 8 
frequencies per octave). All frequencies (f1, f2, 2f1-f2) are listed in Table 3. 
Recording Protocol for DPOAE 
During each study, ear canal sound pressure was recorded with a low noise probe 
microphone (Etymotic ER 10B+). The microphone output was amplified 10X (ER10B+ 
preamplifier) and input to a dynamic signal analyzer (Stanford Research Systems  
SRS785) for sampling (at 200 kHz) and fast Fourier transform (FFT). The amplitude of 
f1, f2, and the 2f1-f2-distortion product was measured from the FFT waveform. The 
noise floor was calculated as the average amplitude in the five frequency bins above and 
below the 2f1-f2 component. The recording system was tested periodically in the 0.35 ml 
coupler to confirm the absence of artifactual distortion.  
ABR and DPOAE Microphone and Stimuli Calibration 
 Stimuli for ABR testing were calibrated using a Bruel & Kjaar (B & K) ¼" 
microphone (4954, Nærum, Denmark), Nexus amplifier (2690), custom software, and 
0.35 ml custom coupler. During calibration the probe tube assembly (housing the 
ER10B+ microphone and exit ports for sound) was inserted into one end of the custom 
coupler (0.35 ml volume) and the B & K microphone was inserted into the other end. The 
output of the ER10B+ microphone was amplified (10X) and routed to one channel of the  
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Table 3.  DPOAE primaries and 2f1-f2 frequencies. Table 3 lists the two primary 
stimulus frequencies introduced into the ear canal and the 2f1-f2 response frequency. 
________________________________________________________________________
f1   f2   2f1-f2  geometric mean frequency 
5.2 6.4 4 5.77 
6 7.6 4.4 6.75 
6.8 8.4 5.2 7.56 
8 10 6 8.94 
9 11.2 6.8 10.03 
9.92 12.24 7.6 11.01 
10.6 13 8.2 11.74 
12 15 9 13.42 
13 16.2 9.8 14.51 
14 17.6 10.4 15.7 
16 20 12 17.89 
17 21.2 12.8 18.98 
19 23.6 14.2 21.27 
21 26.2 15.8 23.46 
22 27.6 16.4 24.64 
24 30 18 26.83 
26 32.4 19.6 29.02 
28 34.8 21.2 31.22 
30 37.6 22.4 33.59 
32 40 24 35.78 
34.8 43.6 26 38.95 
37 46 28 41.26 
39 48.6 29.4 43.54 
41.2 51.4 31 46.02 
42.6 53.2 32 47.61 
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SRS785 signal processor. The output from the B & K microphone was routed to a second 
channel on the SRS785 signal analyzer. The Visual Basic custom software controlled 
stimulus generation and signal analysis for DPOAE stimuli. Two Tucker Davis SW2 
modules were set for a rise fall time of 5 ms and 140 ms plateau, for a total duration of  
150 ms. Each stimulus frequency was presented and the PA4 attenuation was adjusted 
until a level of 60 dB SPL was achieved for the B & K channel. The PA4 attenuation 
level and the ER10B+ output level from the other channel of the SRS785 signal analyzer 
were saved as a probe tube calibration file (PTC) and the ER10B+ microphone sensitivity 
was calculated for each frequency. This PTC file served two purposes. First, the PTC file 
was loaded into the custom Visual Basic software and was used to calculate the target dB 
SPL for the ER10B+ microphone output. This assured that a level of 60 dB SPL was 
achieved for both primary tones presented during DPOAE testing. Secondly, the 
calibration values were used to determine stimulus presentation level for the four 
stimulus frequencies (8, 16, 32, and 41.2 kHz) presented during ABR testing. During 
ABR testing the probe tip was place at the mouse ear canal and the ER10B+ microphone 
measured the stimulus sound pressure level. The output from the microphone was routed 
to an oscilloscope and a peak-to-peak voltage was manually measured and recorded. 
Knowing the ER10B+ microphone sensitivity for each frequency allowed us to convert 
the measured peak-to-peak voltage into a peak equivalent dB SPL (dB pe SPL) for each 
ABR tone burst stimulus. The actual SPL varied from mouse to mouse (due to ear canal 
properties) but the microphone sensitivity determined during the calibration allowed us to 
calculate the actual SPL for each ABR stimulus frequency for each study. 
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Data Analysis 
ABR and VsEP waveforms were plotted as intensity series and peaks P1, P2, P3, 
N1, N2, and N3 were identified (Figures 4 and 5). ABR and VsEP thresholds, peak 
latency, and peak to peak amplitude were quantified. Amplitude and latency measures for  
the first three peaks (P1, P2 and P3) of the response waveform were quantified for the + 6 
dB re: 1.0 g/ms stimulus level. Threshold was defined as the intensity midway between 
the minimum stimulus intensity that produced a discernible response and the maximum 
stimulus intensity that did not result in a visible response. Response peak latency was 
defined as the time, in ms, from onset of the stimulus to the appearance of each positive 
peak (P1, P2 and P3). Peak-to-peak amplitude, (P1-N1, P2-N2, and P3-N3) measured in 
micro volts (µV), represented the difference between each positive peak and its 
respective negative peak.  
  In order to compare cochlear and macular sensitivity it was necessary to 
normalize threshold values. We chose to normalize threshold values in terms of a percent 
change in auditory and macular dynamic range. Dynamic range was defined as the range 
from the best threshold measured for the CBA/CaJ strain to the most intense stimulus 
level possible without inducing a temporary or permanent threshold shift. The CBA strain 
harbors no genetic mutations, maintains hearing until late in life, and will serve as a 
baseline for “normal” hearing. Normalizing thresholds relative to the CBA strain also 
allowed a direct comparison between the four strains. The upper level of the dynamic 
range was based on a pilot study conducted to determine the level at which ABR stimuli 
may cause temporary or permanent threshold shift. The results of this pilot study  
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Figure 4. Representative ABR waveforms for 16 kHz. Peaks P1, P2, P3, N1, N2, and N3 
are labeled and stimulus intensity is labeled on the right. Threshold for this intensity 
series was 41 dB pe SPL. 
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Figure 5. Representative VsEP intensity series. Peaks P1, P2, P3, N1, N2, and N3 are 
labeled and stimulus amplitude for each waveform is indicated on the right. VsEP 
threshold for this intensity series was – 13.5 dB re: 1.0 g/ms. 
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suggested that levels greater than 100 dB SPL resulted in temporary threshold shifts; so 
100 dB SPL was used as the upper limit for the dynamic range. The lower limit for 
dynamic range was set by the best thresholds for the CBA/CaJ strain, which were 12.7, 
13.1, 4.9, and 25.39 dB pe SPL for the test frequencies of 8, 16, 32, and 41.2 kHz, 
respectively. The lowest VsEP threshold measured was – 13.5 dB re: 1.0 g/ms and in this 
author’s experience sustained linear accelerations more intense than + 6 dB re: 1.0 g/ms 
can dislodge macular otoconia. So the upper limit for VsEP dynamic range was set as +6 
dB re: 1.0 g/ms. The resulting dynamic range was 19.5 dB re: 1.0 g/ms. To normalize a 
given threshold (y) the following formula was used: x = [(y – z) / k]*100 where x = the 
normalized value, z = the lowest threshold measured and k is the dynamic range. 
For example, with an absolute threshold of -7.5 dB:   
       x = [(-7.5 - (-13.5) / 19.5] * 100 
      x = [6/19.5] * 100 
      x = 30.77% 
Within strain comparisons were made between auditory and vestibular thresholds. 
Between strain comparisons were made for vestibular function. A between-strain 
auditory comparison was not made. Auditory differences between strains are well 
described in the literature so any auditory functional differences observed between strains 
was not surprising and in fact were expected. A student’s T-test was performed to 
determine if there were significant differences in the linear regression slopes or intercepts 
between: 1) auditory thresholds between males and females within each strain 2) VsEP 
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thresholds between males and females within each strain 3) VsEP thresholds between 
strains 4) ABR and VsEP thresholds within each strain.  
The mean DPOAE amplitude and noise floor were plotted for each age group as a 
function of age and geometric mean frequency. Statistical analysis was not performed on 
DPOAE data, as the main purpose of DPOAE measures was to characterize age related 
changes in OHC function and to confirm the cochlea as the site of lesion.    
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 Figure 6. ABR Stimulus Generation and Presentation 
Stanford Research Systems (SRS) 785 
- Wave: Sine  
- Test frequency: 8,16,32, or 41.2 kHz 
- Amplitude: 10 Vp-p 
- Offset:  0 Mv 
 
Tucker Davis Technology Timing Generator (TG6) 
  -   0.01 ms/pnt 
  -  0 start 
  -  3000 µs duration   
 
Tucker Davis Technology (TDT) SW2 Switch 
- Shape:  Cos2 
- Duration:   0 
- Trigger:  Enable ↑ 
- Rise Fall:  1 ms 
 
Tucker Davis Technology (TDT) PA4 Attenuator 
- TAV software controls PA4 and attenuation of tone burst 
- Stimulus attenuation is adjusted from +6 to sub-threshold level 
 
Tucker Davis Technology (TDT) ED1 Amplifier 
- 0 dB gain  
 
Tucker Davis Technology (TDT) EC1 electrostatic transducer 
- Frequency Response: +/-9 dB from 4 kHz to 110 kHz 
- Typical output (9.9V peak input): EC1 90 dB SPL, +/- 9.9 V 5 kHz 
signal 
- Maximum Output: 110 dB SPL at 10 cm 
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Figure 7. ABR Stimulus Monitoring  
 
Etymotic ER10B+ pre-amplifier 
- 10X 
 
Hewlett Packard 54602B Oscilloscope 
- 1 v/div 
- 1.0 ms/div   
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Figure 8. ABR Recording    
TAV Custom Software 
  -     17 stimuli per sec  - 1024 pnts/swp/ch 
-  128 sweeps   - 1 channel 
-  10 conversion time  - 1024 RC buffer size 
- 1024 pnts after trig PTD - 0 RC trace delay 
- 5 RC AD volt range  - 1220.7 RC V/AD bit; µv/bit 
- 4096 RC # AD bits  - 20 TDT AD voltage range 
- 65536 TDT ADbits  - 305.17 TDT µv/AD  bit 
- 20 Max Amp rej level (µv) - -20 Min Amp rej level (µv) 
- 68 Sweeps per display - 200,000 Ch1 gain  
- 300 Hz Ch1 lf cutoff  - 3000 Hz Ch1 hf cutoff 
- 0 dB applied voltage  - 150 Max # rejects 
- 10 µs sample rate  
 
Tucker Davis Technology Timing Generator (TG6) Channel 4 
  - 0.01 ms/pnt 
  -  0 start 
  -  3000 µs duration 
 
Grass P511 Biological Amplifier 
- calibrator 1 
- cal D.C. 
- ½ Amp lo Freq 300 Hz 
- Amp 200,000 
- ½ Amp hi Freq 3 kHz 
- 60 Hz filter in 
 
Tucker Davis Technology (TDT) AD1 Analogue to digital converter 
- 64 sweeps 
- 10 µs/pnt 
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Figure 9. DPOAE Stimulus Generation and Presentation   
Visual Basic Custom Software 
-  1 dB accept limit   - 5 V peak applied voltage  
- 3.06 stimuli/s   -  60 dB SPL target level 
- 20 µPa acoustic reference level 
 
HP Agilent 33220A arbitrary waveform generators 
- controlled by the Visual Basic custom software 
- waveform: sine 
- 5 Vp-p 
 
Tucker Davis Technology Timing Generator (TG6) Channel 5 
- 0.01 ms/pnt   -  0 start 
  -  15000 µs duration 
    
Tucker Davis Technology (TDT) SW2 Switch 
- Shape:  Cos2   -  Duration:   0 
- Trigger:  Enable ↑    - Rise Fall:  5 ms 
 
Tucker Davis Technology (TDT) PA4 Attenuator 
- Visual basic software controls PA4 and attenuation of tones 
- Stimulus attenuation is adjusted by Visual Basic until a level of  60 
dB SPL is achieved for f1 and f2 
 
Tucker Davis Technology (TDT) ED1 Amplifier 
- 0 dB gain  
Tucker Davis Technology (TDT) EC1 electrostatic transducers 
- Frequency Response: +/-9 dB from 4 kHz to 110 kHz 
- Typical output (9.9V peak input): EC1 90 dB SPL, +/- 9.9 V 5 kHz 
signal 
- Maximum Output: 110 dB SPL at 10 cm 
 
Etymotic ER10B+ pre-amplifier 
- 10X 
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Figure 10. DPOAE Recording   
ER10B+ preamplifier 
- 10X 
 
Stanford Research Systems (SRS) 785 signal analyzer 
- 6.4 kHz Span   - 8 line width 
- 125 acquisition time  - 800 FFT line 
- 24 dB V peak   - -8 dB V peak 
- 102.4 kHz base frequency - A display FFT 
- B display time 1  - Input range -20 dB V peak 
 
Visual Basic custom software 
-  1 dB accept limit   - 5 v peak applied voltage  
- 3.06 stimuli/s   - 60 dB SPL target level 
- 20 µPa acoustic reference level 
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Figure 11. VsEP Stimulus Generation  
TAV Custom Software 
  -      17 stimuli per sec  - 1024 pnts/swp/ch 
-  128 sweeps   - 1 channel 
- 10 RC trigger type  -  10 conversion time 
- 1024 RC buffer size  - 1024 pnts after trig PTD 
- 0 RC trace delay  - 5 RC AD volt range 
- 1220.7 RC V/AD bit; µv/bit - 4096 RC # AD bits  
- 20 TDT AD voltage range - 65536 TDT ADbits 
- 305.17 TDT µv/AD  bit - 20 Max Amp rej level (µv) 
- -20 Min Amp rej level (µv) - 68 Sweeps per display 
- 200,000 Ch1 gain  - 300 Hz Ch1 lf cutoff 
- 3000 Hz Ch1 hf cutoff - 0 dB applied voltage 
- 150 Max # rejects  - 10 µs sample rate 
 
Tucker Davis Technology (TDT) PA4 Attenuator 
- TAV software controls PA4 and attenuation of jerk stimulus 
 
Tucker Davis Technology Timing Generator (TG6) Channel 3 
  - 0.01 ms/pnt 
  -  0 start 
  -  3000 µs duration 
 
Tucker Davis Technology (TDT) DA3-2 digital to analogue converter 
- Acceleration time 2 ms 
- Total time 100 ms 
- Conversion time 20 µs/pnt 
 
Grass P511 Biological Amplifier 
- calibrator 1   - cal D.C. 
- ½ Amp lo Freq 300 Hz - X 1000 
- Amp 200   - ½ Amp hi Freq 3 kHz 
- 60 Hz filter in 
Tucker Davis Technology (TDT) AD1 Analogue to digital converter 
- 64 sweeps   - 10 µs/pnt 
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 Figure 12. VsEP Masker Generation   
Stanford Research Systems (SRS) 785 
- Noise: white noise 
- Amplitude: 1 V 
- Offset:  0 Mv 
 
Tucker Davis Technology Timing Generator (TG6) Channel 3 
  - 0.01 ms/pnt 
  -  0 start 
  -  15000 µs duration 
 
Tucker Davis Technology (TDT) SW2 Switch  
- Shape:  Cos2 
- Duration:   0 
- Trigger:  Enable    
- Rise Fall:  0.5 ms 
 
Peavey Amplifier 
     
Frequency Devices (Ottawa, IL) high pass filtering 
- 20 kHz knee point 
 
Radio Shack Super-tweeter 
   
Midrange speakers 
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 Figure 13. VsEP Jerk Stimulus Monitoring  
Accelerometer amplifier 
- 10 mV/g 
 
Custom differentiator 
  -  Calibrated 0.4 V = 1.0 g/ms 
Hewlett Packard 54602B Oscilloscope  
- 0.2 v/div 
- 1.0 ms/div 
 
 
Custom 
Differentiator 
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Amplifier 
10 mV/g 
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Figure 14. VsEP Recording  
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 Figure 15. Stimulus and Microphone Calibration for ABR and DPOAE Stimuli 
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CHAPTER III: GRAVITY RECEPTOR AGING IN THE CBA/CaJ STRAIN; A 
COMPARISON TO AUDITORY AGING 
Abstract 
The CBA/CaJ strain is a widely studied mouse strain with no known genetic 
mutations affecting the inner ear, it maintains hearing sensitivity to late in life, and is 
commonly used as a genetic background for creating new genetic strains. The purpose of 
the present research was to characterize the effect of age and gender on gravity receptor 
function in the CBA/CaJ mouse strain and compare functional change between auditory 
and vestibular modalities. Vestibular evoked potentials (VsEP), auditory brainstem 
response (ABR) and distortion product otoacoustic emissions (DPOAE) were measured 
in 131 CBA/CaJ mice ranging in age from 1.7 to 23.8 months. VsEP thresholds increased 
significantly (p<0.001) as a function of age and deteriorated by an average of 0.39 dB re: 
1.0 g/ms per month. At the oldest ages mice showed an average loss of 48 % of VsEP 
dynamic range. No loss of otoconia was observed that could account for the loss of 
macular sensitivity. No gender differences were found for VsEP measures. ABR 
thresholds increased significantly (p<0.001) as a function of age and decreased by 1.35, 
1.38, 1.15, and 0.81 dB pe SPL per month for 8, 16, 32, and 41.2 kHz, respectively. 
These increases correspond to an average decrease in ABR dynamic range of 25 to 35%. 
The present study found no difference in the rate of decline in auditory function between 
males and females. DPOAE responses were present at all ages including the oldest ages 
tested but showed some decrease in amplitude consistent with ABR results. Macular and 
auditory sensitivity decreased with age in the CBA/CaJ strain but function is maintained 
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for both modalities even to advanced ages. The rate of change in auditory sensitivity 
varied by frequency and declined at a slower rate than macular sensitivity for all ABR 
test frequencies. When the rate of change for macular sensitivity and ABR 8 kHz was 
compared there was a significantly different rate of change (p < 0.0001), with macular 
function declining at a faster rate than auditory function. The current findings agree with 
previous reports of structural degeneration of the cochlea and vestibular organs, such as 
decreased hair cell densities and loss of primary afferents. Age related decreases in 
macular sensitivity should be considered when using the CBA/CaJ strain for vestibular 
studies. 
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Introduction 
 The inner ear houses the organs for hearing as well as balance. Age related 
declines in auditory function are well known and age related hearing loss (ARHL) is one 
of the most common causes of hearing impairment, affecting 50% of the population by 
age 80 (Gorlin, Toriello, & Cohen, 1995; Morton, 1991). The effects of age on vestibular 
function are much less understood. Studies by the National Institute on Deafness and 
other Communication Disorders estimated that 3.4 % of the U.S. adult population (6.2 
million people) suffers from chronic dizziness and/or imbalance (Hoffman & Sklare, 
2003). The use of mice for auditory research has lead to numerous mouse models of 
syndromic and non-syndromic hearing loss in humans and has facilitated the study of 
environmental and genetic causes of hearing loss, including ARHL.  
 The effect of age on inner ear morphology has been widely studied and structural 
degeneration in the cochlea and vestibular organs have been reported in animal models 
and humans. Common age-related cytoarchitectural changes in the cochlea of rats, mice, 
guinea pigs, monkeys and humans include: loss of outer and inner hair cells (Spongr, et 
al., 1997) loss of supporting cells (Nadol, 1979), reduced vascular supply (Saitoh, et al., 
1995; Spicer & Schulte, 2005; Brown, et al., 1995), degeneration and loss of sensory 
cells (Willott, et al., 1991; Mizuta, et al., 1993: Spongr et al., 1997; Francis, et al., 2003), 
reductions in the number and integrity of afferent and efferent neurons (Felder & Schrott-
Fischer, 1995), atrophy of the stria vascularis and spiral lamina (Suzuki, et al., 2006). 
Vestibular structural changes reported with aging include: a reduction in the number and 
integrity of sensory cells (Gleeson & Felix, 1987; Nakayama, et al., 1994; Rosenhall & 
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Rubin, 1975; Rauch, et al., 2001; Shiga, et al., 2005), reduced number of type 1 and type 
2 hair cells (Gleeson & Felix 1987), reduced blood supply to vestibular sensory organs 
(Lyon & Wanamaker, 1993; Lyon & Davis, 2002), reduced number of globular 
substances (which are secreted precursors to mature otoconia) (Suzuki et al., 1997). 
Animal models have played an important role in identifying inner ear structural changes 
and factors that contribute to functional decline with age. 
Auditory function has been well characterized in the CBA/CaJ strain, which 
maintains auditory sensitivity until late in life (Henry & McGinn, 1992; Zheng, Johnson, 
& Erway, 1999; Vasquez, Luebke, & Martin, 2001; Prosen, Dore, & May, 2003; 
Ohlemiller & Gagnon, 2004). Hearing sensitivity and outer hair cell function are 
maintained until 2 years of age as evidenced by DPOAE amplitudes (Guimaraes, et al., 
2004), frequency tuning (as measured by behavioral testing and notched noise maskers) 
(May, Kimar, & Prosen, 2006) and ABR thresholds (Li & Borg, 1991; Guimaraes et al., 
2004).  
An interaction between age and gender for auditory function has been reported in 
humans and mice and include findings such as: young women generally have better 
hearing than young men (Corso, 1963; Rosen, Plester, & El-Mofty, 1964; Northern, 
Downs, Rudmose, Glorig & Fletcher, 1972; Surjan, 1973) and ARHL may progress faster 
in men than women (Corso, 1963; Pederson, Rosenhall, & Moller, 1989; Wallhagen, 
Strawbridge, Cohen, & Kaplan, 1997; McFadden & Pasanen, 1998; Gates & Cooper, 
1999). Henry (2004) measured ABR and cochlear nerve envelope response in the 
CBA/CaJ and C57BL/6J strains and reported gender differences in hearing sensitivity. In 
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the CBA/CaJ strain he reported that at advanced age (~350 days) males show poorer high 
frequency hearing than females (on average 5-10 dB SPL poorer). In the C57 strain, 
Henry reported that males had better auditory sensitivity at all ages. Guimaraes et al., 
(2004) reported an auditory gender difference in CBA mice, only for the old age group, 
using a between group design and ANOVA. It has been suggested that the female 
hormone estrogen may have a direct influence cochlear function and this idea is 
supported by structural data from Stenberg, Wang, Sahlin, & Hulcrantz, (1999) that 
revealed widespread immunostaining of the estrogen receptors ERα and ERβ in cochlear 
structures in CBA mice. Estrogen is known to have widespread effects on physiology and 
this finding suggests that it may have a direct influence on cochlear structures. A study by 
Hulcrantz, Stenberg, Fransson, & Canlon (2000) using a mutant mouse, X,O “Turner 
mouse” which produces no estrogen, further supports the idea of estrogen influence on 
cochlear structure and function. They found a loss of OHC, primary afferent pathology, 
increased ABR thresholds, and decreased DPOAE amplitudes relative to controls. The 
role of female hormones on inner ear structure and function is poorly understood but 
there is growing evidence suggesting that female hormones may have a protective effect 
against ARHL. 
Are there gender differences in vestibular function? A search of the literature reveals 
no reports of gender differences in vestibular structure or function.  
Are there age related changes in vestibular function? Studies that have investigated 
the effect of age on vestibular function in humans have typically utilized indirect 
measures such as the vestibulo-ocular-reflex (VOR), optokinetic response (OKN), the 
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otolith-ocular reflex, visual-vestibular responses and tests of posture to make inferences 
about vestibular sensory function (Paige, 1992, 1994; Baloh, et al., 1993; Goebel, 2001; 
Enrietto, et al., 1999; Shiga et al., 2005; Furman & Redfern, 2001). In general, these 
studies have reported decreases in VOR gain, increased phase lead, decreased ability to 
suppress the VOR with vision, less foreshortening of the VOR time constant by post-
rotary head tilt, and lower OKN slow-phase velocity saturation. Investigations by Jones et 
al. (2005, 2006) using direct measures of auditory and vestibular function in a variety of 
inbred mouse strains suggested that genetic background may play a role in age-related 
changes in the two sensory systems and that functional change in one sensory system 
does not obligate change in the other. Shiga et al., (2005) measured ABR and VOR and 
examined cochlear and semicircular canal sensory structures in C57BL/6J mice which 
carry Ahl, a cadherin23 mutation that affects cadherin expression in inner ear sensory 
structures and results in ARHL. They found degeneration of sensory structures in both 
the cochlea and semicircular canals but only found significant functional change in ABR. 
Their results could be explained by the fact that the VOR response is an indirect measure 
requiring peripheral input, central integration, and motor output. Using the VOR measure 
it is not possible to separate central and peripheral pathology or to calculate the effect of 
central compensation for peripheral deficits. 
  In the current study we posed the question: “What is the effect of age alone on the 
inner ear sensory modalities?” and used an inbred strain with no known mutations 
(CBA/CaJ) and a direct measure of vestibular function, the VsEP. We hypothesized: 1) 
changes in the macular function, due to age alone, are concurrent with age related 
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functional changes in the cochlea 2) changes in macular function, due to age alone, is the 
same for males and females. 
Auditory and vestibular function (more specifically macular function) was 
characterized in 131 CBA/CaJ mice ranging in age from 1.7 to 23.8 months of age. ABR 
and DPOAE were used to assess auditory function and vestibular evoked potentials 
(VsEP) were used to assess macular function. Response parameters were compared 
between genders and across age. Temporal bones were harvested following functional 
studies and scanning electron microscopy (SEM) was used to qualitatively characterize 
macular otoconia. 
Methods 
Animals and Animal Preparation 
 
Studies were conducted at East Carolina University. Use of animals in this work 
was approved by the Institutional Animal Care and Use Committee and in accordance 
with national and international regulations regarding the use of animals in research. 
Ambient noise levels in the animal housing area were monitored through out the study to 
assure that levels were below those which might result in noise induced hearing loss (See 
Appendix M). Sibling breeding pairs were obtained from The Jackson laboratory (Bar 
Harbor, ME). Animals were housed and maintained in standard husbandry until 
appropriate age for testing.  
During testing mice were anesthetized with ketamine (120 to 126 mg/kg) and 
xylazine (10 to 14 mg/kg) injected intraperitoneally. Body core temperature was 
maintained at 37.0 ± 0.2°C using a homeothermic heating blanket and rectal 
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thermocouple (FHC, Inc.). Mice were excluded from the study if there was any indication 
of potential outer or middle ear dysfunction (i.e. redness or inflammation of the external 
ear canal or tympanic membrane (TM), TM perforation, visible fluid in the middle ear 
space, or excessive cerumen) as determined by examination with an operating 
microscope under anesthesia. Three mice were excluded due to a perforated TM. During 
ABR and VsEP testing, subcutaneous needle electrodes were placed just posterior to the 
lambdoidal suture (noninverting), behind the left pinna (inverting) and at the neck 
(ground). A noninvasive head clip was used to secure the head to a mechanical shaker for 
delivery of vestibular stimuli.  Auditory stimuli for ABR and DPOAE were delivered via 
a probe assembly placed at the entrance of the external acoustic meatus. DPOAE, ABR 
and VsEP were performed in the same mouse, during the same test session, after which 
the mouse was euthanized.  Temporal bones were harvested from mice representative of 
young, middle aged, and advanced age groups for imaging via scanning electron 
microscope. Stimuli for VsEP, ABR, and DPOAE are described in detail below.  
Vestibular Evoked Potentials (VsEP) 
 VsEP stimulus and recording methods were similar to Jones et al., (2005). A 
linear jerk pulse was generated using a linear voltage ramp (2 ms duration) routed 
through a power amplifier, which drove a mechanical shaker (Labworks, Inc. Model E2-
203). The applied voltage produced an acceleration ramp, which was measured by an 
accelerometer (Endevco, Inc., 10mV/g where g = 9.81 m/s2). Output of the accelerometer 
was measured using an electronic differentiator; the output of which was monitored with 
an oscilloscope (Hewlett Packard 54602B). The linear jerk pulses were coupled to the 
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head through a custom platform mounted atop the shaker. Systematically increasing or 
decreasing the amplitude of the stimulus waveform controlled the amplitude of the 
stimulus applied to the head. Amplitude of the jerk stimuli was recorded as the mean 
peak jerk level (measured using an oscilloscope) and was expressed in dB relative to 
1.0g/ms. Stimulus amplitude ranged from –18 to +6 dB (re: 1.0g/ms) and was adjusted in 
3 dB steps. Jerk stimuli had two directions of motion: normal and inverted. Mice were 
placed in a supine position with nose up and stimuli were presented in the naso-occipital 
axis. Normal polarity began with upward movement (naso-occipital +X). Inverted 
stimulus polarity began with downward movement (naso-occipital -X). Responses were 
collected for both normal and inverted polarities and the resulting waveforms were 
averaged online to produce the final waveform for analysis. 
Auditory Brainstem Response (ABR) 
Tone burst stimuli were used to elicit ABR responses. Continuous pure tone 
stimuli (10 Vp-p voltage) were generated by a digital signal analyzer (Stanford Research 
Systems SR785) and shaped/controlled using custom software and Tucker Davis 
Technologies (TDT, Alachua, FL) modules (TG6, SW2, PA4). Tone bursts at 8, 16, 32, 
and 41.2 kHz had a 1.0 ms rise-fall times with 1.0 ms plateau (3 ms total duration). 
During ABR testing a probe assembly was inserted into the mouse ear canal and a 
calibrated ER10B+ microphone was used to measure sound level. The output from the 
ER10B+ was routed to a preamplifier and an oscilloscope and the acoustic peak-to-peak 
voltage was recorded for the maximum stimulus level (+6 dB). Peak equivalent SPL (pe 
SPL) was later calculated based on the microphone sensitivity as determined by 
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calibration in a custom 0.35 ml coupler. Based on these measures, the average maximum 
stimulus levels (at +6 dB) were 97, 90, 78, and 92 dB pe SPL for 8, 16, 32, and 41.2 kHz 
respectively. Stimuli were presented to the left ear via commercial OAE tips (Etymotic 
ER10D-TO5 5mm) and PE-25 tubing. Auditory stimuli were presented at a rate of 17 
stimuli/s. Intensity series were collected with a descending series of stimulus intensities 
(6 or 12 dB steps). Stimulus levels were decreased until no response was visible and then 
dropped an additional 6 dB, in order to ensure that a sub-threshold level had been 
reached.  
Distortion Product Otoacoustic Emissions (DPOAE) 
DPOAEs provide an objective measure of cochlear function and are critically 
dependent on outer hair cell function (Brownell, 1990). Methods for DPOAE stimuli and 
recording were similar to Jimenez, et al., (1999) and Guimaraes et al., (2004). Stimuli for 
DPOAEs were generated and shaped using custom software and modules from TDT 
(TG6, PA4, and SW2). Pure tone frequencies (f1, f2, f2/f1 ratio = 1.25), at equal levels 
(L1 = L2 = 60 dB SPL), 150 ms duration, were generated with independent sources (HP 
Agilent 33220A signal generators) and routed through separate drivers to mix 
acoustically in the ear canal (via commercial OAE tips (Etymotic ER10D-TO5 5mm) and 
PE-25 tubing) placed securely at the external acoustic meatus. Stimulus frequencies for 
the primaries were such that the geometric mean (GM = (f1 x f2)0.5) frequencies ranged 
from 6.0 to 48.5 kHz (at least 8 frequencies per octave). During each study, ear canal 
sound pressure was recorded with a low noise probe microphone (Etymotic ER 10B+). 
The microphone output was amplified 10X (ER10B+ preamplifier) and input to a 
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dynamic signal analyzer (Stanford Research Systems SRS785) for sampling (at 200 kHz) 
and fast Fourier transform (FFT). The amplitude of f1, f2, and the 2f1-f2-distortion 
product was measured from the FFT waveform. The noise floor was measured as the 
average amplitude in the five frequency bins above and below the 2f1-f2 component. The 
recording system was tested periodically in the 0.35 ml coupler to confirm the absence of 
artifactual distortion.  
ABR and DPOAE Microphone and Stimulus Calibration 
 Stimuli for ABR testing were calibrated using a Bruel & Kjaar (B & K) ¼" 
microphone (4954, Nærum, Denmark), Nexus amplifier (2690), custom software, and 
0.35 ml custom coupler. During calibration the probe tube assembly (housing the 
ER10B+ microphone and exit ports for sound) was inserted into one end of the custom 
coupler (0.35 ml volume) and the B & K microphone was inserted into the other end. The 
output of the ER10B+ microphone was amplified (10X) and routed to one channel of the 
SRS785 signal processor. The output from the B & K microphone was routed to a second 
channel on the SRS785 signal analyzer. The custom software controlled stimulus 
generation and signal analysis for DPOAE stimuli. Two Tucker Davis SW2 modules 
were set for a rise fall time of 5 ms and 140 ms plateau, for a total duration of 150 ms. 
Each stimulus frequency was presented and the PA4 attenuation was adjusted until a 
level of 60 dB SPL was achieved for the B & K channel. The PA4 attenuation level and 
the ER10B+ output level from the other channel of the SRS785 signal analyzer were 
saved as a probe tube calibration file (PTC) and the ER10B+ microphone sensitivity was 
calculated for each frequency. This PTC file served two purposes. First, the PTC file was 
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loaded into the custom software and was used to calculate the target dB SPL for the 
ER10B+ microphone output. This assured that a level of 60 dB SPL was achieved for 
both primary tones presented during DPOAE testing. Secondly, during ABR testing the 
calibration values were used to determine the stimulus presentation level for the four 
stimulus frequencies (8, 16, 32, and 41.2 kHz) as measured in the ear canal. During ABR 
testing the probe tip was place at the mouse ear canal and the ER10B+ microphone 
measured the stimulus sound pressure level. The output from the microphone was routed 
to an oscilloscope and a peak-to-peak voltage was manually measured and recorded. 
Knowing the ER10B+ microphone sensitivity for each frequency allowed us to convert 
the measured peak-to-peak voltage into a peak equivalent dB SPL (dB pe SPL) for each 
ABR tone burst stimulus. The actual SPL varied from mouse to mouse (due to ear canal 
properties) but the microphone sensitivity determined during the calibration allowed us to 
calculate the actual SPL for each ABR stimulus frequency for each study. 
Overview and Averaging  
Measurements began with DPOAEs followed by ABR and VsEP. This order was 
chosen in an attempt to limit exposure to high sound pressure levels that could result in a 
temporary auditory threshold shift. Stimulus levels for DPOAE are limited to around 60 
dB SPL compared to ABR maximum stimulus levels, which were as high as 100 dB pe 
SPL. An intense forward masker is presented during VsEPs that has an average intensity 
level as high as 97 dB SPL. VsEP were performed last in order to negate the possibility 
of a temporary auditory threshold shift from exposure to the intense masker during VsEP 
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testing. Test frequencies for ABR and DPOAE were tested in random order. In general, 
the three measures were completed in one mouse in less than two hours.  
Single channel signal averaging was used to record VsEP and ABR response 
waveforms.  Offline analysis was used to determine response thresholds, response peak 
latencies, and peak-to-peak amplitudes. Subcutaneous electrodes were placed as 
described previously. The electroencephalographic activity was amplified (200,000X, 
Grass P511, West Warwick, RI ), band pass filtered (300 to 3000 Hz, -6 dB points, Grass 
P511) and digitized (10 µs per point for 1024 points, TDT AD1) beginning at stimulus 
onset (TDT TG6 triggers system). 256 samples were averaged to produce the final VsEP 
or ABR waveform. Stimuli for VsEPs were linear jerk pulses that physically moved the 
mouse’s head. ABR stimuli were short duration tone bursts. ABR and VsEP threshold, 
peak latency, and peak to peak amplitude were quantified. Amplitude and latency 
measures for the first three peaks (P1, P2 and P3) of the response waveform were 
quantified. Threshold was defined as the intensity midway between the minimum 
stimulus intensity that produced a discernible response and the maximum stimulus 
intensity that did not result in a visible response. Response peak latency was defined as 
the time, in milliseconds, from onset of stimulus to the appearance of each positive peak 
(P1, P2 and P3). Peak-to-peak amplitude, (P1-N1, P2-N2, and P3-N3) measured in 
microvolts (µv), represented the difference between each positive peak and its respective 
negative peak. 
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Data Analysis 
In order to compare cochlear and macular sensitivity it was necessary to 
normalize ABR and VsEP threshold values. We chose to normalize threshold values in 
terms of a percent change in the dynamic range. Dynamic range was defined as the range 
from the best threshold measured for the strain to the most intense stimulus level possible 
without causing a permanent threshold shift with a brief exposure. A pilot study was 
conducted to determine the level at which ABR stimuli may cause a threshold shift. The 
results of the pilot study suggested that levels greater than 100 dB pe SPL could result in 
a threshold shift with a ten minute exposure. Therefore 100 dB pe SPL was used as the 
upper limit for the dynamic range. The lower limit for auditory dynamic range was set by 
the best threshold obtained for each frequency (12, 13.1, 4.9, and 25.4 dB pe SPL for the 
test frequencies 8, 16, 32, and 41.2 kHz respectively). The lowest VsEP threshold 
measured was – 13.5 dB (re; 1 g/ms) and the maximum non-noxious stimulus 
presentation level was + 6 dB re: 1.0 g/ms. The resulting dynamic range was 19.5 dB. To 
normalize a given threshold (y) the following formula was used: 
 x =  y – z   *  100 
k   
 
where x = the normalized value in percent, y = absolute threshold to be normalized, z = 
the lowest threshold measured and k is the dynamic range. 
 
For example, with an absolute threshold of -7.5 dB:   
      x = [(-7.5 - (-13.5) / 19.5] * 100 
      x = [6/19.5] * 100 
      x = 30.77% 
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Auditory and macular function were compared between male and female mice using 
linear regression and a student’s T test (Zar, 1984) was performed to determine if there 
was a significant difference in the linear regression slopes or intercepts for males and 
females. The rate of age related change in normalized ABR and VsEP thresholds was 
compared within strain using linear regression and a student’s T-test. The mean DPOAE 
amplitude and noise floor were plotted for each age group as a function of geometric 
mean frequency but no statistical analysis was performed. 
Structural Analysis 
 Temporal bones from young, middle aged, and old mice were dissected at the end 
of the functional experiments and fixed using 4% paraformaldehyde and 2% 
glutaraldehyde. Following 24 hrs in fixative the temporal bones were dehydrated using 
graded concentrations (70, 90, 95, and 100%) of ethyl alcohol. After a minimum of 24 
hours in 100 % ethyl alcohol, the macular organs were micro-dissected from the temporal 
bone and mounted on aluminum stubs, critical point dried (Bal-Tec CPD 030, 
Liechtenstein ), and sputter coated (Anatech LTD Hummer 6.6, San Diego, Ca.). 
Specimens were imaged with a scanning electron microscope (FEI Quanta 200, 
Hillsboro, Oregon). 
Results 
Auditory Results 
No difference was found between female and male slopes or intercepts for ABR 
threshold at 8 kHz (Fig. 16) so data for the two genders were pooled for further analysis. 
The slope of the linear regression model for the difference between females and males 
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Figure 16. ABR thresholds female vs. males. ABR threshold is plotted as a function of 
age for the four ABR test frequencies. Linear regression analysis found no significant 
difference between the slopes or intercepts for males and females. Linear regression 
equations were y = 28.2 + 1.44x for females (the 95 % confidence interval for slope was 
0.99 to 1.88) and y = 37.3 + 1.34x for males (the 95 % confidence interval for slope was 
0.77 to 1.91). 
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is 1.03, meaning that the estimated average difference between genders is 1.03 dB per 
month. The 95 % confidence interval for the difference in the slope for female and males 
was –0.77 to 2.80. We would argue that an average difference in threshold of 1.03 dB per 
month between females and males does not represent a practical difference. ABR 
responses were generally present for all test frequencies for all age groups. ABR 
thresholds increased significantly as a function of age for the four ABR frequencies and 
increases averaged 1.35 (df (1,126), F = 55.18, p<0.0001, R2= 0.31), 1.38 (df (1,122), p< 
0.0001, R2= 0.31), 1.15 ( df (1, 117) F = 31.16, p< 0.0001, R2= 0.21) , and 0.81 (df 
(1,114), F = 22.9, p<0.0001, R2= 0.16) dB pe SPL per month for 8, 16, 32, and 41.2 kHz, 
respectively (Fig. 17, 18). This represents an average decrease of 25 to 35% in auditory 
dynamic range over the lifespan of CBA mice. P1 latency decreased an average of 0.009, 
0.007, 0.005, and 0.004 ms per month for 8, 16, 32, and 41.2 kHz, respectively (Fig. 19). 
P1-N1 amplitudes decreased an average of 0.06, 0.02, 0.02, and 0.004 μV per month for 
8, 16, 32, and 41.2 kHz respectively (Fig. 20). 
DPOAE amplitudes decreased an average of 30% with age but even at the oldest 
ages tested remained within the 95% population range for the youngest group (Fig. 21).  
DPOAE results indicating decreased cochlear outer hair cell function and are in 
agreement with ABR findings of decreased auditory sensitivity. Table 4 lists the number 
of data points attained for each measure.   
Macular Results 
VsEP thresholds increased as a function of age but no significant difference was found 
for the slope or intercept for females and males (Fig. 22). Female and male datum was  
 
 97
Figure 17. ABR threshold and % responding. ABR thresholds increased significantly as a 
function of age for the four ABR frequencies and increases averaged 1.35 (df (1,126), F = 
55.18, p<0.0001, R2= 0.31), 1.38 (df (1,122), p< 0.0001, R2= 0.31), 1.15 ( df (1, 117) F = 
31.16, p< 0.0001, R2= 0.21) , and 0.81 (df (1,114), F = 22.9, p<0.0001, R2= 0.16) dB pe 
SPL per month for 8, 16, 32, and 41.2 kHz, respectively. 
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Figure 18. Audiogram. Average ABR thresholds plotted against ABR stimuli frequency 
for the data grouped into 12 age groups. Mean ages are listed at the right. 
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Figure 19. ABR latency. ABR P1(○), P2 (□), and P3 (∆) latency as a function of age. P1 
latency decreased an average of 0.009, 0.007, 0.005, and 0.004 ms per month for 8, 16, 
32, and 41.2 kHz, respectively. 8 kHz P1 latency linear regression equations were y = 
0.99 + 0.009x, y = 0.84 + 0.007x, y = 0.73 + 0.005x, and y = 0.7 + 0.004 for 8, 16, 32, 
and 41.2 kHz respectively. 
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Figure 20. ABR amplitude. P1-N1 amplitude at maximum stimulus levels  as a function 
of age. P1-N1 amplitudes decreased an average of 0.015, 0.023, 0.017, and 0.004 μV per 
month for 8, 16, 32, and 41.2 kHz respectively. Linear regression equations were y = 0.6 
– 0.015x, y = 0.78 – 0.023x, y = 0.62 – 0.017x, and y = 0.35 – .004x for 8, 16, 32, and 
41.2 kHz.  
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 Figure 21. DPOAE amplitudes. Average DPOAE amplitude as a function of geometric 
mean frequency. The dashed line represents the 95% population range for the 2 to 3 
month age group. 
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Table 4. Number of data points for each measure. The table indicates the number of mice 
tested for each measure and includes cases where the measurement was performed but 
there was no measurable response (no response). 
8 kHz        16 kHz      32 kHz         41.2 kHz      VsEP           DPOAE 
Male 58 59 59 58 56 56 
Female 71 71 72 72 62 65 
Total 129 130 131 130 118 121 
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Figure 22. VsEP Gender. Female and male VsEP threshold as a function of age. Linear 
regression equations were y = -11.7 + 0.37x (the 95 % confidence interval for slope was 
0.27 to 0.47) and y = -13 + 0.41x (the 95 % confidence interval for slope was 0.30 to 
0.52) for females and males, respectively. No significant difference was found between 
females and males for the slope or intercept of the linear regression line.  
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pooled for further analysis. VsEP responses were generally present for all age groups 
(Fig. 23, 24). VsEP thresholds increased significantly as a function of age (df (1,115), F = 
112.1, p<0.0001, R2= 0.49) by an average of 0.39 dB (re: 1.0 g/ms) per month and 
showed an average loss of 48 % of dynamic range at the oldest ages. VsEP P1 latency 
showed small, yet significant increases (df (1,106), F = 25.47, p<0.0001, R2= 0.19) (Fig. 
25). P1-N1 amplitude decreased significantly (df (1,106), F = 25.45, p<0.0001, R2= 
0.19), by an average of 0.02 μv per month as a function of age (Fig. 26). 
 In regard to otoconia, we found no qualitative difference in macular otoconia 
between young and old mice that would explain the observed decline in macular function. 
Scanning electron microscopy images of macular otoconia showed dense populations of 
otoconia in the utricle and saccule at advanced age, with similar morphology to that seen 
at younger ages (Fig. 27). 
  VsEP and ABR thresholds both increased significantly as a function of age. A 
comparison of the rate of change (linear regression slopes of normalized thresholds) 
between the two measures, by student’s t-test, revealed a significant difference (p < 
0.001) (Fig. 28). Macular sensitivity declined faster than auditory sensitivity for all 
frequencies. In spite the statistical significance, it is apparent from the plot that the loss of 
sensitivity occurred a similar rate in the two modalities. This finding suggests that while 
there are subtle differences, overall the rate of age related change in auditory and macular 
sensitivity are similar in the CBA strain.   
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 Figure 23. Representative VsEP waveforms.  Representative VsEP waveforms for + 6 
dB re: 1.0 g/ms for mice at 5 selected ages. 
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Figure 24. VsEP threshold. Pooled male and female VsEP threshold. VsEP thresholds 
increased significantly as a function of age (df (1,115), F = 112.1, p<0.0001, R2= 0.49) 
by an average of 0.39 dB (re: 1.0 g/ms) per month and showed an average loss of 48 % of 
dynamic range at the oldest ages. The linear regression equation was y = -12.4 + 0.39X. 
Of 119 animals tested, two had no response (one at 18.4 months and a second at 20.4 
months).   
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Figure 25. VsEP latency. VsEP P1 (○), P2 (□), and P3 (∆) latency as a function of age. 
VsEP P1 latency showed small, yet significant increases (df (1,106), F = 25.47, 
p<0.0001, R2= 0.19). P2 and P3 increased by an average of 0.01 and 0.01 ms per month. 
Linear regression equations were y = 1.3 + 0.01x, y = 2.13 + 0.01x, and y = 3.07 + 0.01x 
for P1, P2, and P3 respectively. 
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Figure 26. VsEP amplitude. VsEP P1-N1 amplitude decreased significantly as a function 
of age (df (1,106), F = 25.45, p<0.0001, R2= 0.19), by an average of 0.02 μv per month 
as a function of age. The linear regression equation was y = 0.77 – 0.02x. 
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Figure 27. SEM Images. Scanning electron microscopy images of the utricle and saccule 
from 18 month old mice (top two images) and 12.2 month old mice (bottom two images). 
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 Figure 28. Auditory and macular comparison. Normalized VsEP and ABR thresholds 
plotted as a function of age. The average monthly decline in dynamic range was 2.17 % 
for VsEP (dashed line) and 1.77, 1.58, 1.23, and 1.08 % for 8, 16, 32, 41.2 kHz (solid 
lines), respectively. There was significant difference in the rate of change in VsEP and 8 
kHz thresholds (p<0.0001). The 95% confidence interval for VsEP percent deficit slope 
was 1.76 to 2.59 and for 8 kHz slope was 1.32 to 2.22. 
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Discussion 
 The CBA/CaJ strain is widely used to investigate the environmental and genetic 
causes of hearing and balance disorders. It serves as the background strain for 
development of many mutant inbred strains that facilitate the study of the genetic origins 
of syndromic and non-syndromic auditory and vestibular disorders. It is important that 
the hearing and balance function be well characterized over the entire lifespan of this 
important inbred strain. The present study’s auditory findings are in agreement with 
previous studies showing a gradual decline in auditory sensitivity and outer hair cell 
function. Vestibular results also show a slow progressive loss of macular sensitivity that 
has a significantly different rate of change than the observed auditory decline. Auditory 
function declined faster than macular function for three of the four ABR test frequencies. 
The current auditory findings are in agreement with previous studies that show increasing 
ABR thresholds beginning in mid-life, and reduced DPOAE amplitudes as a function of 
age; however we did not find any significant gender differences in auditory function as 
reported by others.  
This study provides unique knowledge concerning the effect of age on gravity 
receptor function and how it relates to cochlear functional change with age. The results 
indicate a gradual decline in both modalities that follow different time courses. ABR 
results (increased threshold, small increases in latency, and small decreases in amplitude) 
along with DPOAE findings (reduced response amplitudes as a function of age) suggest 
the cochlea, and more specifically cochlear outer hair cells, as the source of declining 
auditory function. These findings are in agreement with reports of progressive age-related 
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decreases in inner and outer hair densities (Spongr et al., 1997) and loss of spiral 
ganglion fibers (Ohlemiller & Gagnon, 2004).  
VsEP results (decreased sensitivity, small increases in latency, and decreases in 
amplitude) reveal a gradual decline in macular sensitivity that parallels the decrease in 
auditory sensitivity. Age related changes in vestibular sensory organs (pathology and loss 
of type I and II hair cells, pathology and loss of stereocilia/kinocilia, reduced blood flow, 
changes in the globular substance and otoconia, and increased presence of lipofuscin) are 
reported in humans and animal models (rats, guinea pigs, monkeys and C57 mice). 
Gravity receptor structural studies in the CBA/CaJ strain however, are not reported in the 
literature. Future morphological studies concerning age related changes in the macular 
organs of CBA/CaJ mice may identify the source of age related decline in gravity 
receptor sensitivity.  
Could age related change in the number, distribution, or density of macular 
otoconia be responsible for the observed loss of macular sensitivity? There are reports in 
the literature of age-related morphological changes in macular otoconia (Jang, Hwang, 
Shin, Bae, & Kim, 2006; Campos, Canizares, Sanchez-Quevedo, & Romero, 1990) and 
the globular substance (Suzuki et al., 1997), which is involved in otoconia formation. It is 
conceivable that pathological changes in otoconia turnover/production could lead to 
otoconia with reduced density, resulting in increased VsEP thresholds. Scanning electron 
microscopy may not reveal this hypothetical change in otoconia density. The scanning 
electron microscopy images of macular otoconia in this study show no qualitative 
difference between the macular otoconia of young and old mice that would explain the 
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loss of macular sensitivity. The finding of reduced sensitivity of both the cochlea and 
macular organs suggests that there are global changes in the peripheral membranous 
labyrinth of CBA mice that affect both modalities. What broad acting structural changes 
might explain the observed functional decline of the cochlea and macular organs?  
Age related structural changes in the cochlea and vestibular organs have been 
studied in depth in humans and a variety of animal models and are generally placed into 
several conceptual categories; 1) neural, involving primarily a loss of afferent neurons 2) 
metabolic, involving blood supply and non-sensory structures (stria vascularis, spiral 
lamina, vestibular dark cells, etc.) responsible for the endolymphatic potential 3) sensory, 
involving hair cells, stereocilia/kinocilia, or sensory supporting cells (Schuknecht & 
Gacek, 1993). Schuknecht’s human temporal bone studies have shown that these 
pathologies may exist independently and concurrently. Studies focusing on the effect of 
age on cochlear and vestibular sensory structures have identified a myriad of pathologies 
including: loss of inner and outer hair cells in the cochlea, loss of type I and type II 
vestibular hair cells, missing/disarranged/fused stereocilia and kinocilia, hair cell 
cytoplasmic protrusions, giant hair cells, degeneration of structures responsible for the 
endolymphatic potential such as the stria vascularis and spiral ligament, increased 
fragility of the cuticular plate, decreases in otoconia turnover, loss of primary afferent 
fibers, and the accumulation of a “wear and tear” pigment known as lipofuscin.  
One global change that could potentially affect cochlear and vestibular function 
involves the unique extracellular fluid known as endolymph that fills the membranous 
labyrinth. Endolymph has a high concentration of potassium, which results in a relatively 
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strong positive charge relative to the sensory hair cells of the cochlea and vestibular 
organs. This electrical gradient is known as the endolymphatic potential (EP) and both 
sensory systems are dependent upon this electrical charge for sensory transduction. It is 
possible that pathological changes in the EP or the structures that maintain the EP (stria 
vascularis and spiral ligament in the cochlea and dark cells in the vestibular organs) could 
effect both cochlear and vestibular function. Studies that have focused on the 
endolymphatic potential (EP) and the cochlear structures responsible for the ion pumping 
necessary to maintain the EP (Gratton & Schulte, 1995; Gratton, Schmiedt, & Schulte, 
1996; Gratton & Schulte, 2003; Hequembourg & Liberman, 2001; Lang, Schulte, & 
Schmiedt, 2003; Ohlemiller, Lett & Gagnon, 2006) have identified degenerative changes 
in the stria vascularis and spiral ligament which are believed to maintain the EP in the 
cochlea. A search of the literature fails to find investigations on the effect of age on 
vestibular dark cells, which are responsible for ion pumping in the vestibular labyrinth. 
These studies are in agreement that there are age-related degenerative changes in the stria 
vascularis and spiral ligament; however the results concerning the EP itself are mixed. 
The EP is inherently difficult to measure and varies by measurement site, species, and 
genetic strain and the findings concerning the EP itself vary depending on the animal 
model and genetic strain utilized; e.g. gerbils and BALB/cJ mice show a reduced EP as 
function of age (Gratton et al., 1996) while the C57 and CBA/CaJ mouse strains show no 
change or limited change in the EP. (Lang et al., 2002; Ohlemiller et al. 2006; Wu & 
Marcus, 2003, Sha et al., 2008). The finding that the EP does not decrease with age in the 
CBA strain makes it unlikely that this is a source of decreased auditory and macular 
 
 115
sensitivity seen with aging. The ion pumping that occurs in the cochlear and vestibular 
structures is a “global” metabolic process that takes place in the membranous labyrinth. 
Other metabolic processes occur at the cellular level and degenerative changes in these 
cellular processes are another possible explanation for age related decreases in function.  
Pathology of the cochlear hair cells (primarily OHC) and their accompanying 
stereocilia are widely accepted as a primary cause of age related hearing loss and loss of 
spiral ganglion fibers is generally considered to be secondary to the loss of hair cells. 
However, the specific mechanisms behind hair cell degeneration and neuronal loss are 
not known. One possible explanation is the membrane hypothesis of aging, also known as 
the mitochondrial clock theory. This theory proposes that reduced vascular supply, an 
increase in reactive oxygen metabolites (ROM) and accumulation of mitochondrial 
deletions result in apoptosis of sensory structures in the inner ear. Cochlear and vestibular 
hair cells do not regenerate in humans therefore the maintenance and repair of these 
sensory structures is critical for maintaining cochlear and vestibular function with 
advancing age. Vascular changes in the cochlea and vestibular organs, including 
decreased vascular plasticity and permeability (Prazma, Carrasco, Butler, Waters, 
Anderson, & Pillsbury, 1990; Seidman, et al., 1996; Lyon & Wanamaker, 1993; Gratton 
et al, 1996), decreased capillary diameter and blood flow (Lyon & Davis, 2002) result in 
reduced oxygen and nutrient delivery and elimination of cellular metabolic by products 
(Rosenhall & Rubin, 1986; McFadden, Ding, & Salvi, 2001) and an increase in ROM. 
ROM are toxic molecules that can damage tissue and have been shown to damage 
mitochondrial DNA (mtDNA) and result in specific mtDNA deletions (mtDNA del 4977 
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in humans and mtDNA del 4834 in rats). These mtDNA mutations are directly 
proportional to aging (Liu, Kong, & Liu, 2003; Markaryan, Nelson, & Hinojosa, 2008) 
and as these mutations accumulate with advancing age, the mitochondrial metabolic 
processes become progressively less efficient. One common finding in histological 
studies of the effect of age on cochlear and vestibular structures is the presence of 
lipofuscin (Anniko, 1983; Bohne, Gruner, & Harding, 1990; Igarashi & Ishii, 1990; Li & 
Hulcrantz, 1994; Gleeson, et al., 1990; Rosenhall & Rubin, 1975; Park, Hubel, & Woods, 
1987), a wear-and-tear pigment that is a by product of cellular metabolic processes. The 
lipofuscin pigment results from peroxidation and may have negative affects on cellular 
function (Jung, Bader, & Grune, 2007). Its presence indicates decreased efficiency of 
cellular metabolic processes which may be indicative of membrane damage or 
mitochondrial/lysomal damage. Mitochondria are a critical component of cellular energy 
production and an age-related increased in mitochondrial deletions, and resulting 
decrease in cellular metabolic efficiency, is one possible explanation for age-related 
apoptosis of cochlear and vestibular sensory structures.  
 In summary, the current study found that CBA mice maintain macular function 
until late in life but demonstrate a gradual progressive decline in macular sensitivity that 
is slightly accelerated relative to the time course observed for declines in auditory 
sensitivity. We found no significant gender differences in auditory or macular function 
and qualitative changes in macular otoconia were ruled out as possible explanations for 
decreased macular sensitivity. Decreased vascular supply, decreased metabolic 
efficiency, increased ROM production, increased numbers of mtDNA deletions, and 
 
  
117
eventual apoptosis of cochlear and vestibular hair cells and afferent neurons is one 
possible explanation for the observed reduction in auditory and vestibular sensitivity. The 
observed decline in macular sensitivity should be considered when using the CBA strain 
for vestibular studies. 
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CHAPTER IV: AGE EFFECTS ON GRAVITY RECEPTOR FUNCTION IN 
TWO MOUSE STRAINS WITH Ahl MUTATIONS  
Abstract 
 
The C57BL/6J (C57) and CE/J strains both carry a Cadherin23 (Cdh23) mutation 
(Ahl), which affects inner ear auditory structures (Bolz, von Brederlow, & Ramirez,  
2001; Di Palma et al., 2001) and results in age related hearing loss (ARHL) (Johnson, et 
al., 1997). The effect of Ahl on vestibular structures and function is not well understood. 
The purpose of the present study was to characterize the effect of age and gender on 
macular function in the C57 and CE/J strains and to compare functional change between 
auditory and vestibular modalities and genders. Vestibular Evoked Potentials (VsEP), 
Auditory Brainstem Response (ABR), and Distortion Product Otoacoustic Emissions 
(DPOAE) were measured in 148 C57BL/6J mice, ages 1.01 to 23.8 months, and 96 CE/J 
mice, ages 1.0 to 20.6 months. ABR and DPOAE were used to assess cochlear function 
and VsEP testing was used to assess macular function. Thresholds, peak latencies, and 
peak-to-peak amplitudes were quantified for VsEP and ABR responses. DPOAE 
amplitude was plotted as a function of geometric mean frequency and age. The macular 
organs from young, mid-life, and old animals were harvested, prepared, and imaged using 
scanning electron microscopy and a qualitative comparison of macular otoconia was 
made.  
VsEP and ABR thresholds increased significantly (p<0.0001) as a function of age 
in both strains. No significant gender difference was found for ABR or VsEP threshold 
linear regression slopes or intercepts for either strain. Average decreases of 0.12 dB re: 
 
 119
1.0 g/ms and 0.47 dB re: 1.0 g/ms per month were seen in VsEP thresholds for the C57 
and CE/J strains, respectively. The rate of change in macular sensitivity was significantly 
different (p<0.0001) between the two strains. Average total loss of dynamic range for 
VsEP at the oldest ages was 21 % for C57 (22-23 months of age) and 56 % for CE/J (20-
21 months of age). No loss of otoconia was observed that could account for the loss of 
macular sensitivity. ABR thresholds decreased an average of 2.75, 2.76, 4.14, and 1.37 
dB pe SPL per month for the C57 strain and 2.07, 2.69, 0.97, 0.41 dB pe SPL per month 
for the CE/J strain for 8, 16, 32, and 41.2 kHz, respectively. The average decrease in 
auditory dynamic range for the oldest age groups was 100% for both strains. DPOAE 
amplitudes were initially more robust in the C57 strain than the CE/J strain and declined 
as a function of age in both strains in agreement with ABR results. 
 A comparison of VsEP and 8 kHz ABR linear regression slopes for normalized 
thresholds shows that the rate of decline of auditory and macular sensitivity is 
significantly different (p< 0.001) in both strains. This trend was more pronounced in the 
C57 strain. 
In summary, our results show; 1) no gender differences for auditory or macular 
function 2) OHC dysfunction (and hearing loss) begins earlier in the CE/J strain than the 
C57 strain 3) macular function decreases at a faster rate in the CE/J strain than in the C57 
strain 4) auditory function declines at a faster rate than macular function in both strains 
(this finding is more pronounced in the C57 strain). 5) aging of one inner ear sensory 
system does not predict aging of the other inner ear sensory system.  
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The minimal loss of macular sensitivity in the C57 strain suggests that this strain 
may harbor an unknown mutation that serves to inhibit degeneration of macular 
structures and preserves macular sensitivity at advanced age. 
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      Introduction 
The inner ear houses the organs for hearing and balance. The organ of Corti in 
the cochlea transduces sound while the maculae in the vestibule and the cristae in the 
semicircular canals transduce linear and angular motion of the head, respectively. 
Deficits in these sensory systems or their neural pathways can lead to hearing 
impairment and/or balance disorders. Age related hearing loss (ARHL) is the most 
common type of hearing impairment in humans affecting 50% of the population by age 
80 (Gorlin, et al., 1995; Morton, 1991). While many studies have examined the 
prevalence and impact of presbycusis on society (e.g., decreased potential earnings, 
increased social isolation, and cost of treatment) (Mulrow et al. 1990; Lutman, 1990; 
Hinchcliffe, 1990; Stach, et al., 1990; Gates, & Cooper, 1991; Mohr, et al., 2000; 
Strawbridge, et al., 2000) relatively little has been done to investigate the effects of 
vestibular dysfunction on society or public health. Studies by the National Institute on 
Deafness and other Communication Disorders estimated that 3.4 % of the U.S. adult 
population (6.2 million people) suffers from chronic dizziness and/or imbalance 
(Hoffman & Sklare, 2003) and an estimated 7 million people a year seek care for 
disequilibrium and/or vertigo. Vestibular end organs make an important contribution to 
balance and their degeneration due to aging may be an important factor in the increased 
incidence of falls in the elderly. Functional changes in the auditory and vestibular 
systems due to aging are influenced by factors such as noise exposure, exposure to 
ototoxins, ear disease (e.g., see review by Gratton & Vazquez, 2003), the central 
auditory system (Willott, et al., 2001), lifestyle (diet, exercise, etc) (Willott et al., 2001), 
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genetic make up (Johnson, et al., 1997; Li, 1992; Fransen, et al., 2003), and gender 
(Guimaraes, et al., 2004; Henry, 2004). 
Gender differences in auditory function, including ARHL, are reported in animal 
models as well as humans and include reports that young women generally have better 
hearing than young men (Corso, 1963; Rosen, et al., 1964; Northern, et al., 1972; Surjan, 
1973), ARHL progresses faster in men than women (Corso, 1963; Pederson, et al., 1989; 
Wallhagen, et al., 1997; McFadden & Pasanen, 1998) and that female mice lose hearing 
earlier than males in mouse models of early onset ARHL (Henry, 2004). Guimaraes, et al. 
(2004), measured both ABR and DPOAEs in CBA mice, and found that female mice 
have lower thresholds and maintain DPOAE amplitudes at advanced age compared to 
males. This suggests that female hormones may have a protective effect against ARHL.  
Mock, Jones, & Jones (unpublished) however, found no gender differences in 131 
CBA/CaJ mice ranging in age from 1.7 to 23.8 months. Mock, Jones, & Jones gender 
analysis was performed on ABR threshold only using linear regression and student’s T-
test in contrast to Guimaraes et al., who analyzed ABR and DPOAE, separated subjects 
into arbitrary age groups, and utilized ANOVA. 
Genetic studies have identified a large and ever growing number of mutations 
that contribute to both syndromic and non-syndromic hearing loss and have revealed the 
heterogeneous nature of hearing loss. To date eight mutations that contribute to ARHL 
have been identified. Johnson et al. (1997) were the first to identify a specific mutation 
(Ahl) that results in ARHL in mice. The Ahl mutation is a recessive, single nucleotide 
mutation at 753 (A/G) on the Cdh23 gene on Chromosome 10 in the C57BL/6J strain. 
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This mutation occurs in approximately 80% of inbred strains with hearing loss (Drayton 
and Noben-Trauth, 2006) and is referred to as Cdh23753A (Noben-Trauth, Zheng, & 
Johnson, 2003). Cdh23 is a gene that encodes cadherin, a protein necessary for inner ear 
development and maintenance of sensory cell structures such as stereociliary tip links 
(Siemens et al., 2004; Sollner et al., 2004) and transient lateral links (Michel et al., 
2005; Lagziel et al., 2005). Mutations in Cdh23 are associated with syndromic (Usher 
syndrome type 1D) and non-syndromic hearing loss (DFNB12) and have been shown to 
result in deafness and vestibular disorders in humans and mice (Bolz et al., 2001, Jones 
et al., 2004, 2005). Cochlear and vestibular cytoarchitectural abnormalities reported in 
strains that carry the Ahl mutation include: loss of inner and outer cochlear hair cells, 
loss of spiral ganglion cells, degeneration of fibrocytes in the spiral ligament, 
disorganized stereociliary bundles, misplaced kinocilia, and disruption of stereociliary 
tip links (Di Palma et al,. 2001; Alagramam et al., 2001; Holme & Steel, 2002; Raphael, 
Kobayashi, & Dootz, 2001; Shiga et al., 2005).  
A second mutation, named Ahl2, was subsequently mapped to Chromosome 5 
using backcross and linkage analysis in the NOD/LtJ strain. Johnson and Zheng (2002) 
concluded that the contribution of Ahl2 to hearing loss is dependent on a predisposing 
Ahl genotype and that the interaction of Ah1 and Ahl2 results in an earlier onset of 
hearing loss than for Ahl alone.  
A third ARHL locus (Ahl3) was identified by Nemoto et al. (2004) and fine 
mapped to Chromosome 17 by Morita et al. (2007). Ahl3, when present along with Ahl, 
has a protective effect against early onset hearing loss and hearing sensitivity is preserved 
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until late in life. In contrast to Ahl and Ahl2, it appears that the Ahl3 mutation does not 
result in age-related hearing loss but functions to inhibit age-related hearing loss.  
Zheng et al. (2007) identified and mapped a fourth ARHL locus, designated Ahl4, 
on Chromosome 10, of the A/J inbred mouse strain. The A/J strain harbors Ahl, as well as 
Ahl4, and exhibits early onset hearing loss relative to strains with Ahl alone. Using 
genetic analysis of a backcross strain Zheng et al. provide a compelling argument that 
Ahl4 contributes to the accelerated onset of hearing loss in the A/J strain. Studies of this 
strain in our laboratory have revealed poor macular sensitivity and abnormal macular 
otoconia in this strain (Jones, Jones, Johnson, Yu, Erway, & Zheng, 2006). 
Dreyton and Noben-Trauth (2006) investigated the genetic basis of hearing loss in 
the non-inbred Black Swiss strain and identified two loci (Ahl5 and Ahl6) that contribute 
to hearing loss in this strain. Ahl5 and Ahl6 were localized to chromosome 10 and 18, 
respectively. Black Swiss mice demonstrate an early onset hearing loss which begins in 
the high frequencies and eventually reaches profound levels at all frequencies. 
The latest ARHL mutation to be identified is Ahl8 (Ahl7 is reserved) by Johnson 
et al. in the DBA/2J strain (Johnson, Zheng, & Noben-Trauth, 2006). Ahl8 results in 
accelerated hearing loss and occurs on the distal portion of chromosome 11. 
While the effect of Ahl mutations on auditory function is well studied, their effect 
on vestibular function is much less understood. A study by Shiga et al. (2005) 
characterized age related changes in auditory and vestibular structures and function in the 
C57 strain which carries Ahl, using vestibulo ocular reflex (VOR) gain as a measure of 
vestibular function and ABR as a measure of cochlear function. Histology showed a 30% 
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decrease in hair cell counts in the horizontal semi-circular canal crista, a significant loss 
of inner and outer hair cells in the basal cochlea, and 50% reduction in spiral ganglion 
densities. Their functional results show a significant decrease in auditory sensitivity but 
no corresponding decrease in VOR gain was observed. Based on these findings, the 
investigators suggested that the mechanisms for vestibular functional change might differ 
from those for the cochlea. They conceded however, that VOR is an indirect measure of 
vestibular function and that central mechanisms may compensate for peripheral 
degeneration. Investigations by Jones et al. (2005, 2006) using direct measures of 
auditory (ABR) and vestibular function (VsEP) in inbred mouse strains showed some 
interesting trends. Some strains (e.g., BUB/BnJ, NOD/LtJ, A/J) showed severe hearing 
loss and severe vestibular impairment at the ages tested. Other strains (e.g., DBA/2J, 
A/WySnJ, NOD.NONH2kb, A/HeJ) had severe vestibular impairment with relatively 
little change in hearing at the ages tested. Three strains (MRL/MpJ, CE/J, SJL/J) had 
significant vestibular loss with no concomitant hearing loss (at least to 32 kHz). These 
studies were limited to small sample sizes and few ages. However, the results highlight 
the importance of genetic background on age-related changes in the two sensory systems 
and suggest that functional change in one sensory system does not obligate change in the 
other. 
What is the effect of the Ahl mutation on macular function and does macular 
function decline at the same rate as auditory function? Furthermore, are there gender 
differences in auditory and macular aging in these two Ahl strains? To answer these 
questions we measured cochlear and macular function in female and male C57 and CE/J 
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mice, both of which carry the Ahl mutation, and compared within strain functional 
changes, between the two genders and the two modalities. VsEP was used to assess 
macular function and ABR and DPOAE were used to characterize cochlear function. 
Temporal bones were harvested, dissected and prepared for SEM following functional 
measures. SEM images of the utricle and saccule from young and old mice were 
qualitatively compared to determine if any age related functional changes might be 
explained by changes in distribution or number of macular otoconia present.  
We hypothesized the following: 
1) Macular sensitivity will decline as a function of age. 
2) Declines in auditory and macular function will occur at the same rate within 
strain and between strains. 
3) The time course for ARHL will be different between females than males. 
Methods 
Animals and Animal Preparation 
Studies were conducted at East Carolina University. Use of animals in this work 
was approved by the Institutional Animal Care and Use Committee and in accordance 
with national and international regulations regarding the use of animals in research. 
Ambient noise levels in the animal housing area were monitored through out the study to 
assure that noise levels were below those which might result in noise induced hearing 
loss (See Appendix K). Sibling breeding pairs were obtained from the Jackson laboratory 
(http://www.jax.org/). Animals were housed and maintained in standard husbandry until 
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appropriate age for testing was reached. Table 5 indicates the number of animals tested 
for the different measures and includes cases when there was no measurable response. 
During testing mice were anesthetized with ketamine (120 to 126 mg/kg) and 
xylazine (10 to 14 mg/kg) injected intraperitoneally. Body core temperature was 
maintained at 37.0 ± 0.2°C using a homeothermic heating blanket and rectal 
thermocouple (FHC Inc, Bowdoin, ME). Mice were excluded from the study if there was 
any indication of potential outer or middle ear dysfunction (i.e. redness or inflammation 
of the external ear canal or tympanic membrane (TM), TM perforation, visible fluid in 
the middle ear space, excessive cerumen) as determined by examination of the external 
acoustic meatus and tympanic membrane with an operating microscope under anesthesia. 
During ABR and VsEP testing, subcutaneous needle electrodes were placed just posterior 
to the lambdoidal suture (noninverting), behind the left pinna (inverting) and at the neck 
(ground). A noninvasive head clip was used to secure the head to a mechanical shaker for 
delivery of vestibular stimuli. Auditory stimuli were delivered via a probe assembly 
placed at the entrance of the left external acoustic meatus. DPOAE, ABR and VsEP were 
performed during the same session after which the mouse was euthanized. Temporal 
bones were harvested from mice representative of young, mid-life, and advanced age 
groups for imaging with a scanning electron microscope. Stimuli for VsEP, ABR, and 
DPOAE are described in detail below. 
Vestibular Evoked Potentials (VsEP) 
 VsEPs were used to measure macular sensitivity to linear accelerations and 
characterize macular function. VsEPs are an objective measure of macular sensitivity, are  
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Table 5. Number of data points for each measure. The table indicates the number of mice 
tested for each measure and includes cases where the measurement was performed but 
there was no measurable response (no response). 
 
Strain         8 kHz       16 kHz      32 kHz           41.2 kHz       VsEP        DPOAE 
C57BL/6J 75 females 
72 males 
 
147 total 
 
75 females 
72 males  
 
147 total 
 
73 female 
75 male  
 
148 total 
 
72 female 
73 males  
 
145 total 
 
66 females 
67 males  
 
133 total 
 
144 total 
CE/J 44 female 
46 male 
 
90 total  
 
44 female 
48 male 
 
92 total  
44 female 
48 male 
 
92 total 
 
 
44 female 
48 male 
 
92 total 
 
 
44 female 
51 male 
 
95 total 
 
96 total 
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critically dependent on the macular organs (utricle and saccule), the vestibular portion of 
cranial nerve VIII, and vestibular brainstem relays. VsEP peak latency and peak to peak 
amplitude are determined by the number, timing and the synchrony of firing of vestibular 
afferents and the integrity of vestibular brainstem relays. VsEP stimuli and recording 
methods were similar to Jones et al. (2005). A linear jerk pulse generated by Tucker 
Davis Technologies (TDT, Alachua, FL) modules (TG6, DA3-2, PA4) and controlled by 
custom software (Jones and Jones, 1996, 1999; Jones et al., 1997, 1998a,b; 2002) was 
used to elicit VsEPs. The jerk pulse was generated using a linear voltage ramp of 2 ms 
duration, routed through a power amplifier, which drove a mechanical shaker (Labworks, 
Inc. model E2-203). The applied voltage produced an acceleration ramp, which was 
measured by an accelerometer (Endevco, Inc., 10mV/g where g = 9.81 m/s2). Output of 
the accelerometer was measured using an electronic differentiator; the output of which 
was monitored with an oscilloscope. The linear jerk pulses were coupled to the head 
through a custom platform mounted atop the shaker. Systematically increasing or 
decreasing the amplitude of the stimulus waveform controlled the intensity of the 
stimulus. Amplitude of the jerk stimuli was recorded as the mean peak jerk level 
(measured using an oscilloscope) and was expressed in dB relative to 1.0g/ms. Magnitude 
of the stimulus was calibrated to produce an onset jerk magnitude of 1.0 g/ms with an 
attenuator setting of 0 dB. Stimulus amplitude ranged from –18 to +6 dB re: 1.0g/ms and 
was adjusted in 3 dB steps. Maximum stimulus amplitude (+ 6 dB re: 1.0 g/ms) resulted 
in jerk amplitude of 2 g/ms and a platform displacement of approximately 26 µm at peak 
acceleration. Jerk stimuli had two directions of motion: normal and inverted. Mice were 
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placed in a supine position with nose up. The axis of motion for normal polarity began 
with upward movement (naso-occipital +X). Inverted stimulus polarity began with 
downward movement (naso-occipital -X). Responses were collected for both normal and 
inverted polarities and the resulting waveforms were averaged online to produce the final 
waveform for analysis.  
Auditory Brainstem Response (ABR) 
ABR is an objective measure of cochlear sensitivity and the timing and synchrony 
of firing of auditory afferent neurons. Tone burst stimuli were used to illicit ABR 
responses. Continuous pure tone stimuli were generated by a digital signal analyzer 
(Stanford Research Systems SR785, Sunnyvale, CA.) and shaped/controlled using 
custom software and Tucker Davis Technologies (TDT, Alachua, FL) modules (TG6, 
SW2, PA4). Tone bursts at 8, 16, 32, and 41.2 kHz had 1.0 ms rise-fall times with 1.0 ms 
plateau (3 ms total duration). During ABR testing the probe tip was inserted into the 
mouse ear canal and an ER10B+ microphone measured the stimulus sound pressure level. 
The output from the microphone was routed to an oscilloscope and a peak-to-peak 
voltage was recorded. Peak equivalent SPL (pe SPL) was later calculated based on the 
microphone sensitivity as determined by a calibration in a custom coupler. The average 
maximum stimulus levels were 97, 90, 78, and 92 dB pe SPL for 8, 16, 32, and 41.2 kHz 
respectively. Stimuli were presented to the left ear via commercial OAE tips (Etymotic 
ER10D-TO5 5mm, Elk Grove, IL.) and tapered at the ear canal with PE-25 tubing. 
Auditory stimuli were presented at a rate of 17 stimuli/sec. Intensity series were collected 
with a descending series of stimulus intensities (6 or 12 dB steps) beginning at +6 dB. 
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Stimulus levels were decreased until no response was visible and then dropped an 
additional 6 dB, in order to ensure that a sub-threshold level had been reached.  
Distortion Product Otoacoustic Emissions (DPOAE) 
DPOAEs provide an objective measure of cochlear function and are critically 
dependent on outer hair cell function (Brownell, 1990). Methods for DPOAE stimuli and 
recording were similar to Jimenez et al. (1999) and Guimaraes et al. (2004). Stimuli for 
DPOAEs were generated and shaped using custom software and modules from TDT 
(TG6, PA4, and SW2). Pure tone frequencies (f1, f2, f2/f1 ratio = 1.25), at equal levels 
(L1 = L2 = 60 dB SPL), 150 ms duration, were generated with independent sources 
(Hewlett Packard Agilent signal generators model 33220 A, Santa Clara, Ca.) and routed 
through separate drivers to mix acoustically in the ear canal via commercial OAE tips 
(Etymotic ER10D-TO5 5mm), tapered at the ear canal with PE-25 tubing, and placed 
securely in the external acoustic meatus. Stimulus frequencies for the primaries were 
such that the geometric mean (GM = (f1 x f2)0.5) frequencies ranged from 6.0 to 48.5 kHz 
(at least 8 frequencies per octave). During each study ear canal sound pressure was 
recorded with a low noise probe microphone (Etymotic ER 10B+). The microphone 
output was amplified 10X (ER10B+ preamplifier) and input to a dynamic signal analyzer 
(Stanford Research Systems SRS785) for sampling at 200 kHz and fast Fourier transform 
(FFT). The amplitude of f1, f2, and the 2f1-f2-distortion product was measured from the 
FFT waveform. The noise floor was calculated as the average amplitude in the five 
frequency bins above and below the 2f1-f2 component. The recording system was tested 
periodically in the 0.35 ml coupler to confirm the absence of artifactual distortion.  
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ABR and DPOAE Microphone and Stimulus Calibration 
ABR and DPOAE stimuli were calibrated monthly using a 0.35 ml custom 
coupler, ¼” B&K microphone with Nexus amplifier, and custom software. During 
calibration the probe tube assembly (housing the ER10B+ microphone and exit ports for 
sound) was inserted into one end of the custom coupler (0.35 ml volume) and the  
¼ B & K microphone was inserted into the other end. The output of the ER10B+ 
microphone was amplified (10X) and routed to one channel of the SRS785 signal 
processor and the output from the ¼ B & K microphone was amplified and routed to a 
second channel on the SRS785 signal analyzer. Each stimulus frequency was presented 
and the attenuation was adjusted until a level of 60 dB SPL was achieved for the B & K 
channel. The attenuation level and the ER10B+ output level from the other channel of 
the SRS785 signal analyzer were saved as a probe tube calibration file (PTC) and the 
ER10B+ microphone sensitivity was calculated for each frequency. This PTC file was 
used to set the target dB SPL for the ER10B+ microphone output during each DPOAE 
study. This assured that a level of 60 dB SPL was achieved for both primary tones 
presented during DPOAE measures. The PTC file was also used to calculate the 
ER10B+ sensitivity, which is needed to calculate dB pe SPL for ABR stimulus 
intensity. During ABR studies, the ER10B+ microphone output was routed to an 
oscilloscope (Hewlett Packard 54602B) and peak-to-peak amplitude was recorded. 
Stimulus intensity (dB pe SPL) was later calculated based on the stimulus peak-to-peak 
amplitude and microphone sensitivity at that frequency.   
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Overview and Averaging  
Measurements began with DPOAE followed by ABR and VsEPs. This order was 
chosen in an attempt to limit exposure to high sound pressure levels that could result in 
an auditory threshold shift. Stimulus levels for DPOAE are limited to around 60 dB SPL 
compared to ABR maximum stimulus levels, which can be as high as 100 dB pe SPL. An 
intense forward masker is presented during VsEPs that has an average intensity level as 
high as 97 dB SPL. Vestibular evoked potentials were performed last in order to negate 
the possibility of noise-induced damage to the auditory system from exposure to the 
intense broad-band masker during VsEP testing. The broad-band masker is not required 
for VsEP recording but demonstrates that there is no auditory contribution or 
contamination in the VsEP waveforms. Test frequencies for ABR and DPOAE were 
tested in random order. In general, the three measures were completed in one mouse in 
less than two hours.  
Single channel signal averaging was used to record VsEP and ABR response 
waveforms.  Offline analysis was used to determine response thresholds, response peak 
latencies, and peak-to-peak amplitudes. Subcutaneous electrodes were placed as 
described previously. The electroencephalographic activity was amplified (200,000X, 
Grass P511), band pass filtered (300 to 3000 Hz, -6 dB points, Grass P511, West 
Warwick, RI) and digitized (10 µs per point for 1024 points, TDT AD1) beginning at 
stimulus onset (TDT TG6 triggers system). 256 samples were averaged to produce the 
final VsEP or ABR waveform. Stimuli for VsEPs were linear jerk pulses that physically 
moved the mouse’s head. ABR stimuli were short duration tone bursts. ABR and VsEP 
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threshold, peak latency, and peak to peak amplitude were quantified. Amplitude and 
latency measures for the first three peaks (PI, PII and PIII) of the response waveform 
were quantified. Threshold was defined as the intensity midway between the minimum 
stimulus intensity that produced a discernible response and the maximum stimulus 
intensity that did not result in a visible response. Response peak latency was defined as 
the time, in milliseconds, from onset of the stimulus to the appearance of each positive 
peak (PI, PII and PIII). Peak-to-peak amplitude, (PI-NI, PII-NII, and PIII-NIII) measured 
in microvolts (µv), represented the difference between each positive peak and its 
respective negative peak. 
Data Analysis 
 In order to compare cochlear and macular sensitivity, ABR and VsEP 
thresholds were normalized to establish a common unit of measure. We chose to 
normalize threshold values in terms of a percent change in auditory and macular dynamic 
range. Dynamic range was defined as the range from the best threshold measured 
previously in the CBA/CaJ strain to the most intense stimulus level possible without 
inducing a temporary threshold shift or permanent damage (e.g. noise induced hearing 
loss or dislodging macular otoconia). The CBA strain harbors no genetic mutations, 
maintains hearing until late in life, and served as a baseline for “normal” hearing. ABR 
and VsEP absolute threshold values were normalized relative to the dynamic range 
established for the CBA strain. Normalizing thresholds relative to the CBA strain allows 
a direct comparison between the two Ahl strains (C57 & CE/J) and between the two Ahl 
strains the control strain (CBA). The upper level of the dynamic range was determined 
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based on a pilot study that was conducted to determine the level at which ABR stimuli 
may cause temporary or permanent threshold shift. The results of this pilot study 
suggested that levels greater than 100 dB pe SPL might result in threshold shifts; so 100 
dB pe SPL was used as the upper range for auditory dynamic range. The lower limit for 
dynamic range was set by the best thresholds measured in the CBA/CaJ strain and were 
12.7, 13.1, 4.9, and 25.39 dB pe SPL for the test frequencies of 8, 16, 32, and 41.2 kHz, 
respectively. The lowest VsEP threshold measured was – 13.5 dB re: 1 g/ms and the most 
intense non-noxious sustained stimulus presentation level is + 6 dB re: 1 g/ms. The 
resulting dynamic range was 19.5 dB re: 1 g/ms. To normalize a given threshold (y) the 
following formula was used:  
 x =  y – z   *  100 
k  
where x = the normalized value, z = the lowest threshold measured and k is the dynamic 
range. 
For example, with an absolute threshold of -7.5 dB:   
       x = [(-7.5 - (-13.5) / 19.5] * 100 
      x = [6/19.5] * 100 
      x = 30.77% 
 
Age related changes in auditory sensitivity were compared between genders 
within strain. Age related changes in macular sensitivity were compared between genders 
within strain and between strains. The rate of change between auditory and macular 
sensitivity was compared within strain using linear regression and student’s T-test. Linear 
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regression analysis was performed to determine if there were significant differences in 
the linear regression slopes or intercepts of; female and male auditory thresholds, female 
and male macular thresholds, between auditory and macular thresholds within strain, and 
macular thresholds between strains. The mean DPOAE amplitude and noise floor were 
plotted for each age group as a function of age and geometric mean frequency. Extensive 
statistical analysis will not be performed on DPOAE data, as the main purpose of 
DPOAE measures was to characterize age related change in OHC function and to 
confirm the cochlea as the site of lesion.    
Structural Analysis 
 Temporal bones from young, middle, and old mice were dissected at the end of 
the functional experiments and fixed using 4% paraformaldehyde and 2% glutaraldehyde. 
Following 24 hours in fixative the temporal bones were then dehydrating using graded 
concentrations (70, 90, 95, and 100%) of ethyl alcohol. After a minimum of 24 hours in 
100 % ethyl alcohol, the macular organs were micro-dissected and mounted on aluminum 
stubs, critical point dried (Bal-Tec CPD 030, Liechtenstein), and sputter coated (Anatech 
LTD Hummer 6.6, San Diego, Ca.), before imaging with a scanning electron microscope 
(FEI Quanta 200, Hillsboro, Oregon). 
Results 
ABR thresholds increased significantly as a function of age for both strains. No 
significant gender difference was found for either strain for ABR threshold slopes or 
intercepts for 8 kHz (Fig. 29), so ABR data for the two genders were pooled for further 
analysis. Regression analysis for ABR and VsEP threshold comparisons between genders  
 
 137
Figure 29. Female and Male 8 kHz Threshold Comparison. Linear regression equations 
were: C57: females y = 30.6 + 2.86x, males y = 25.7 + 2.78x (confidence intervals were 
2.04 to 3.67 and 2.29 to 3.28 for females and males respectively). CE/J: females y = 34.1 
+ 2.20x males y = 36.4 + 1.93x (confidence intervals were 1.33 to 3.08 and 0.92 to 2.94 
for females and males respectively). No significant differences were found for slope or 
intercept between females and males of either strain.  
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was limited to data for ages less than 12 months due to the large number of missing data 
points (no responses) after 12 months of age. ABR and VsEP gender regression analysis 
focused on the difference between slopes of female and male VsEP and 8 kHz thresholds. 
In C57 mice, the slope of the linear regression model for the difference between females 
and males was 1.15, meaning that the estimated average difference between genders was 
1.15 dB per month. The 95 % confidence interval for difference in the slope for female 
and males was also calculated and values were from - 0.44 to 2.7. In CE/J mice, the slope 
of the linear regression model for the difference between females and males was 0.09, 
meaning that the estimated average difference between genders was 0.09 dB per month. 
The 95 % confidence interval for the difference in the slope for CE/J female and males 
was also calculated and values were from –2.24 to 2.05. We would argue that an average 
difference between females and males thresholds of 1.03 dB and 0.09 dB per month for 
C57 and CE/J strains respectively, does not represent a practical difference. The ABR 
and VsEP data for both genders was pooled for further analysis. 
ABR thresholds increased significantly as a function of age for both strains for all 
frequencies (with the exception of 41 kHz for CE/J) (Fig. 30, 31). Auditory sensitivity at 
the young ages was similar for the two strains for 8 and 16 kHz; however the CE/J 
showed elevated thresholds at 32 and 41.2 kHz at young ages relative to the C57 strain 
(Fig. 31).  C57 thresholds increased an average of 2.75, 2.76, 4.14, and 1.37 dB pe SPL 
per month and CE/J thresholds increased an average of 2.07, 2.69, 0.97, and 0.41 dB pe 
SPL per month for the test frequencies of 8, 16, 32, and 41.2 kHz, respectively. These 
average increases in threshold must be interpreted cautiously due to the large number of  
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Figure 30. ABR Audiogram for Both Strains. Data points represent the mean ABR 
threshold for each age group (listed on the right).  
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Figure 31. Comparison of ABR Thresholds. ABR threshold for the four test frequencies 
plotted as a function of age. Auditory sensitivity and rate of change for the two strains 
were similar for 8 and 16 kHz. The CE/J strain exhibits poor sensitivity for 32 and 41.2 
kHz even at the youngest ages. The right axis and line plots (dotted line for C57 and solid 
line for CE/J) reflect the percent of animals tested with a response (percent responding). 
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missing data points that occur as hearing loss progresses with age and reaches a level 
where no ABR response can be measured. P1 peak latencies increased an average of 
0.03, 0.03, 0.03, and 0.04 ms per month in the C57 strain (Fig. 33) and decreased an 
average of 0.002, 0.007, 0.0007, and 0.002 ms per month in the CE/J strain for 8, 16, 32, 
and 41.2 kHz respectively (Fig. 33).  
P1-N1 amplitude declined in both strains; an average of 0.06, 0.07, 0.11, and 0.04 
µv per month for C57 and 0.06, 0.07, 0.02, and 0.009 µv per month for CE/J for 8, 16,32, 
and 41.2 kHz respectively (Fig. 34).  
The VsEP response was generally present for all age groups (Fig. 35) in both 
strains and no significant gender differences were found for VsEP linear regression 
intercepts or slopes (Fig. 36). Macular sensitivity was similar for both strains at the 
earliest ages tested but the rate of decline in VsEP thresholds was significantly faster in 
the CE/J strain (p<0.001)(Fig. 37). The C57 strain showed an average decrease of 0.12 
dB re: 1 g/ms per month compared to 0.47 dB re: 1 g/ms per month for the CE/J strain. A 
student’s T-test comparing the slope of the linear regression line for VsEP threshold for 
the two strains, shows a significant difference (p< 0.001) in the rate of change of macular 
sensitivity between the two strains. VsEP P1 latency was similar for the two strains and 
increased as a function of age by an average of 0.01 and 0.008 ms per month for C57 and 
CE/J respectively (Fig. 38). VsEP P1-N1 amplitude decreased as a function of age by an 
average of 0.01 μv per month for both strains (Fig. 39).  
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Figure 32. ABR P1 Latency Comparison. ABR P1 latency plotted as a function of age for 
the two strains for the four ABR test frequencies. Least squares linear regression are 
indicated by the dashed (C57) and solid (CE/J) lines. Stable P1 latencies suggest minimal 
age related change in synaptic mechanisms and activation of primary afferents.  
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Figure 33. ABR P1-N1 Amplitude Comparison. ABR P1-N1 amplitude plotted against 
age for the C57 and CE/J strains for the four ABR test frequencies. There was a 
significant decrease (p< 0.0001) in P1-N1 amplitudes as a function of age for both 
strains. Significant decreases in P1-N1 amplitude suggests a dramatic reduction in the 
number of hair cells and primary afferents contributing to the response.  
 
41.2 kHz
Age (months)
0 2 4 6 8 10 12 14 16 18 20 22 24 26
A
m
pl
itu
de
 (m
ic
ro
vo
lts
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
CE/J
C57
8 kHz
Age (months)
0 2 4 6 8 10 12 14 16 18 20 22 24 26
A
m
pl
itu
de
 (m
ic
ro
vo
lts
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
C57
CE/J 
16 kHz
Age (months)
0 2 4 6 8 10 12 14 16 18 20 22 24 26
A
m
pl
itu
de
 (m
ic
ro
vo
lts
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
C57
CE/J 
32 kHz
Age (months)
0 2 4 6 8 10 12 14 16 18 20 22 24 26
A
m
pl
itu
de
 (m
ic
ro
vo
lts
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
C57 
CE/J
  
 
 144
Figure 34. Representative VsEP Waveforms. Representative VsEP waveforms for the  
two strains at selected ages. 
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Figure 35. Comparison of Female and Male VsEP Threshold. A comparison of female 
and male VsEP thresholds for the two strains. Linear regression equations were:  C57: 
females  y = -11.02 + 0.09x and males y = -11.84 + 0.15x  (the 95 % confidence intervals 
were 0.17 to 0.18 for females and 0.06 to 0.23 for males). CE/J: females y = -10.4 + 
0.53x and males y = -10 + 0.43x (the 95 % confidence intervals were 0.37 to 0.70 for 
females and 0.28 to 0.57 for males). No significant gender difference was found for slope 
or intercept for either strain. 
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Figure 36. Comparison of VsEP threshold. A comparison of age related change in VsEP 
thresholds between the two strains. Linear regression equations were: C57: y = -11.4 + 
0.12x and CE/J: y = -10.19 + 0.46x (the 95% confidence intervals for slope were 0.06 to 
0.18 and 0.36 to 0.57 for C57 and CE/J, respectively). Intercepts were not significantly 
different. The slopes of the linear regression lines were significantly different (p<0.0001). 
All 149 C57 mice tested had a VsEP response. Out of 102 CE/J mice tested two had no 
response (one at 7.4 months and one at 14.2 months). 
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Figure 37. Comparison of VsEP P1 Latency. A comparison of VsEP P1 latency between 
the two strains. Linear regression equations were: C57: y = 1.29 + 0.01x. CE/J: y = 1.26 
+ 0.01x (the 95% confidence intervals were 0.006 to 0.014 and 0.004 to 0.013 for C57 
and CE/J respectively). No significant difference was found for intercept or slope 
between the two strains. Small changes in P1 latencies suggest minimal age related 
change in synaptic processes and activation of primary afferents. 
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Figure 38. Comparison of VsEP P1-N1 Amplitude. A comparison of VsEP P1-N1 
amplitude between the two strains. Amplitude declined significantly (p<0.0001) as a 
function of age in both strains. Linear regression equations were: C57: y = 0.78 – 0.01x 
and CE/J: y = 0.50 – 0.01x. Significant decreases in P1-N1 amplitude suggests a dramatic 
reduction in the number of hair cells and primary afferents contributing to the response. 
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SEM images of the utricle and saccule from young and old animals show no 
apparent qualitative difference in macular otoconia of young and old mice that would 
explain a decrease in macular sensitivity in either strain (Fig. 40). SEM images of the 
macular organs showed full coverage of the utricular and saccular epithelia with dense 
populations of otoconia at young and advanced ages. This finding suggests that the 
observed age related decrease in macular sensitivity is not due to a loss of otoconia. 
A student’s T-test was used to compare VsEP and ABR threshold slopes within-
strain and this test revealed a significant difference (p< 0.0001) in the rate of change for 
the two modalities for both strains (Fig. 41). The comparison is based on 8 kHz only 
because both strains exhibit or develop high frequency hearing loss very young. A 
significant difference was found for both strains but the relationship between auditory 
and macular change is very different between the two strains. In the CE/J strain, the 
linear regression slopes for VsEP and ABR normalized thresholds were 2.15 and 2.37, 
respectively (Fig. 41). In the C57 strain, the linear regression slope for normalized VsEP 
and ABR thresholds were 0.62 and 3.15, respectively (Fig. 41). The difference in the rate 
of change between auditory and macular sensitivity is greater in the in C57 strain than the 
CE/J strain. 
DPOAE amplitudes decrease as a function of age in both strains (Fig. 42). The 
C57 strain exhibits larger amplitude DPOEA than the CE/J strain at all ages, except < 2 
months. DPOAE amplitudes in the CE/J strain generally fall below “normal” levels (as 
established by the 95% population range for the CBA strain) for all  
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Figure 39. Scanning Electron Microscopy Images of the Macular Organs. Representative 
SEM images of the utricle and saccule for old and young mice of both strains. The first 
set of images are from 20.9 month old C57 mice. The second set of images are from 10 
month old C57 mice. The third set are from 39 day old CE/J mice and the fourth set are 
from 14.9 and 16 month old CE/J mice.  
C57  
 
Saccule     Utricle  
     
300 µm     300 µm  
Saccule     Utricle      
  
 
300 µm     300 µm 
 
 
 151
CE/J  
 
Saccule     Utricle  
 
     
    300 µm           200µm 
Saccule       Utricle  
  
 
300 µm      300 µm 
 
 152
 Figure 40. Comparison of Age Related Change in Auditory and Macular Sensitivity. 
Normalized VsEP and ABR thresholds plotted against age for both strains. Linear 
regression equations were: C57: 8 kHz: y = 18.1 + 3.15x. VsEP: y = 10.76 + 0.62x. CE/J: 
8 kHz: y = 25.6 + 2.37x. VsEP: y = 18.51 + 2.15x. There was a significant difference 
between 8 kHz and VsEP slopes for both strains but the difference in rate of change 
between auditory and macular sensitivity is more pronounced in the C57 strain. 
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Figure 41. DPOAE Plots. DPOAE amplitude as a function of geometric mean frequency 
for the C57 and CE/J strains. Ages represents the mean age for the mice in each 
bimonthly age group. The black dashed line represents the 95% population range for 
DPOAE amplitudes for the 2 to 3 month age group for the CBA strain. Outer hair cell 
function declines with age in both strains but is reduced in the CE/J strain from an early 
age. 
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frequencies for all age groups except the youngest group. This is an indication that outer 
hair cell function is reduced from an early age in the CE/J strain.  
    Discussion 
The current ABR and DPOAE findings are in good agreement with the auditory 
structural degeneration and age related functional decline previously reported in both  
strains. Auditory structural and functional changes due to age have been well 
characterized in the C57 strain, which is widely accepted as an animal model for early  
 onset ARHL, and gender differences in auditory function have been reported in this 
strain (Henry, 2004). Henry did not perform statistical analysis and characterized gender 
differences based on line plots of ABR and cochlear nerve envelope thresholds for mice 
at selected ages. Henry’s line plots suggest that male C57 mice tend to have more 
sensitive hearing than females prior to hearing loss onset. In the current study, ABR 
thresholds versus age scatter plots for the C57 strain also show that males tend to have 
more sensitive hearing than females, even though no statistical difference was found. 
ABR gender plots for the CE/J strain show similar auditory sensitivity and rate of change 
between female and male mice. 
There is growing structural and functional data that supports the idea of auditory 
gender differences in mouse models of ARHL and it has been suggested that the female 
hormone estrogen may have a direct influence on cochlear function. This idea is 
supported by structural data from Stenberg et al. (1999) that revealed widespread 
immunostaining of the estrogen receptors ERα and ERβ in cochlear structures in CBA 
mice. Estrogen is known to have widespread effects on physiology and this finding 
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suggests that it may have a direct influence on cochlear structures. Further evidence is 
provided by Hulcrantz et al. (2000) who characterized cochlear structure and function in 
the X,O “Turner mouse” which produces no estrogen. They found a loss of outer hair 
cells (OHC), primary afferent pathology, increased ABR thresholds, and decreased 
DPOAE amplitudes relative to controls. Guimaraes et al. (2004) provide further evidence 
for the protective effects of estrogen on auditory function. Using both ABR and DPOAE, 
they found differences in auditory function pre and post menopause in female CBA mice. 
Females had lower thresholds and larger amplitude DPOAEs than males at middle and 
old ages but this advantage was lost following menopause. Study of the CBA strain in our 
laboratory, found that females tended to have lower ABR thresholds than males but no 
significant statistical difference was found between the genders. The role of female 
hormones on inner ear structure and function is poorly understood but there is growing 
evidence suggesting that female hormones may have a protective effect against ARHL. 
While previously described C57 strain auditory gender differences were not confirmed 
with statistical analysis there are small gender differences apparent in ABR threshold 
scatter plots.   
The effect of gender on vestibular structures and function is poorly understood. A 
search of the literature reveals no reports of gender differences in vestibular structures or 
function in relation to aging. We found no significant differences for macular sensitivity 
or the rate of change in macular sensitivity between the two genders for either strain.  
The auditory structural and functional changes seen in mice that carry Ahl may be 
explained by the effect of Ahl on cadherin23 expression in cochlear sensory structures 
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such as stereocilia, and transient and lateral tip links (Bolz et al., 2001; Bork et al., 2001; 
Di Palma et al., 2001). Cadherin23 is also expressed in vestibular stereocilia/kinocilia so 
it is reasonable to expect vestibular structural and functional degeneration with age as 
well. Vestibular structural pathologies have been identified in mice carrying  Cdh23 
mutations, including C57 (Shiga et al., 2004), modified deafwaddler (Noben-Trauth et 
al., 2003), waltzer (Di Palma et al., 2001), and Ames waltzer (Raphael et al., 2001) yet no 
significant functional change was found in C57 vestibular function using the VOR 
measure (Shiga et al., 2004). VOR relies on peripheral input, central integration and 
motor output and central compensation for peripheral deficits may explain the poor 
correlation between peripheral structural degeneration and functional results. Shiga et al. 
(2004) did not assess macular function. The current study utilized VsEP, which does not 
rely on central integration of peripheral input or motor output and therefore assesses 
peripheral function directly. The present study found an age related decline in macular 
sensitivity in both strains (21% and 56% loss of dynamic range at the oldest ages for C57 
and CE/J, respectively), with a more rapid decline in the CE/J strain (0.12 dB vs. 0.47 dB 
per month decrease for C57 and CE/J respectively). No qualitative difference was 
observed between young and old animals, of either strain, that would explain the 
observed macular functional decline. Reports in the literature concerning age related 
change in macular otoconia suggest structural (Ross, Peacor, Johnsson, & Allard, 1976; 
Jang et al., 2006) & ultra-structural changes (Campos, Canizares, Sanchez-Quevedo, & 
Romero, 1990), and an increased presence of giant otoconia, occurring more frequently 
on the edges of the macular surface (Suzuki, Katsuhisa, & Takasaka, 1997). In the current 
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study our assessment of macular otoconia was limited to a gross characterization of 
macular otoconia. Hypothetically, age related changes in otoconia production/turnover 
could result in ultra-structural differences (such as reduced Ca+ concentrations reported 
by Campos et al. (1990) in rats) in otoconia that could result in reduced otoconia density 
and decreased sensitivity to linear acceleration. It is unknown if this type of ultra-
structural change would be apparent in SEM images. Suzuki et al., (1997) compared the 
globular substance (secreted precursors to mature otoconia) between young and old C57 
mice (they did not assess otoconia numbers or structure directly) and their finding 
suggest reduced otoconia turnover in C57 mice. This is in sharp contrast to our findings 
of widespread coverage and dense concentrations of otoconia in the utricle and saccule of 
old C57 and CE/J mice. The observed decline in vestibular sensitivity therefore, may be 
due to degeneration of other macular structures such as hair cells (Anniko, 1983; Park et 
al., 1987; Nakayama et al., 1994), stereocilia/kinocilia (Rosenhall & Rubin, 1975; 
Nakayama et al., 1994), and/or primary afferents (Gleeson, et al., 1990) which are 
reported in the literature. 
 Work with the CBA strain has demonstrated age related decreases in auditory and 
macular function due to age alone (see the Chapter 4: Gravity Receptor Aging in the 
CBA/CaJ Strain; A Comparison to Auditory Aging). Age related auditory dysfunction is 
accelerated in Ahl strains, likely due to the Ahl mutation, but vestibular findings vary in 
the C57 and CE/J strains. Siemens et al. (2003) and Sollner et al. (2004) have shown that 
cadherin 23 is an essential component of cochlear and vestibular hair cell tip links and 
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lateral links and is necessary for the development and maintenance of 
mechanotransduction by these sensory structures.  
If Ahl effects Cdh23 expression in both cochlear and vestibular hair 
cells/stereocilia, why do auditory and macular function decline at significantly different 
rates in the C57 and CE/J strains and why does macular sensitivity decline at a 
significantly faster rate in the CE/J strain?  A reasonable genetic explanation for these 
findings is the presence of an unknown genetic modifier in the C57 strain that modifies 
Cdh23 expression in the vestibular macula and inhibits degeneration of macular 
structures/function. Genetic modifiers are “heritable factors capable of modifying the 
phenotype of a mutant gene without having an obvious effect on the normal condition” 
(Johnson, Zheng, & Noben-Trauth, (2006). Genetic modifiers are prevalent in all 
genetically mixed populations and their aggregate influence on a mutant phenotype is 
known as the genetic background effect or the strain background effect when referring to 
inbred strains. It is conceivable that the C57 strain carries a genetic modifier that is not 
present in the CE/J strain, which results in differential expression of the Cdh23753A 
mutation in cochlear and macular structures and results in preserved macular structures 
and function in the C57 strain. Further study is needed to: 1) pinpoint the genetic and 
anatomical sources of macular decline 2) identify the mechanisms for macular 
preservation in the C57 strain and 3) to determine the source of such disparate declines in 
macular function between strains carrying the Ahl mutation.  
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CHAPTER V: DISCUSSION 
Mouse Models: Why?     
Animal models play an important role in auditory and vestibular research and 
their use has resulted in a wealth of knowledge concerning the genetic and 
environmental causes of hearing loss and balance disorders. The mouse model has been 
of particular importance in the search for genetic contributions to hearing loss and 
balance disorders and a large and ever growing number of mutations that result in 
syndromic and non-syndromic hearing loss and balance disorders have been identified. 
The study of age effects on auditory and vestibular function in humans is hampered by 
individual differences in terms of lifestyle, the inherent heterogeneity of human 
genetics, and environmental factors such as infection, disease, physical insult, noise, 
and exposure to ototoxins. Anatomical and functional changes in the auditory system 
associated with aging are well studied and described in the literature. The effect of age 
on the vestibular system is much less understood and research in humans is impeded by 
the lack of a direct measure of vestibular function. The mouse model allows researchers 
to address many of these challenges to experimental control because mice can be 
selectively bred and housed in a controlled environment, function can be readily 
measured over the entire lifespan, and a direct measure of vestibular function is 
available. In order to develop appropriate mouse models for auditory and vestibular 
aging, it is necessary to accurately describe function over the whole lifespan of the 
potential mouse model.  
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Summary of “Age Alone” Study 
The goals of this project regarding age effects alone (utilizing the CBA/CaJ 
strain) were:  
1) to describe the effect of age alone on auditory and vestibular function  
2) to describe the effect of age and gender on auditory and vestibular function  
3) to compare the time course of changes between auditory and vestibular function.  
The results of auditory measures in the current study are in good agreement with 
previously published structural studies that have identified decreases in the number of 
cochlear hair cells and reduced spiral ganglion densities with aging. Our results  
replicated previous studies in terms of the onset and rate of change of auditory function. 
The finding that CBA exhibit a slow progressive decline in auditory sensitivity for all 
frequencies, which begins around midlife, supports the widely held belief that the CBA 
strain is a good control strain for auditory measures, and genetic background for 
creation of new strains. 
Gender 
The current study differs from previous studies regarding gender differences in 
auditory sensitivity and change over time. Henry (2004) reported that male CBA mice 
showed poorer high frequency sensitivity than females at 1 year of age based on the 
ABR audiogram although no statistical analysis was performed. Henry (2002) reported 
that female C57 mice had poorer auditory sensitivity than males. Guimaraes et al. 
(2004) reported a gender difference in CBA mice, only for the old age group, using 
arbitrary age groups and ANOVA. Our results show no significant difference for the 
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slope or intercept of the linear regression line between male and female CBA mice. 
However, the ABR scatter plots for CBA do reveal small gender differences that 
replicate the trends reported by Henry (2002, 2004) and Guimaraes (2004). In the 
current study, male CBA mice tended to have poorer auditory sensitivity than females. 
Henry (2002, 2004) did not perform statistical analysis and his conclusions are based on 
characterization of scatter plots. Guimaraes et al., (2002) separated subjects into 
arbitrary young, middle, and old, age groups and only found a statistically significant 
ABR gender difference in the oldest group using ANOVA. It is possible that we did not 
find a significant gender difference like Guimaraes et al., 2002 for two reasons. 1) Their 
oldest age group included mice from 24 to 29 months of age. We did not measure mice 
older than 24 months. 2) They separated mice into arbitrary age groups and compared 
groups using ANOVA. We chose to use linear regression analysis and student’s T-test 
to compare slopes. 
Auditory Aging 
Overall, auditory sensitivity showed a gradual decline and DPOAE results 
indicate decreased OHC function as once source of decreased auditory sensitivity. It is 
well established that the cochlea of CBA mice show age related structural change and 
gradual age related functional changes. What was not known before the current study 
was the effect of age and gender on macular function and the relationship between 
auditory and vestibular functional aging. 
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Macular Aging 
 The information gained by measuring macular function over the majority of the 
lifespan of the CBA mouse is completely new. The limited functional data available 
previously for the CBA strain suggested that macular function was maintained until at 
least 5 months of age. Our results show that there is gradual decline in macular 
sensitivity (an average of 0.39 dB per month) and that by 23 months of age there is an 
average loss of 48% of the dynamic range for VsEP. This slow progressive loss of 
macular function must be taken into consideration when utilizing the CBA strain as a 
control for vestibular studies or as a background strain for creation of new mouse 
strains. 
SEM Findings 
Scanning electron microscopy imaging of the macular organs rules out gross 
qualitative change in macular otoconia as possible explanations for the observed 
functional decline. Previous reports of age related change in otoconia include: reduced 
numbers of globular substance (substance secreted from the statoconial layer that 
develop into mature otoconia) in old C57 mice, which suggests reduced otoconia 
turnover (Suzuki et al., 1997) 2) ultra structural changes in otoconia morphology such 
as: increased fracturing, pitting, fragmentation, collapse, and weakened or broken 
linking filaments links (Jang et al., 2006; Campos et al., 1990) and 3) increased 
presence of giant otoconia, occurring more frequently on the edges of the macular 
surface. These studies suggest age related change at the cellular level in the macular 
organs and it is possible that these changes could result in otoconia with reduced 
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density. Reduced otoconial density could conceivably result in higher thresholds to 
linear acceleration. It is unknown if this hypothetical reduction in otoconia density 
would be revealed in SEM images. A reduction in otoconia density therefore cannot be 
ruled out as a possible explanation for age related reduction in macular sensitivity.  
Global Membranous Labyrinth Change 
The finding that auditory and macular sensitivity both decline in the CBA strain 
leads us to the question: What global change in the membranous labyrinth might affect 
the auditory and vestibular organs equally? Morphological studies of the inner ear have 
identified widespread age related change in the cochlea and vestibular organs. Reports 
of cochlear degeneration with age include: loss of inner and outer hair cells, 
missing/disarranged/fused stereocilia, increased fragility of the cuticular plate, reduced 
blood flow, degeneration of structures responsible for the maintenance of the 
endolymphatic potential such as the stria vascularis and spiral ligament, reduction in the 
density of primary afferent fibers, hair cell cytoplasmic protrusions, giant hair cells, the 
accumulation of a “wear and tear” pigment known as lipofuscin, and increased numbers 
of mitochondrial mutations. In the vestibular organs reports of age related structural 
change include: loss of type I and type II vestibular hair cells, 
missing/disarranged/fused stereocilia and kinocilia, hair cell cytoplasmic protrusions, 
giant hair cells, increased fragility of the cuticular plate, reduced primary afferent 
densities, reduced blood flow, morphological changes in macular otoconia, and reduced 
numbers of globular substances and otoconia turnover.  
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Schuknecht and Gacek’s Classification  
Age related degeneration of membranous labyrinth structures have typically 
been placed into several conceptual categories; 1) neural, involving primarily a loss of 
afferent innervation 2) metabolic, involving blood supply and non-sensory structures 
(stria vascularis, spiral ligament, vestibular dark cells, etc.) responsible for producing 
the endolymphatic potential 3) sensory, involving hair cells, stereocilia/kinocilia, or 
sensory supporting cells (Schuknecht & Gacek, 1993). Schuknecht’s human temporal 
bone studies have shown that these pathologies may exist independently and 
concurrently. Pathology of the cochlear hair cells (primarily OHC) and their 
accompanying stereocilia are widely accepted as a primary cause of age related hearing 
loss and loss of spiral ganglion fibers is generally considered to be secondary to the loss 
of hair cells. The specific mechanisms behind hair cell degeneration and neuronal loss 
are not known. Several researchers have suggested that pathological changes in the stria 
vascularis and spiral ligament, which are critical structures to the maintenance of the 
endolymphatic homeostasis, are precursors to hair cell degeneration and neuronal loss 
(Ohlemiller & Gagnon, 2004; Hequembourg & Liberman, 2001; Gratton & Schulte, 
1995; Spicer & Schulte, 2005). While there is strong evidence for age related 
degeneration of these structures, the results from studies of the EP itself are mixed 
depending on the location of measurement, species studied, and genetic strain utilized. 
The EP is inherently difficult to measure and varies by measurement site, species, and 
genetic strain and the findings concerning the EP itself vary depending on the animal 
model and genetic strain utilized; e.g. gerbils and BALB/cJ mice show a reduced EP as 
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function of age (Gratton et al., 1996) while the C57 and CBA/CaJ mouse strains do not 
(Lang et al., 2002; Ohlemiller et al. 2006; Wu & Marcus, 2003, Sha et al., 2008). The 
finding that the EP does not decrease with age in the CBA or C57 strains makes it 
unlikely that this is the source of decreased auditory and macular sensitivity seen with 
aging in these strains.  
Mitochondrial Clock Theory 
The maintenance of endolymphatic homeostasis is one type of metabolic process 
that occurs in the cochlea and vestibular organs. Another type of metabolic process 
occurs at the cellular level in all sensory and supporting cells of the cochlea and 
vestibular organs. Cellular metabolic activity involves mitochondria and aerobic 
respiration to create energy for cellular activity. Mitochondria produce cellular energy 
for virtually every cell in the body through mitochondrial oxidative phosphorylation and 
mitochondria are unique in that they contain their own DNA (mtDNA) (Anderson, et 
al., 1955; Chance & Williams, 1981). The membrane theory of aging, or mitochondrial 
clock theory, maintains that as animals age mtDNA mutations/deletions increase due to 
damage from reactive oxygen metabolites (ROM), which are toxic enzymes produced 
as by products of oxidative phosphorylation. An increase in mtDNA 
mutations/deletions and decreased metabolic efficiency eventually lead to a cellular 
“energy crisis” and cell death (apoptosis) (Harmon, 2002). Increased ROM production 
and mtDNA mutations/deletions are associated with reduced blood flow (Ohlemiller & 
Dugan, 1999), aging (Bai et al., 1997), and specific genetic mutations (Niu, Trifunovic, 
Larsson, & Canlon, 2007; Mcfadden, Ding, & Salvi, 2001; Yamasoba et al., 2007) and 
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commonly occur in post mitotic tissues that have high energy requirements (e.g. brain, 
heart, eyes, inner ear, muscle, and kidneys). An increased rate of mtDNA 
mutations/deletions in the cochlea with aging is supported by direct measures of 
cochlear tissues using polymerase chain reaction (PCR) (Wu, Du, Wang, Niu, & Jin, 
2002, Markaryan, Nelson, & Hinojosa, 2008, Han, Han, & Jiang, 2000, Bai et al., 1997) 
and DNA microarrays (Yamasoba et al., 2007). Indirect evidence for decreased cochlear 
metabolic efficiency and increased ROM production as a result of aging includes: 
increased presence of lipofuscin (a wear-and-tear pigment that is a by product of 
cellular metabolic processes) in inner ear structures, reduced immunohistochemical 
staining for key molecules and proteins that detoxify ROM (SOD (Cu/Zn), SOD (Mn), 
Catalase, Glutathione perioxidase) (Staecker et al., 2001; Jiang et al., 2007; 
Lautermann, Crann, McLaren, & Schacht, 1997), poor auditory sensitivity in mutant 
strains with a genetic predisposition for increased mtDNA mutations/deletions 
(McFadden et al, 2001; Yamasoba et al., 2007; Niu et al., 2007), and amelioration of 
oxidative stress through use of antioxidants or dietary restriction (Seidman, Bai, khan, 
& Quirk, 2001; Seidman, 2000; Le & Keithley, 2007, Someya, Yamasoba, Weindruch, 
Prolla, & Tanokura, 2007).  
A search of the literature found no direct evidence for decreased metabolic 
efficiency, increased ROM production, or mitochondrial mutations/deletions in the 
vestibular organs as an effect of age. Many studies however have reported the presence 
of lipofuscin in sensory (more pronounced in type I hair cells than type II hair cells) and 
supporting structures (Rosenhall & Rubin, 1975; Park et al., 1987; Gleeson et al., 1990; 
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Anniko, 1983) providing indirect evidence for reduced metabolic efficiency in 
vestibular sensory structures as an effect of age. A study by Lyon and Jensen (2001) in 
rats indicates that the blood flow to the cochlea is approximately double that of any of 
the individual vestibular organs and blood flow to each of the vestibular organs is 
roughly equal. The large vascular supply to the cochlea, relative to the macular organs, 
suggests that the metabolic demands of the cochlea are higher than those of the 
vestibular organs and would indicate that the cochlea may be at higher risk for mtDNA 
mutations/deletions and resulting apoptosis. This idea is not borne out by our functional 
findings in the CBA strain however. In spite of significant statistical difference between 
ABR and VsEP normalized threshold slopes, CBA results show functional decline that 
is similar for the cochlea and macular organs. In general, macular function declined at a 
slightly faster rate than auditory function in this strain but overall the rate of change in 
the two modalities is similar. A study of mtDNA mutations/deletions that included the 
vestibular organs as well as the cochlea in the CBA strain would further our 
understanding of inner ear degeneration at the cellular level and help elucidate the 
origin of the metabolic, sensory, and neuronal degeneration seen in the inner ear with 
aging.  
Summary of Ahl Models 
The primary goal of the current study was to characterize macular function in 
three inbred strains known to harbor Ahl mutations and determine the effect of Ahl and 
Ahl2 on vestibular function. We were successful in establishing breeding colonies and 
measuring function in two strains that harbor Ahl (C57 and CE/J) but had limited 
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success in breeding sufficient numbers of the strain that carries Ahl and Ahl2 (NOD. 
NON).  
NOD. NON 
The minimal functional data (22 mice to 11 months of age) collected for the NOD. 
NON strain shows that they have profound hearing loss from an early age (there were 
only 5 measurable ABR threshold in 22 animals tested) and maintain macular 
sensitivity out to 11 months of age (Fig. 42). These auditory results are in good 
agreement with previous auditory reports of profound hearing loss very early in life for 
this strain (Johnson & Zheng, 2002). The maintenance of macular function to mid-life is 
new information concerning vestibular function in a strain carrying Ahl and Ahl2. This 
finding indicates that macular function does not follow the rapid degeneration that 
occurs in auditory function when both Ahl and Ahl2 are present.  A larger sample size is 
needed to determine if this preliminary finding is correct and to characterize macular 
function beyond 11 months of age. 
C57 and CE/J  
We chose to use the C57 and CE/J strains to assess the effect of Ahl on vestibular 
function. The Ahl mutation effects Cdh23 expression (a gene which encodes a family of 
proteins necessary for inner ear development/maintenance of sensory cell structures (Di 
Palma, Pellegrino, & Noben-Trauth, 2001). Immunostaining studies in mice, rats, frogs,   
and fish have identified Cdh23 as a key component in cochlear and vestibular stereocilia 
and kinocilia ontogeny but the role of Cdh23 later in the lifespan remains controversial. 
Seimens et al. (2004), Sollner et al. (2004), and Rzadzinska, Derr, Kachar, &  
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Figure 42. VsEP vs. Age for the NOD. NON strain. 100% of animals measured had a 
VsEP response. The limited data collected suggest that macular sensitivity is maintained 
until mid-life in the presence of the Ahl and Ahl2 mutations in the NOD. NON strain. 
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Noben-Trauth et al., (2005) present evidence that Cdh23 is a component of tip links and 
is present in adult mouse cochlear stereocilia; while Boeda et al. (2002) and Lagziel et al.  
(2005) present evidence that Cdh23 is absent from stereocilia but remains present in 
Reissner’s membrane (RM), in hair cell centrosomes, and in areas of kinocilia-stereocilia 
attachment. While age related morphological changes in the C57 cochlea have been well 
described (loss of inner and outer hair cells, missing/disarranged/fused stereocilia, 
increased fragility of the cuticular plate, reduced blood flow, degeneration of the stria  
cytoplasmic protrusions, giant hair cells, the accumulation of a “wear and tear” pigment 
known as lipofuscin, and increased numbers of mitochondrial mutations), the precise role 
of Cdh23 in age related cochlear dysfunction is unknown. The fact that C57 mice have 
“normal” hearing and macular sensitivity at young ages and maintain macular sensitivity 
while losing hearing suggests that Cdh23 participation during cochlear and macular 
development is normal. This suggests that Cdh23 expression later becomes abnormal for 
maintenance of cochlear stereocilia structures while remaining normal in macular 
structures. The CE/J strain loses auditory and macular sensitivity at a similar rate 
suggesting that Cdh23 expression may become abnormal in both the cochlea and macular 
organs as a function of age. Interestingly, the rate of change in macular sensitivity for the 
C57 strain is significantly slower than the of the CBA strain; 0.12 dB loss per month and 
21% total loss of dynamic range in C57 vs. 0.39 for CBA and 48 % for CBA (Fig. 43). 
The VsEP response appears more robust in C57 mice at advanced age compared to the 
CBA response (Fig. 44). In the CE/J strain, auditory and macular function declined at a 
similar rate suggesting that cochlear and vestibular stereocilia/kinocilia degenerate  
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Figure 43. A comparison of VsEP threshold for the C57 and CBA strains. The linear 
regression equations were y = -11.4 + 0.12x for C57 and y = -12.4 + 0.39x for CBA. 
The slope of the linear regression line for the two strains is significantly different 
(p<0.001).  
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Figure 44. Representative waveforms for 6 ages for the C57 and CBA strains. Peaks P1, 
P2, P3, N1, N2, and N3 are labeled. 
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simultaneously in this strain. No significant difference was found for the rate of change in 
macular sensitivity between the CE/J and CBA strains, 0.58 dB loss per month reaching  
 48% total loss of dynamic range for CE/J versus 0.39 dB loss per month reaching 48 % 
total loss of dynamic range for CBA (Fig. 45). The slope of the linear regression lines for 
VsEP threshold between C57 and CE/J were significantly different (Fig. 46), suggesting 
distinct rates of change in macular sensitivity for these two Ahl strains. Figures 47 and 48 
compare the rate of age related change in VsEP and 8 kHz ABR thresholds between the 
three strains. 
C57 Genetic Modifier? 
The finding that macular aging occurs at different rates in these two Ahl strains 
suggests that the effect of the Ahl mutation on Cdh23 expression in vestibular hair 
cells/stereocilia is distinct in these two strains. A reasonable genetic explanation for this  
finding is the presence of an unknown genetic modifier, in the C57 strain, that modifies 
Cdh23 expression in the vestibular macula and inhibits degeneration of macular 
structures/function. Genetic modifiers are “heritable factors capable of modifying the 
phenotype of a mutant gene without having an obvious effect on the normal condition” 
(Johnson, Zheng, & Noben-Trauth, 2006). Genetic modifiers are prevalent in all 
genetically mixed populations and their aggregate influence on a mutant phenotype is 
known as the genetic background effect or the strain background effect when referring 
to inbred strains. It is conceivable that the C57 strain carries a genetic modifier that is 
not present in the CE/J strain, which results in differential expression of the Cdh23753A  
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Figure 45. A comparison of VsEP threshold for the CE/J and CBA strains. The linear 
regression equations were y = -10.2 + 0.47x for CE/J and y = -12.4 + 0.39x for CBA. 
The slope of the linear regression line for the two strains is not significantly different. 
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Figure 46. A comparison of VsEP threshold for the CE/J and C57 strains. The linear 
regression equations were y = -10.2 + 0.47x for CE/J and y = -11.4 + 0.12x for C57. 
The slope of the linear regression line for the two strains is significantly different  
(p< 0.0001). 
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Figure 47. VsEP comparison between the CBA, C57, and CE/J strains. VsEP threshold 
plotted as a function of age for the CBA, C57, and CE/J strains. Linear regression 
equations were y = -11.4 + 0.12x  for C57 (dotted line), y = -10.2 + 0.47x for CE/J (solid 
line), and y = -12.4 + 0.39x for CBA (long dashed line) strains respectively. 
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Figure 48. 8 kHz ABR threshold comparison between CBA, C57, and CE/J strains. 8 
kHz threshold plotted as a function of age for the C57, CE/J, and CBA strains. The linear 
regression equations were y = 28.5 + 2.8x, y = 35.1 + 2.1x, and y = 32.8 + 1.36x for the 
C57 (dotted line), CE/J (long dashed line), and CBA (solid line) strains respectively. 
There is a large number of missing data points for advanced ages in the C57 and CE/J 
strains which results in a slope that underestimates the rate of decline in auditory 
sensitivity. 
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mutation in cochlear and macular structures and results in preserved macular structures 
and function in the C57 strain. Further study is needed to determine if such a genetic  
 modifier exists in the C57 strain and explains such a disparate decline in macular 
function between the two strains.  
Limitation of the Study and Implications for Future Research 
Limitation of the Study  
The vestibular measure used in the current study assesses the integrity of the 
macular organs and provides no direct information concerning the functional status of 
the SCC. Due to the complex morphological polarization vectors of macular hair cells it 
is likely that during both macular organs are stimulated by linear accelerations and both 
macular organs contribute to the response. The VsEP measures in the current study 
utilized a linear acceleration stimulus. The macular organs are vestibular structures that 
are primarily stimulated by gravitation force and linear accelerations and are the 
primary contributors to linear acceleration VsEPs (Nazareth & Jones, 1998; Jones & 
Jones, 1999). As a result, linear acceleration VsEPs originate primarily in the macular 
organs and the contribution of the SCC is likely minimal. Morphological studies that 
have assessed age related change in each of the five vestibular organs have shown 
mixed results, depending on the species and strain utilized. There are studies that have 
shown disparate changes in the SCC and the macular organs (Rauch, et al. 2001; 
Merchant, et al., 2000). The present study does not contribute any useful information 
for determining if aging effects are equivalent for the SCC and macular organs.  
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It was discussed previously that age related structural change in the macular 
organs are reported in the literature. These reports include 1) reduced numbers of 
globular substance (substance secreted from the statoconial layer that develop into 
mature otoconia) in old C57 mice, which suggests reduced otoconia turnover (Suzuki et 
al., 1997) 2) ultra structural changes in otoconia morphology such as: increased 
fracturing, pitting, fragmentation, collapse, and weakened or broken linking filaments 
links (Jang et al., 2006; Campos et al., 1990) and 3) increased presence of giant 
otoconia, occurring more frequently on the edges of the macular surface. These studies 
describe gross and ultra structural age related changes in otoconia and suggest 
degeneration at the cellular level in otoconia production. Such gross or ultra structural 
changes could conceivably result in otoconia with reduced density and result in higher 
thresholds to linear acceleration. A search of the literature fails to reveal studies 
regarding age related change in otoconia density. It is unknown if this hypothetical 
reduction in otoconia density would be revealed in SEM images. A reduction in 
otoconia density therefore cannot be ruled out as a possible explanation for age related 
reduction in macular sensitivity. SEM imaging in the current study was limited to views 
of the whole otoconial surface rather than individual otoconia or small groups of 
otoconia. As a result, images do not have the resolution necessary to identify structural 
or ultra structural changes at the level of individual otoconia. Though limited in 
resolution, these images do reveal large numbers of widely distributed, dense inclusions 
of otoconia in the utricle and saccule of old mice of all three strains with no apparent 
difference between young and old macular otoconia. 
 180
Research and Clinical Implications 
Research Implications 
In the discussion of age related changes in macular sensitivity of the CBA strain 
(our “age alone” model), we suggested that the changes seen in auditory and macular 
function may be due to reduced efficiency of metabolic processes, increased ROM 
production, and cumulative damage to mtDNA. Future study into the role of oxidative 
stress on macular structures in the CBA strain might help identify the role of oxidative 
stress in age related declines in macular sensitivity.  
In the current study, the C57 strain auditory results replicate previous studies 
showing early onset hearing loss and our VsEP results indicate a slow decline in 
macular sensitivity reaching an average loss of 21 % in the oldest age group. We 
hypothesized that C57 auditory and macular function would decline at similar rates, as 
it does in the CBA strain and the second Ahl strain (CE/J) measured. This hypothesis 
was not borne out by our findings and auditory and macular function was shown to 
decline at significantly different rates in the C57 strain. Park, Hubel, and Wood (1987) 
reported on detailed morphological study of the vestibular organs of young and old 
C57BL/6NNia mice and describe an average 14 % and 19% age related loss of hair cell 
densities for the utricle and saccule respectively. The elderly mice in their study were 
between 29 and 31 months. They did not assess cochlear structures but other studies 
have reported losses of 80% of OHC and 100% in the base and 20% of IHC in the apex 
by 26 months of age (Spongr et al., 1997). It would be interesting to perform  similar 
studies in mice closer to the oldest ages (23 months) used in our study and compare hair 
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cell densities to our functional data. Disparate rates of age related change in auditory 
and macular function, in the presence of a Cdh23 mutation, suggests an unknown 
genetic modifier of the Ahl mutation in the macular organs of the C57 strain. Future 
genetic studies may identify this hypothetical genetic modifier of Ahl expression in C57 
macular organs.  
DPOAE measures were performed in the current study to characterize age 
related change in OHC function, to confirm the cochlea as the site of lesion, and to 
provide an indication of where in the cochlea the pathology is occurring (e.g. IHC vs. 
OHC). As a result, we measured and describe DPOAE amplitudes only. Future studies 
that utilize other DPOAE parameters, (threshold, input/output functions, phase, 
contralateral suppression, etc.) and focus on the time period surrounding the epoch 
when functional decline begins, may identify alterations in DPOAE that proceed (and 
therefore might predict) hearing loss.  
Clinical Implications 
 The development of appropriate animal models is a critical step in determining 
factors that contribute to age related declines in auditory and vestibular function. 
Furthermore, animal models are a valuable tool for determining the genetic, structural, 
and physiological pathogenesis of age related declines in inner ear function. The 
indirect nature of existing vestibular measures in humans and central compensation for 
peripheral deficits makes it difficult to definitively separate peripheral and central 
pathologies. The findings of the current study, using a direct vestibular measure, for the 
CBA strain (our model for age alone) indicate similar rates of change in auditory and 
 182
macular sensitivity. If this finding is generalized to humans, it would suggest that 
patients diagnosed with ARHL are likely to suffer decreased peripheral vestibular 
function concomitantly. Unfortunately, audiological tests that differentiate between 
genetic and acquired hearing loss are not currently available. Even if such a diagnosis 
were possible, such generalizations must be made cautiously. The findings from the 
C57 strain (profound hearing loss and maintenance of macular sensitivity) highlights 
the fact that a genetic predisposition for change in one inner ear modality does not 
obligate change in the other inner ear modality. Clinicians must be cognizant of the role 
that genetic background plays in ARHL and vestibular dysfunction. It is conceivable 
that in the future, genetic profiles may be an integral part of medical records and 
clinicians may direct diagnostic testing and interventions based on an individual’s 
known genetic background. 
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APPENDIX A: CBA/CaJ RAW EXPERIMENTAL DATA  
 
Study Gender Study Date
Age 
(months) VsEP ABR 8k ABR 16k ABR 32k ABR 41.2
Age27 F 7/21/2005 1.94 -7.5 30.96 47.78 28.1 59.8
Age28 F 7/21/2005 1.94 -7.5 27.96 28.13 20.7 38.84
Age29 F 7/21/2005 1.94 -7.5 42.96 26.78 25.08 48.9
Age70 F 10/28/2005 1.87 -13.5 54.67 25.19 32.58 61.75
Age71 F 10/28/2005 1.87 -10.5 24 19.17 5.5 52.4
Age72 F 10/28/2005 1.74 -13.5 30.46 22.2 14.5 28.98
Age73 M 10/28/2005 1.87 -13.5 36.24 35.95 33.24 54.59
Age74 M 10/28/2005 1.87 -13.5 54.2 28.9 35.24 53
Age55 F 9/16/2005 2.20 -7.5 12.7 21.65 8.6 37.3
Age86 M 11/15/2005 2.47 -10.5 40.61 31.98 46.28 52.39
Age87 M 11/15/2005 2.47 NA 40.61 37.98 25.28 47.89
Age89 F 11/22/2005 2.70 -10.5 31.61 34.98 22.28 37.39
a225 F 10/13/2006 2.20 -7.5 33.46 47.53 37.88 41.77
a226 F 10/13/2006 2.20 NA 32.79 34.07 26.24 53.7
a227 F 10/13/2006 2.20 NA 33.89 35.3 38.53 53.27
a228 F 10/18/2006 2.37 -10.5 44 34.03 25.88 51.9
a292 M 1/11/2007 2.63 -10.5 51.6 31.4 12.4 68
a294 M 1/12/2007 2.66 -13.5 30.18 35.1 4.9 43.23
a295 F 1/12/2007 2.66 -10.5 35.63 47.1 21.9 29.27
Age5 M 1/11/2005 4.54 -10.5 67.61 43.98 58.28 61.39
Age8 M 2/3/2005 5.95 -10.5 NA NA NA NA
Age20 F 5/3/2005 4.96 -10.5 40.61 13.98 19.28 25.39
Age38 F 8/25/2005 4.70 -10.5 37.7 20.5 19.3 48.5
Age39 F 8/25/2005 4.70 -13.5 32.8 19.7 25.1 37.3
Age46 M 9/8/2005 5.06 -10.5 37.78 44.3 6 59.9
Age47 M 9/9/2005 5.10 -13.5 31 20.95 12.5 50.8
Age48 M 9/9/2005 5.10 -10.5 15.9 30.67 16.2 47.8
Age49 M 9/13/2005 5.33 -10.5 33.87 23.78 31.54 46.4
Age50 M 9/15/2005 5.39 -10.5 36.57 28.17 27.52 60.18
Age51 M 9/15/2005 5.39 -7.5 13.9 13.27 11.7 43.1
Age85 M 11/11/2005 4.18 -13.5 46.41 34.98 22.26 49.42
a285 F 1/3/2007 4.96 -10.5 56 33 25 65.4
a300 M 1/19/2007 5.42 -10.5 52.6 29.86 42.48 49.3
Age12 F 2/17/2005 6.41 -10.5 NA NA NA NA
Age19 M 4/21/2005 7.82 -7.5 NA NA NA NA
Age26 M 7/15/2005 7.40 NA 42.9 37.98 34.28 64.39
Age32 F 7/26/2005 7.73 NA 39.23 30.67 15.52 38.84
Age33 F 7/26/2005 7.73 -7.5 34.66 45.59 27.6 49.56
a243 F 11/2/2006 7.17 -10.5 20.9 24 13.1 55.58
a244 F 11/2/2006 7.17 -10.5 20.9 23.28 10.6 42.2
a245 F 11/2/2006 7.17 -10.5 19.39 13.1 10.75 52.55
a246 F 11/2/2006 7.17 -13.5 33.02 31.9 25.2 31.86
a286 M 1/3/2007 7.69 -10.5 31 34.36 12.75 41.86
a287 M 1/3/2007 7.69 -13.5 53.78 45.3 53 58
a290 F 1/10/2007 7.92 -13.5 30.8 21.1 23.5 43
a291 F 1/10/2007 7.92 -7.5 26.8 42.1 26 68.3
a293 M 1/11/2007 7.96 -10.5 43.46 45.2 16.1 51.6
Study Gender Study Date
Age 
(months) VsEP ABR 8k ABR 16k ABR 32k ABR 41.2
Age18 F 4/14/2005 8.25 NA 22.61 16.98 40.28 61.39
age61 M 9/23/2005 9.67 -4.5 55.75 39.26 29.36 60.7
age62 M 9/23/2005 9.67 -4.5 56.38 28.4 23.52 61.55
age63 M 9/23/2005 9.67 -7.5 71.49 39.13 30.8 59.5
a126 M 3/9/2006 9.53 -10.5 62.4 29.95 40.7 46.4
a127 M 3/9/2006 9.53 -10.5 39.3 31.88 13.06 42
a168 M 5/4/2006 9.90 -10.5 54.16 63.6 33.94 62.76
a169 M 5/4/2006 9.90 -10.5 45.99 39.77 22.6 63
a170 M 5/4/2006 9.90 NA 45.99 51.6 47.78 60.7
a302 F 3/7/2007 9.76 NA 40.86 23.43 49.7 49.9
a304 F 3/8/2007 9.80 NA 39.75 45.9 28.7 31.47
a307 F 3/22/2007 8.38 -7.5 28.86 32.3 28.7 44.9
a308 M 3/22/2007 8.38 -7.5 51.7 46 41.3 45.6
a309 M 3/22/2007 8.38 -10.5 54.8 46.86 37.83 71.3
Age75 F 11/2/2005 10.98 NA 51.2 55.3 24 68.9
Age76 F 11/2/2005 10.98 -7.5 25 30.2 12.34 44.5
Age77 F 11/2/2005 10.98 -1.5 68.73 53.6 61.88 64.9
Age78 F 11/2/2005 10.98 -4.5 50.95 40.13 22.6 39.68
a128 M 3/9/2006 10.22 -7.5 39.67 46.75 23.8 56.86
a129 F 3/9/2006 11.70 -7.5 41 43.75 39 63.2
a133 F 3/10/2006 11.74 -7.5 30.99 46.11 26.1 54.53
a152 M 4/7/2006 10.49 NA 61.48 51.6 47.8 66.12
a303 M 3/8/2007 10.49 -10.5 52 35 23.99 57
a310 M 3/22/2007 10.49 -10.5 52.99 45.37 52.77 56.89
a311 M 3/22/2007 10.49 -10.5 43.25 47.7 31.85 36.45
a332 M 4/25/2007 11.38 -7.5 82.23 77.48 NR NR
a132 M 3/10/2006 12.39 -1.5 42.19 49.32 26.27 39.81
a156 M 4/20/2006 13.08 -4.5 57.68 53.9 31.2 63.36
a157 M 4/20/2006 13.08 -7.5 51.33 47.28 25.58 46.9
a171 F 5/8/2006 12.20 -7.5 34.68 39.6 12.24 39
a172 F 5/8/2006 12.20 -10.5 32.84 40.2 20.36 39.47
a173 F 5/8/2006 12.20 -7.5 46.14 51.6 47 73.08
a336 F 4/25/2007 12.20 -10.5 31.79 37.46 42.93 39.09
a434 M 8/23/2006 12.72 -7.5 56.55 53.15 62.25 68.12
Age36 F 8/19/2005 15.35 -1.5 65.46 NR 50.28 NR
age64 M 10/11/2005 14.17 -10.5 62.4 47.95 37.6 61.13
age65 M 10/11/2005 14.17 -7.5 58.17 37.79 39 51.3
age66 M 10/12/2005 15.72 -4.5 59.4 42.6 39.09 54.36
age67 M 10/12/2005 15.72 -4.5 56.5 45.6 40.1 48
a187 F 7/19/2006 14.56 -7.5 53.8 42.67 47.38 56.86
a188 F 7/19/2006 14.56 NA 42.67 33.4 21.84 47.72
a275 F 12/27/2006 15.95 -4.5 69.67 42.2 36.59 54
a276 F 12/27/2006 15.95 -4.5 NA NA NA NA
a430 M 6/21/2006 14.53 -7.5 63.92 49.35 51.48 73.26
a431 M 6/21/2006 14.53 -1.5 69.78 62.98 52.7 69.98
a432 F 6/21/2006 14.73 -13.5 53.69 50.73 66.48 45.34
Age59 F 9/21/2005 17.92 -4.5 56.38 48.28 41.68 NR
Study Gender Study Date
Age 
(months) VsEP ABR 8k ABR 16k ABR 32k ABR 41.2
age60 F 9/21/2005 17.92 -7.5 85.07 55.72 31.2 68.86
Age68 F 10/21/2005 16.01 -4.5 54.24 67.42 52.53 63.8
Age69 F 10/21/2005 16.01 -1.5 37.5 35.8 51 49.8
a197 M 8/21/2006 17.26 NA 61.58 44.8 63.84 75.11
a229 M 10/23/2006 17.03 NA 43.97 46.19 48.39 NA
a231 M 10/23/2006 17.03 -4.5 NA NA NA NA
a445 F 10/30/2007 16.21 -7.5 38.56 49.1 46.58 69.2
a446 F 10/30/2007 16.21 -7.5 53.2 45.8 53.45 57.34
a447 F 10/30/2007 16.21 -7.5 39 58.36 54 65.7
a448 M 10/30/2007 16.21 -4.5 51 59.2 52.85 71.77
a449 M 10/30/2007 16.21 NA 63.39 45.2 NR NR
Age21 F 5/3/2005 18.18 -4.5 28.61 31.98 16.28 37.39
Age54 M 9/16/2005 19.20 -4.5 71.1 NR 35.6 75.3
Age56 F 9/21/2005 19.36 -4.5 40.85 47.23 44.44 60.9
Age88 F 11/22/2005 18.48 -4.5 64.61 49.98 43.28 73.39
a184 F 7/14/2006 19.46 -4.5 76.66 56.76 46.42 63.92
a232 F 10/24/2006 19.36 NA 44.55 44.75 49 52.44
a450 F 10/31/2007 18.41 NA NR NR NR NR
a451 F 10/31/2007 18.41 -4.5 85.44 76.83 NR 76.3
a452 F 10/31/2007 18.41 -4.5 74.36 70.1 41.19 61.53
a453 F 10/31/2007 18.41 1.5 51.58 NA 53.19 62.9
a454 F 11/1/2007 18.44 -4.5 71.86 83.7 40.7 NR
Age34 M 7/27/2005 20.98 -1.5 73.39 59.25 NR NR
Age35 M 7/27/2005 20.25 -1.5 NR NR NR NR
a198 M 8/21/2006 20.71 -4.5 78.24 NR NR NR
a233 F 10/25/2006 20.12 NA 54.94 22.34 36.54 66.52
a277 M 12/27/2006 21.34 -4.5 42.3 31.65 23.9 53.68
a278 M 12/27/2006 21.34 NA 56 31.26 48.39 NR
a463 M 12/7/2007 20.32 -1.5 49.3 53.9 53.5 75.8
a464 M 12/10/2007 20.42 -4.5 61.68 56.9 62.67 NR
a465 M 12/10/2007 20.42 -4.5 81.25 69.27 NR NR
a466 M 12/10/2007 20.42 NA NR 78.3 NR NR
a123 F 3/6/2006 23.38 -1.5 57.36 48 39 61
a125 F 3/9/2006 23.47 -1.5 65.79 59.95 41.08 76.42
a234 F 10/25/2006 22.75 -4.5 41.2 43.34 47.75 52.24
a235 F 10/25/2006 22.75 -1.5 53.24 43 48 64.13
a258 M 11/22/2006 23.77 -4.5 NA NA NA NA
a284 F 1/3/2007 22.22 NA 44.5 45 22 42.8
a455 F 11/6/2007 22.09 -4.5 46.48 60.54 38.5 67.28
a456 F 11/6/2007 22.09 -1.5 59.86 84.3 60.29 68.2
a457 F 11/6/2007 22.09 1.5 82.4 86.9 NR NR
a458 F 11/7/2007 22.13 -4.5 72.2 NR NR 72.3
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Study Gender Study Date
Age 
(months) VsEP ABR 8k ABR 16k ABR 32k ABR 41.2
a176 F 5/26/2006 1.91 -10.5 45.78 61.5 10.4 71.9
a177 F 5/26/2006 1.91 NA 53.8 57.28 30.07 87.35
a221 F 10/12/2006 1.45 -7.5 18.89 22.7 12.39 42.68
a222 F 10/12/2006 1.45 -7.5 28.66 46.36 35.18 69.83
a238 M 10/27/2006 1.94 -10.5 30.76 32.6 36.88 54.68
a268 F 12/16/2006 1.02 NA 33.35 40.77 NA 55.65
a269 F 12/16/2006 1.02 -13.5 34.24 24.5 12.96 67.58
a270 M 12/18/2006 1.15 -13.5 20 26.3 23.78 55.4
a271 M 12/18/2006 1.15 -10.5 34.96 24.24 25 66.99
a279 M 12/28/2006 1.41 -10.5 43.86 21 23.78 66.36
a280 F 12/28/2006 1.48 -7.5 44.66 33.59 16.97 79.58
a281 F 12/28/2006 1.48 -10.5 57.46 32.94 13.88 67.29
a282 F 12/28/2006 1.48 -7.5 45.57 34.6 10.95 79.58
a296 F 1/19/2007 1.97 NA NA NA NA NA
a297 F 1/19/2007 1.97 -7.5 28 26.5 17 53.38
a298 F 1/19/2007 1.97 -13.5 61.89 51.49 64.37 77.27
a299 F 1/19/2007 1.97 -10.5 50.68 28.68 52.6 84.6
Age3 F 1/6/2005 3.62 -10.5 58.61 43.98 58.28 79.39
Age40 F 8/26/2005 3.95 -10.5 38.4 34.8 73.2 NR
Age41 F 8/26/2005 3.95 -10.5 23.55 13.1 21.89 34.99
Age42 F 8/26/2005 3.95 -7.5 51.25 37.38 54.46 NR
a199 F 8/24/2006 2.17 -13.5 19.52 22.75 26.24 31.29
a200 F 8/24/2006 2.17 -10.5 39 30.67 22.23 40.34
a201 F 8/24/2006 2.17 NA 30.8 18.67 9.76 50.25
a205 M 9/18/2006 2.17 -7.5 30.2 47 31.6 52.39
a206 M 9/18/2006 2.17 NA 38 43.58 19.3 41.27
a207 M 9/18/2006 2.17 -7.5 43.47 43.1 31.86 65.3
a211 F 9/20/2006 2.01 NA 32.43 49.1 14.48 42.68
a212 M 9/20/2006 2.04 NA 28.84 20.1 23.26 65.18
a217 M 10/9/2006 3.45 -10.5 45.13 34.75 26.36 55.07
a218 M 10/9/2006 3.45 NA 40.27 31.26 11.62 66.68
a219 M 10/9/2006 3.45 NA 37.77 29 11.46 67.44
a239 M 10/30/2006 2.63 -13.5 31.39 31.07 37.37 63.9
a240 M 10/30/2006 2.63 -13.5 21.57 21.59 13.35 41.68
a242 M 10/30/2006 2.63 NA 20.8 7.9 13.26 27.47
a305 F 3/21/2007 2.43 -13.5 40.25 19.44 4.9 34.9
a306 F 3/21/2007 2.43 -13.5 40.4 44 24.7 70.3
Age22 F 5/18/2005 4.67 -13.5 52.61 28.98 13.28 73.39
Age43 M 8/30/2005 4.08 -4.5 33.74 16.4 57.43 NR
Age44 M 8/30/2005 4.08 -13.5 26.53 24.57 45 67.4
a111 M 2/27/2006 5.75 NA 31.93 37.19 56.28 NR
a112 M 2/27/2006 5.75 -10.5 44.38 36.28 53.5 81
a113 M 2/27/2006 5.75 -7.5 53.55 33.9 NR 75
a160 M 4/26/2006 4.27 NA 32.11 48.15 28.4 27.3
a161 M 4/26/2006 4.27 -13.5 NA NA NA NA
a202 M 9/14/2006 5.52 -7.5 54.5 47 NR NR
a204 M 9/14/2006 5.52 NA 42.3 21.5 33.2 NR
Study Gender Study Date
Age 
(months) VsEP ABR 8k ABR 16k ABR 32k ABR 41.2
a209 M 9/19/2006 4.01 -13.5 32.3 33.5 23 79
a210 M 9/19/2006 4.01 -13.5 27.4 29.99 9.8 66.88
a272 F 12/19/2006 5.19 -7.5 21.57 39.73 53 75.5
a273 F 12/19/2006 5.19 -13.5 57.86 45.7 57.76 81.68
a213 F 10/5/2006 6.21 -10.5 57.99 55.78 NR NR
a223 M 10/12/2006 6.48 NA 29 19.38 45.7 65.13
a247 M 11/6/2006 6.25 -13.5 38.89 30.3 37.23 68.53
a248 F 11/6/2006 6.25 NA 54.55 42.97 36.17 NR
a254 F 11/13/2006 6.05 NA 29.5 37.9 22.95 56
a255 F 11/13/2006 6.05 -13.5 21.99 25.5 56.19 74.77
a256 M 11/20/2006 6.48 -13.5 42.5 34.07 44 67.14
a257 M 11/20/2006 6.05 -13.5 55.1 44.25 34.87 NR
a263 F 11/27/2006 6.71 -13.5 44.67 33.96 51.66 NR
a264 F 11/27/2006 6.71 -13.5 28.99 40.64 NR 65.4
a334 M 4/25/2007 7.82 -13.5 35.93 33.38 NR NR
a335 M 4/25/2007 7.82 -10.5 49 no data NR NR
a162 M 4/27/2006 8.75 -10.5 69.94 80.18 NR NR
a163 M 4/27/2006 8.75 -10.5 58.7 62.95 NR NR
a164 F 4/28/2006 9.83 -10.5 42.52 56.14 49.24 72.97
a165 F 4/28/2006 9.83 NA 40.47 75.93 NR NR
a166 M 5/3/2006 8.25 -10.5 31.99 48.4 23.62 63.97
a174 M 5/9/2006 9.57 -10.5 43.18 62 NR NR
a175 M 5/9/2006 9.57 -7.5 51.97 58.75 NR NR
a214 F 10/6/2006 9.63 -4.5 23.28 41 63.96 56.78
a215 F 10/6/2006 9.63 -10.5 63.66 41.66 NR NR
a216 F 10/6/2006 9.63 -10.5 46.1 59.43 NR NR
a220 F 10/11/2006 9.24 -10.5 70.29 59.28 NR NR
a312 F 3/28/2007 9.93 -10.5 54.67 46.2 NR NR
Age52 F 9/16/2005 11.21 -4.5 60.23 NR NR NR
a249 F 11/8/2006 10.16 -13.5 45.68 82.52 NR NR
a250 M 11/8/2006 10.16 -13.5 58.44 62.4 NR NR
a251 M 11/8/2006 10.16 -13.5 58.68 61.79 NR NR
a252 M 11/9/2006 10.19 -10.5 44.3 NR NR NR
a253 M 11/9/2006 10.19 -13.5 70.68 48.86 NR NR
a314 M 4/2/2007 10.09 -13.5 41.95 46.86 NR NR
a317 M 4/4/2007 10.16 -13.5 54.06 63.5 NR NR
a318 M 4/4/2007 10.16 -10.5 NR NR NR NR
a319 M 4/4/2007 10.16 -4.5 56.76 51.9 61.49 78.23
a409 F 7/30/2007 10.98 -4.5 76.98 NR NR NR
Age30 F 7/22/2005 12.30 -7.5 68.95 NR NR NR
Age31 F 7/22/2005 12.30 -10.5 NR NR NR NR
Age98 M 12/8/2005 13.94 -13.5 NR NR NR NR
Age99 M 12/8/2005 13.94 -10.5 69.19 NR NR NR
Age100 M 12/8/2005 13.94 -7.5 79.75 NR NR NR
a101 M 12/8/2005 13.94 -7.5 NR NR NR NR
a105 F 2/16/2006 13.87 -7.5 NR NR NR NR
a192 M 7/21/2006 12.53 -10.5 NR NR NR NR
Study Gender Study Date
Age 
(months) VsEP ABR 8k ABR 16k ABR 32k ABR 41.2
a193 M 7/21/2006 12.53 NA 60.46 49.9 NR NR
a316 F 4/4/2007 12.20 -7.5 NR NR NR NR
a346 F 5/7/2007 12.00 -7.5 63.14 NR NR NR
a347 F 5/7/2007 12.00 -7.5 NR NR NR NR
a116 F 3/2/2006 15.25 -10.5 NR NR NR NR
a117 F 3/2/2006 15.25 -10.5 78.62 NR NR NR
a118 F 3/2/2006 15.25 -7.5 NR NR NR NR
a119 F 3/3/2006 14.37 NA NR NR NR NR
a138 M 3/20/2006 14.93 -7.5 76.52 52.5 NR NR
a141 M 3/20/2006 14.93 -10.5 42.96 57.22 NR NR
a144 M 3/22/2006 15.91 NA NR NR NR NR
a145 M 3/22/2006 15.91 -7.5 NA NA NA NA
a146 M 3/23/2006 14.83 -10.5 NR NR NR NR
a148 M 3/23/2006 14.83 -10.5 NR NR NR NR
a189 F 7/20/2006 15.52 -7.5 NR NR NR NR
a190 F 7/20/2006 15.52 -7.5 93.46 NR NR NR
a191 F 7/20/2006 15.52 -7.5 82.79 79.97 NR NR
a106 F 2/23/2006 17.19 -10.5 NR NR NR NR
a107 F 2/23/2006 16.47 -10.5 NR NR NR NR
a134 M 3/20/2006 17.29 -7.5 NA NA NA NA
a135 M 3/20/2006 17.29 -10.5 NR NR NR NR
a136 M 3/20/2006 17.29 -7.5 76.39 NR NR NR
a137 M 3/20/2006 17.29 NA NR NR NR NR
a195 M 8/17/2006 17.10 -7.5 NR NR NR NR
a196 F 8/17/2006 17.10 -7.5 NR NR NR NR
a265 F 11/30/2006 16.87 -10.5 83.55 NR NR NR
a266 F 11/30/2006 16.87 -13.5 90 NR NR NR
a267 F 11/30/2006 16.87 -10.5 85.39 NR NR NR
Age23 F 5/19/2005 19.36 -10.5 NR NR NR NR
Age90 F 11/29/2005 18.84 -10.5 NR NR NR NR
Age91 F 11/29/2005 18.84 -10.5 NR NR NR NR
Age92 F 11/29/2005 18.84 -10.5 NR NR NR NR
Age96 M 12/7/2005 19.10 -10.5 NR NR NR NR
Age97 M 12/7/2005 19.10 -7.5 NR NR NR NR
a109 M 2/24/2006 18.12 -10.5 NR NR NR NR
a115 F 3/2/2006 19.66 -10.5 NR NR NR NR
a120 M 3/3/2006 18.35 -10.5 74.64 NR NR NR
a155 M 4/17/2006 19.82 -10.5 86.23 NR NR NR
Age93 M 12/7/2005 20.55 -10.5 NR NR NR NR
Age94 M 12/7/2005 20.55 -4.5 NR NR NR NR
Age95 M 12/7/2005 20.55 -10.5 NA NA NA NA
a104 M 2/16/2006 21.44 -7.5 NR NR NR NR
a114 F 2/27/2006 20.22 -4.5 NR NR NR NR
a131 M 3/9/2006 20.55 -7.5 NR NR NR NR
a142 F 3/22/2006 21.76 -10.5 NR NR NR NR
a149 F 3/23/2006 21.01 -7.5 NR NR NA NA
a150 F 3/23/2006 21.01 -10.5 NR NR NR NR
Study Gender Study Date
Age 
(months) VsEP ABR 8k ABR 16k ABR 32k ABR 41.2
a158 M 4/25/2006 21.40 -10.5 NR NR NR NR
a159 M 4/25/2006 21.40 -7.5 85.1 NR NR NR
a167 F 5/3/2006 20.35 -10.5 NR NR NR NR
a178 M 5/26/2006 21.11 -7.5 NR NR NR NR
a179 M 5/26/2006 21.11 -7.5 77.53 NR NR NR
a208 M 9/18/2006 21.57 -4.5 NR NR NR NR
a236 F 10/27/2006 20.15 -7.5 NR NR NR NR
a315 F 4/2/2007 20.91 -10.5 NR NR NR NR
a103 F 2/15/2006 22.88 -10.5 NR NR NR NR
a108 F 2/23/2006 23.80 -7.5 NR NR NR NR
a110 M 2/24/2006 23.18 -10.5 NR NR NR NR
a121 M 3/6/2006 22.03 -10.5 NR NR NR NR
a122 M 3/6/2006 22.03 -7.5 NR NR NR NR
a348 F 5/31/2007 22.85 -10.5 NR NR NR NR
C57_2 M 7/23/2006 23.01 -10.5 NA NA NA NA
C57_3 M 7/23/2006 22.13 -7.5 NA NA NA NA
Old2 M 5/24/2006 23.31 -10.5 NA NA NA NA
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APPENDIX C: CE/J ABR and VsEP RAW DATA 
 
Study Gender
Study 
Date
Age 
(months) VsEP ABR 8k ABR 16k ABR 32k ABR 41.2
a382 M 6/29/07 1.15 -7.5 19.75 28.45 44.5 57.54
a395 M 7/20/07 1.12 -7.5 41.9 36.78 62.58 68.65
a396 F 7/23/07 1.22 -4.5 41.7 26.67 60.99 NR
a397 F 7/23/07 1.94 -7.5 55 39.1 66.1 58.76
a398 F 7/23/07 1.94 -7.5 54.9 27.6 62 69.56
a399 F 7/23/07 1.94 -7.5 30.9 39.7 NR NR
a402 F 7/25/07 1.28 -7.5 43.3 29.1 58.95 57.98
a404 F 7/25/07 1.28 -10.5 42.9 28.7 54.75 58.1
a321 M 4/12/07 3.12 -10.5 53.5 26.4 54 71.56
a322 F 4/12/07 3.12 -7.5 54.4 37.95 64.9 71.56
a323 F 4/12/07 3.12 -7.5 31.32 25.24 42.19 70.38
a324 F 4/13/07 3.22 -7.5 63.3 50.89 53.89 65.59
a325 F 4/13/07 3.22 -7.5 39.75 20 48.34 72.2
a326 F 4/13/07 3.22 -10.5 40.86 20 39.67 69.34
a327 M 4/17/07 3.29 -10.5 64.59 26 63 NR
a330 M 4/19/07 3.35 -13.5 29.48 29.13 55.45 72.53
a331 M 4/19/07 3.35 -10.5 52.59 27.86 53.26 70.76
a333 M 4/25/07 3.55 -7.5 77.14 69.3 NR NR
a180 M 6/22/06 5.06 -10.5 46.15 28.11 51.1 55.34
a181 M 6/22/06 5.06 -7.5 26.5 33.34 49.88 63.62
a182 F 7/12/06 5.72 -10.5 47.4 50.2 44.7 58.24
a183 F 7/12/06 5.72 -10.5 38.48 44.25 56.39 77.23
a339 F 4/30/07 5.19 -10.5 41.23 33.55 66 NR
a340 F 4/30/07 5.19 -7.5 53.67 35.15 41.39 68.89
a341 F 4/30/07 5.19 -7.5 41.56 34.56 54.59 72.29
a342 F 4/30/07 5.19 -7.5 42.18 34.15 NR NR
a343 M 5/1/07 4.67 -10.5 40.46 27.1 37.22 67.94
a344 F 5/1/07 5.23 -10.5 41.56 39.16 62.56 74.2
a345 F 5/1/07 5.23 -13.5 31.15 38.48 NR NR
a349 F 6/4/07 7.63 -10.5 49.93 52.98 NR NR
a350 F 6/4/07 7.30 -7.5 30.07 29.89 34.23 55.3
a351 F 6/4/07 7.30 -4.5 41.7 37 61.2 67.5
a352 F 6/4/07 7.30 -7.5 24.33 46.7 39.7 56.23
a353 F 6/4/07 7.30 -10.5 33.2 22.96 41.97 67.78
a354 F 6/5/07 7.23 -13.5 41.18 43.15 60.03 55.65
a355 F 6/5/07 7.23 -7.5 43.18 28.33 NR 70.08
a356 F 6/5/07 7.23 -4.5 75.24 73.3 NR NR
a357 M 6/6/07 7.36 -1.5 82.03 69.7 NR NR
a358 M 6/6/07 7.69 -4.5 41.84 38.58 66.2 72
a359 M 6/7/07 7.40 NA 55.96 38.77 63.67 71.39
a360 M 6/7/07 7.40 -7.5 41.95 39.74 63.98 74.2
a288 M 1/4/06 8.09 -7.5 58 25.3 36.96 NR
a289 M 1/4/06 8.09 -10.5 34.29 25 34 65.4
a328 M 4/18/07 9.60 -7.5 52 62.94 60.5 NR
a361 M 6/13/07 9.27 -7.5 53.95 27.46 NR NR
a362 F 6/13/07 9.27 -7.5 31.28 43.48 49.41 71.89
a363 F 6/13/07 9.27 -4.5 42.61 41.49 60.69 71.72
Study Gender
Study 
Date
Age 
(months) VsEP ABR 8k ABR 16k ABR 32k ABR 41.2
a364 F 6/13/07 9.27 -4.5 67.66 52.38 NR NR
a365 M 6/14/07 9.30 -7.5 NR 75.72 NR NR
a405 M 7/27/07 8.09 NA 43.7 27.9 49.29 74.3
a406 M 7/27/07 8.09 -4.5 55.6 44.27 NR NR
a373 M 6/25/07 11.01 -4.5 55.72 51.06 NR NR
a374 M 6/25/07 11.01 1.5 55.98 40.64 NR NR
a371 M 6/25/07 11.01 -4.5 41.24 38.74 NR NR
a372 M 6/25/07 11.01 -4.5 55.37 71.15 67.64 NR
a375 M 6/25/07 11.01 -1.5 79.72 72.16 NR NR
a376 M 6/25/07 11.01 -4.5 44.3 53.89 56 73.08
a377 F 6/26/07 11.05 -4.5 78.85 74.35 66.58 NR
a378 F 6/27/07 11.08 -4.5 55.74 38.48 NR NR
a379 F 6/27/07 11.08 -1.5 56 25.46 51.58 66.66
a380 M 6/27/07 10.62 -4.5 31.4 44.93 NR NR
a381 M 6/27/07 10.62 -1.5 56.55 53.89 58.09 NR
a429 F 8/8/07 11.51 -4.5 54.57 61.67 NR NR
a368 F 6/22/07 13.05 1.5 80.36 61.09 NR NR
a369 F 6/22/07 13.05 -4.5 64.66 50.15 62.46 71.03
a366 M 6/18/07 12.49 NA 53.84 71 NR NR
a367 M 6/18/07 12.49 -7.5 62 31.58 63.18 NR
a400 F 7/25/07 12.00 -1.5 54.97 53.36 NR NR
a425 M 8/22/07 12.46 -4.5 68.16 71.58 67.1 NR
a426 M 8/22/07 12.46 -7.5 51.5 49.24 NR NR
a428 M 8/22/07 12.46 -4.5 51.5 49.24 NR NR
a467 F 12/13/07 12.10 1.5 47.3 52.6 NR NR
a468 M 12/13/07 12.10 -4.5 66 64.8 NR NR
a469 F 12/17/07 12.23 -7.5 61.6 67.3 49.7 NR
a470 F 12/17/07 12.23 -4.5 49.9 43.5 NR 72.8
a320 F 4/11/07 14.70 -1.5 79 65.8 62.8 NR
a329 M 4/18/07 14.93 -1.5 62.49 51.5 66.59 NR
a384 M 7/9/07 14.14 1.5 67.32 53.87 NR NR
a385 F 7/9/07 14.14 -4.5 83.92 80.68 NR NR
a386 F 7/9/07 14.14 -1.5 68.2 74.67 NR NR
a387 F 7/9/07 14.14 -4.5 75.95 75.46 NR NR
a389 M 7/11/07 14.20 -1.5 NR NR NR NR
a390 M 7/11/07 14.20 NA NR 75.65 NR NR
a391 M 7/11/07 14.20 4.5 75.88 NR NR NR
a392 M 7/12/07 14.93 -4.5 54.98 53.85 63.86 66.56
a393 M 7/12/07 14.93 -4.5 NR NR NR NR
a435 F 10/10/07 16.04 -1.5 NR NR NR NR
a436 F 10/10/07 16.04 -1.5 NR NR NR NR
a437 M 10/10/07 16.04 -7.5 NR NR NR NR
a438 M 10/12/07 16.11 -1.5 NR NR NR NR
a439 M 10/12/07 16.11 -4.5 NR NR NR NR
a440 M 10/12/07 16.11 -1.5 NR NR NR NR
a441 M 10/16/07 16.24 -7.5 NR NR NR NR
a442 M 10/16/07 16.24 -7.5 67 76.73 NR NR
Study Gender
Study 
Date
Age 
(months) VsEP ABR 8k ABR 16k ABR 32k ABR 41.2
a443 M 10/16/07 16.24 -7.5 NR 81.2 NR NR
km2 F 1/18/08 16.37 NA NR NR NR NR
km3 F 1/25/08 16.60 1.5 NR NR NR NR
km4 F 1/25/08 16.60 -1.5 71.6 77.5 NR NR
a444 F 10/29/07 18.51 -7.5 NR NR NR NR
km5 M 3/20/08 18.67 NA NA NA NA NA
km6 M 3/20/08 18.67 NA NA NA NA
km7 F 3/30/08 19.00 1.5 NA NA NA NA
km8 M 3/30/08 19.00 -1.5 NA NA NA NA
km9 M 3/30/08 19.00 -4.5 NA NA NA NA
km12 M 4/24/08 20.38 NA NR NR NR NR
km13 4/24/08 20.38 NA NA NA NA NA
km14 M 5/2/08 20.65 -1.5 NA NA NA NA
km15 M 5/3/08 20.42 1.5 98 83 NR NR
km16 M 5/3/08 20.42 NA NA NA NA NA
km18 M 5/7/08 20.25 -1.5 NR NA NA NA
km19 M 5/8/08 20.28 1.5 NR NR NR NR
km20 M 5/8/08 20.58 NA NA NA NA NA
km21 M 5/8/08 20.58 -4.5 NA NA NA NA
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Study Gender DOB Study Date Age (months) VsEP ABR 8k ABR 16k ABR 32k ABR 41.2
a411 F 04/18/07 08/01/07 3.45 -4.5 NR NR NR NR
a412 F 04/18/07 08/01/07 3.45 -7.5 NR NR NR NR
a413 F 04/18/07 08/02/07 3.48 -7.5 NR NR 69.45 NR
a414 F 04/18/07 08/02/07 3.48 -7.5 63.6 NR NR NR
a422 M 04/18/07 08/08/07 3.68 -10.5 NR NR NR NR
a424 M 04/18/07 08/15/07 3.91 -7.5 NR NR NR NR
a274 M 07/31/06 12/21/06 4.70 -7.5 NR NR NR NR
a313 F 07/31/06 03/28/07 7.89 -10.5 72 NR NR NR
a415 M 11/02/06 08/06/07 9.11 -7.5 NR NR NR NR
a416 M 11/02/06 08/06/07 9.11 NA NR NR NR NR
a417 F 11/02/06 08/07/07 9.14 -10.5 NR NR NR NR
a418 F 11/02/06 08/07/07 9.14 NA NR NR NR NR
a419 F 11/02/06 08/07/07 9 14 7 5 NR NR 64 4 NR. - . .
a420 M 11/02/06 08/07/07 9.14 -7.5 NR NR 64.2 NR
a421 M 11/02/06 08/07/07 9.14 -7.5 NR NR NR NR
a459 M 01/10/07 11/09/07 9.96 -1.5 NR NR NR NR
a460 M 01/10/07 11/09/07 9.96 -4.5 NR NR NR NR
a461 M 01/10/07 11/09/07 9.96 -7.5 NR NR NR NR
a462 F 01/10/07 11/10/07 9.99 -10.5 NR NR NR NR
a407 F 07/31/06 07/30/07 11.97 -10.5 NR NR NR NR
a408 M 08/14/06 07/30/07 11.51 NA NR NR NR NR
a410 M 07/31/06 07/30/07 11.97 -4.5 NR NR NR NR
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APPENDIX E: CBA/CaJ DPOAE AVERAGE AMPLITUDES BY AGE GROUP  
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floor
5.77 -11.09 -7.25 -4.43 -0.96 0.71 -7.93 -7.25 -11.05 -5.43 -9.77 -16.57 -12.54 -22.23
6.75 -2.64 -5.18 -4.25 2.40 4.42 1.72 -1.61 -10.23 -2.75 -7.57 -18.92 -4.83 -22.33
7.56 5.83 6.55 2.90 11.56 8.10 13.37 8.01 0.64 9.10 -1.52 -4.63 4.33 -17.76
8.94 13.35 13.77 10.45 17.61 14.64 18.59 8.59 7.97 14.58 6.92 2.46 14.06 -18.74
10.04 18.64 13.30 10.66 20.47 9.57 15.67 13.00 12.08 15.13 6.70 2.86 14.03 -14.98
11.02 11.86 1.38 10.11 14.89 4.47 3.69 4.78 8.68 5.72 -5.60 0.49 6.30 -17.05
11.74 21.14 9.74 14.68 16.05 14.20 15.64 20.72 16.91 4.84 -1.37 3.74 -0.37 -16.80
13.42 33.65 25.08 25.93 28.41 28.83 34.89 34.61 27.29 24.11 16.89 10.57 15.36 -17.43
14.51 37.13 25.11 27.42 28.80 28.95 32.28 31.77 32.50 26.43 18.03 18.98 19.82 -18.09
15.70 34.16 24.92 25.70 24.88 21.34 23.69 24.76 27.01 21.93 21.50 13.64 21.49 -17.06
17.89 35.10 27.24 25.90 26.68 21.30 28.26 28.13 18.09 19.50 21.11 5.35 19.78 -15.36
18.98 34.88 26.42 21.83 25.76 17.76 23.54 20.92 26.92 15.46 21.43 17.28 18.43 -16.29
21.26 17.45 6.27 9.31 9.27 8.81 4.86 9.37 13.33 1.64 5.10 19.81 2.84 -15.25
23.46 18.53 -1.54 9.80 -0.84 9.12 17.73 18.56 18.49 4.28 1.94 11.27 -1.14 -17.29
24 64. 15 09. 5 40. 11 08. 5 77. 9 13. 10 67. 14 13. 19 73. 9 20. 7 05 9 06 1 49 18 21. . . - .
26.83 15.91 15.26 7.82 20.86 10.98 2.51 -2.25 13.07 6.56 7.08 12.85 -0.37 -17.51
29.02 22.24 21.49 12.25 20.88 18.49 9.87 9.29 16.55 14.69 9.47 11.31 3.76 -17.55
31.22 9.58 9.95 0.04 5.82 6.74 9.64 18.47 10.00 -0.73 3.24 2.76 4.74 -17.32
33.59 10.59 4.61 2.67 4.28 7.99 13.01 15.17 2.88 1.06 4.46 -8.16 -0.92 -17.81
35.78 4.55 1.74 -1.61 6.27 4.99 5.48 8.79 -2.41 -2.70 0.66 -8.39 6.61 -17.35
38.95 7.47 4.49 -0.84 4.78 0.83 8.64 -3.91 2.12 -7.69 -3.58 -3.71 1.52 -16.50
41.26 5.13 1.18 -3.73 6.47 0.56 6.47 -1.21 2.83 1.88 1.13 -9.10 -1.70 -18.03
43.54 2.48 -6.01 -5.78 -6.69 -1.43 2.56 -0.92 -2.52 -2.05 -6.91 -2.43 -1.06 -19.22
46.02 -2.00 -12.28 -6.92 -11.69 -7.69 -10.03 -5.24 -0.59 -8.99 -14.18 -9.31 -11.63 -18.44
47.61 -7.74 -9.77 -8.28 -12.84 -10.19 -7.15 -9.50 2.60 -9.82 -14.34 -9.37 -10.18 -19.24
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APPENDIX F: C57BL/6J DPOAE AVERAGE AMPLITUDES BY AGE GROUP 
 
Geometric Me
Frequen
an 
cy <2 Months M
2-3 
onths
4-5
Months
 6
Month
-7 
s Mon
8-9 
ths
1
Mo
0-11 
nths M
12-13 
onths
14-15
Months
 16-1
Month
7 
s
18
Mon
-19 
ths
20-21 
Months
22-23 
Months
Mean noise 
floor
5.77 -11.09 -7.25 -4.43 -0.96 0.71 -7.93 -7.25 -11.05 -5.43 -9.77 -16.57 -12.54 -22.23
6.75 -2.64 -5.18 -4.25 2.40 4.42 1.72 -1.61 -10.23 -2.75 -7.57 -18.92 -4.83 -22.33
7.56 5.83 6.55 2.90 11.56 8.10 13.37 8.01 0.64 9.10 -1.52 -4.63 4.33 -17.76
8.94 13.35 13.77 10.45 17.61 14.64 18.59 8.59 7.97 14.58 6.92 2.46 14.06 -18.74
10.04 18.64 13.30 10.66 20.47 9.57 15.67 13.00 12.08 15.13 6.70 2.86 14.03 -14.98
11.02 11.86 1.38 10.11 14.89 4.47 3.69 4.78 8.68 5.72 -5.60 0.49 6.30 -17.05
11.74 21.14 9.74 14.68 16.05 14.20 15.64 20.72 16.91 4.84 -1.37 3.74 -0.37 -16.80
13.42 33.65 25.08 25.93 28.41 28.83 34.89 34.61 27.29 24.11 16.89 10.57 15.36 -17.43
14.51 37.13 25.11 27.42 28.80 28.95 32.28 31.77 32.50 26.43 18.03 18.98 19.82 -18.09
15.70 34.16 24.92 25.70 24.88 21.34 23.69 24.76 27.01 21.93 21.50 13.64 21.49 -17.06
17.89 35.10 27.24 25.90 26.68 21.30 28.26 28.13 18.09 19.50 21.11 5.35 19.78 -15.36
18.98 34.88 26.42 21.83 25.76 17.76 23.54 20.92 26.92 15.46 21.43 17.28 18.43 -16.29
21.26 17.45 6.27 9.31 9.27 8.81 4.86 9.37 13.33 1.64 5.10 19.81 2.84 -15.25
23.46 18.53 -1.54 9.80 -0.84 9.12 17.73 18.56 18.49 4.28 1.94 11.27 -1.14 -17.29
24 64. 15 09. 5 40. 11 08. 5 77. 9 13. 10 67. 14 13. 19 73. 9 20. 7 05 9 06 1 49 18 21. . . - .
26.83 15.91 15.26 7.82 20.86 10.98 2.51 -2.25 13.07 6.56 7.08 12.85 -0.37 -17.51
29.02 22.24 21.49 12.25 20.88 18.49 9.87 9.29 16.55 14.69 9.47 11.31 3.76 -17.55
31.22 9.58 9.95 0.04 5.82 6.74 9.64 18.47 10.00 -0.73 3.24 2.76 4.74 -17.32
33.59 10.59 4.61 2.67 4.28 7.99 13.01 15.17 2.88 1.06 4.46 -8.16 -0.92 -17.81
35.78 4.55 1.74 -1.61 6.27 4.99 5.48 8.79 -2.41 -2.70 0.66 -8.39 6.61 -17.35
38.95 7.47 4.49 -0.84 4.78 0.83 8.64 -3.91 2.12 -7.69 -3.58 -3.71 1.52 -16.50
41.26 5.13 1.18 -3.73 6.47 0.56 6.47 -1.21 2.83 1.88 1.13 -9.10 -1.70 -18.03
43.54 2.48 -6.01 -5.78 -6.69 -1.43 2.56 -0.92 -2.52 -2.05 -6.91 -2.43 -1.06 -19.22
46.02 -2.00 -12.28 -6.92 -11.69 -7.69 -10.03 -5.24 -0.59 -8.99 -14.18 -9.31 -11.63 -18.44
47.61 -7.74 -9.77 -8.28 -12.84 -10.19 -7.15 -9.50 2.60 -9.82 -14.34 -9.37 -10.18 -19.24
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APPENDIX G: CE/J DPOAE AVERAGE AMPLITUDES BY AGE GROUP 
18 98 15 49 10 85 16 29
Geometric 
mean 
frequency
<2 
Months
2-3 
Months
4-5 
Months
6-7 
Months
8-9 
Months
10-11 
Months
12-13 
Months
14-15 
Months
16-17 
Months
Mean 
noise 
floor
5.77 -12.89 -18.72 -17.01 -14.87 -16.22 -16.92 -14.42 -15.70 -15.22 -22.23
6.75 -14.80 -15.63 -12.24 -10.37 -14.26 -8.18 -6.85 -14.33 -14.07 -22.33
7.56 -4.22 -6.08 -3.45 -1.10 -7.85 -2.03 -5.65 -6.99 -9.26 -17.76
8.94 9.35 -5.03 3.83 2.55 -0.59 -1.56 -2.08 -3.16 -11.25 -18.74
10.04 5.90 -3.41 2.16 7.34 -2.12 0.82 1.64 1.40 -7.15 -14.98
11.02 -6.68 -8.53 -3.28 -5.70 -12.37 -11.42 -6.47 -10.95 -11.87 -17.05
11.74 1.16 -5.11 1.92 -3.25 -7.05 -5.23 -7.11 -7.75 -11.88 -16.80
13.42 16.87 4.00 10.55 9.65 5.06 2.03 3.11 5.67 -3.56 -17.43
14.51 19.79 3.91 10.21 9.61 6.43 9.64 5.08 5.40 -9.06 -18.09
15.70 18.06 2.52 8.40 8.94 6.47 8.15 3.37 6.61 -9.08 -17.06
17.89 18.91 1.71 9.55 7.21 2.52 3.25 -1.61 0.62 -12.08 -15.36
. . 0 47- . 2 12. 0 93. 2 39. 0 37- . 2 19- . 5 63- . - . - .
21.26 -7.82 -12.54 -11.10 -14.41 -9.59 -12.82 -11.96 -14.57 -13.54 -15.25
23.46 -5.62 -16.51 -10.49 -15.38 -15.62 -13.48 -14.09 -11.52 -14.08 -17.29
24.64 -3.55 -17.04 -6.88 -16.37 -12.22 -13.98 -14.37 -15.07 -16.55 -18.21
26.83 3.26 -0.55 -0.82 -11.26 -7.16 -6.97 -9.50 -11.29 -11.25 -17.51
29.02 14.40 2.14 -1.20 -3.82 -5.18 -2.18 -2.53 0.94 -11.06 -17.55
31.22 11.12 -12.33 -8.40 -15.30 -12.94 -12.17 -13.36 -10.64 -14.59 -17.32
33.59 0.47 -11.46 -7.26 -6.91 -10.36 -14.09 -13.47 -13.14 -17.59 -17.81
35.78 2.58 -14.24 -12.66 -5.21 -12.09 -5.88 -11.19 -11.39 -14.66 -17.35
38.95 -7.59 -12.12 -13.60 -19.24 -13.13 -11.32 -13.71 -15.93 -17.07 -16.50
41.26 -17.01 -14.49 -14.76 -15.98 -14.84 -18.66 -14.05 -17.96 -18.58 -18.03
43.54 -12.51 -14.22 -13.58 -17.90 -15.01 -17.79 -14.09 -19.18 -19.21 -19.22
46.02 -13.58 -15.28 -17.06 -15.81 -13.46 -16.34 -13.16 -17.91 -18.75 -18.44
47.61 -15.13 -16.70 -16.93 -15.79 -13.39 -19.49 -16.06 -19.77 -22.46 -19.24
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APPENDIX H. CHEMICAL RECIPES 
  
4% Paraformaldehyde, 2% Glutaraldehyde in 0.1 M PB 
 
   Desired Final Volume 
 
Ingredients 50 mL 100 mL 250 mL 500 mL 1000 mL 
Sodium Phosphate 
(monobasic) 
0.13 g 0.26 g 0.66 g 1.31 g 2.62 g 
Sodium Phosphate 
(dinobasic 
Heptahydrate)) 
1.09 g 2.17 g 5.43 g 10.85 g  21.70 g 
Distilled water See directions for 
appropriate 
volumes 
See directions for 
appropriate 
volumes 
See directions for 
appropriate 
volumes 
See directions for 
appropriate 
volumes 
See directions for 
appropriate 
volumes 
Paraformaldehyde 2.00 g 4.00 g 10.00 g 20.00 g 40.00 g 
2N NaOH 0.50 mL 1.00 mL 2.50 ml 5.00 mL 10.00 mL 
50% 
Glutaraldehyde 
1.00 mL 2.00 mL 5.00 mL 10.00 mL 20.00 mL 
 
Directions 
1. Dissolve sodium phosphate(monobasic) and sodium phosphate (dibasic heptahydrate) in distilled water. 
2. Bring to volume with distilled water (1/2 total expected volume, e.g. 500mL for 1L 4% paraformaldehyde, 1% 
glutaraldehyde in 0.1 M PB).  Label this solution 0.2 M PB. 
3. Add 40g paraformaldehyde to 450 ml distilled water. 
4. Heat solution to 55-60ºC on a hot stirring plate. 
5. Add drops of 1M NaOH until solution clears, then filter.  (usually ~10mL per 1L) 
6. Add 500ml of 0.2M PB, pH 7.4 for 1L total volume. 
7. Add 20ml of 50% gluteraldehyde (or 40mL if using 25% gluteraldehyde) 
8. Dilute with distilled water to 1L.  Bring to room temperature before proceeding. 
9. Adjust pH to 7.2-7.4 with either NaOH or HCL. 
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APPENDIX I. ANIMAL CARE AND USE APPROVAL LETTER 
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APPENDIX J. LIST OF EQUIPMENT MANUFACTURERS AND ADDRESSES 
 
 
Systems Division - Anatech USA 
21363 Cabot Blvd. 
Hayward, CA 94545  
Toll Free: 800-390-4449 
Tel: 510-732-6961 
Fax: 510-732-6971 
E-mail: tawatts@anatechusa.com 
 
BAL-TEC AG 
Neugruet 7 
FL-9496 Balzers 
Principality of Liechtenstein 
Tel. +423 3881 212 
Fax +423 3881 260 
 
Brüel & Kjær Sound & Vibration Measurement A/S 
Skodsborgvej 307 
DK-2850 Nærum     
Denmark 
Phone: +45 4580 0500 
Fax: +45 4580 1405 
 
Endevco Corporation 
30700 Rancho Viejo Rd. 
Juan Capistrano, CA 92675 San  
Phone: 1-888-ENDEVCO 
 
Etymotic Research, Inc. 
61 Martin Lane 
Elk Grove Village, IL 60007 USA  
Phone: 847-228-0006 
Toll-free 1-888-Etymotic (1-888-389-6684)  
Fax: 847-228-6836 
 
FEI Corporation 
North America NanoPort 
5350 NE Dawson Creek Drive 
Hillsboro, Oregon 97124 USA 
Phone: +1 (503) 726-7500 
Sales: +1 (503) 726-7500 
Sales Fax: +1 (503) 726-2615 
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FHC Inc.  
1201 Main Street 
Bowdoin, ME 04287 
Tel: 207-666-8190, Canada & US 1-800-326-2905, 
Fax: 207-666-8292 
email: fhcinc@fh-co.com 
 
 
Grass TechnologiesA 
Astro-Med Industrial Park 
600 East Greenwich Avenue  
West Warwick, RI 02893 U.S.A.  
phone: 401-828-4000 . fax: 401-822-2430 
toll-free: 1-877-472-7779 (U.S.A. & Canada only) 
e-mail: grass@astromed.com  
web site: www.GrassTechnologies.com 
 
Hewlett Packard Corporation 
20555 SH 24P 
Houston, Tx 
Phone: 281-370-0670 
Fax: 281-514-1740 
 
Labworks, Inc. 
2950 Airway, Ave., #A-16 
Costa Mesa, CA  92626 
U.S.A.Phone: (714) 549-1981 
Fax: (714) 549-8041 
 
Peavey Electronics Corporation 
5022 Hartley Peavey Drive 
Meridian, MS 39305 
Customer Phone: 601-483-5365 
Fax: 601-486-1278 
 
Stanford Research Systems 
1290-D Reamwood Avenue 
Sunnyvale, CA 94089 
Phone (408) 744-9040 
Fax (408) 744-9049 
Email: info@thinkSRS.com 
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Tucker Davis Technologies 
11930 Research Circle  
Alachua, FL 32615  
USA 
Phone: 386.462.9622 
Fax: 386.462.5365 
E-mail: info@tdt.com 
 
Vibra-metrics 
195 Clarksville Road 
Princeton Jct, NJ 08550 
USA    
Phn: +1 609.716.4130 
Fax: +1 609.716.0706 
 236
APPENDIX K. AVERAGE NOISE LEVELS IN ANIMAL HOUSING. 
Average noise amplitude (dB SPL) plotted against the time of day in the animal housing 
area. There were 48 noise samples, comprised of 16 hour periods, taken on random days 
over a five month period. The data logging dosimeter had a minimum level of 65 dB 
SPL, any sound level measured that was lower than 65 dB was given a 65 db SPL value. 
Each data point represents the mean SPL for ten one minute samples. The logarithmic 
mean SPL for all samples was 66.8 dB SPL. 
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